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SUMMARY
Exercise rehabilitation is now widely used in cardiac disease as a means 
of attaining and even exceeding the pre-morbid functional state and level of 
physical activity.
This is a study of exercise rehabilitation after coronary artery surgery. 
The main aim was to compare the efiects of aerobic exercise training with those 
o f power or strength exercise training on aspects of cardiovascular function. 
There are few reports on power exercise training in previously untrained 
cardiac patients. In this study, exercise performance on a treadmill was the 
primary variable measured. Others were physical changes, arrhythmias, ST 
segments, haemostatic factors, lipids and lipoproteins, left ventricular function 
and myocardial perfusion. Efiects of the programme that were not assessed 
include psychological factors, general wellbeing, employment status, dietary 
and smoking habits.
Eighty one men were studied. Their mean age was 56 years (range 35 
to 70 years). They were assessed at baseline, three months and six months. 
After baseline measurenents, they were randomised to three groups. The 
control group (n — 27) had no formal exercise training. The aerobic group (n 
— 27) had six months’ graduated supervised aerobic exercise training. The 
power group (n =  27) had six months’ graduated supervised power (strength) 
exercise training using circuit weight training.
The exercise sessions lasted 1 2 - 6 0  minutes and were held three times 
a week in a specially equipped gymnasium. They were supervised by a
13
physiotherapist, cardiac rehabilitation sister and a physician. No cardiovascular 
monitoring took place.
All measurements were done at each assessment except Thallium-201 
scintigraphy and gated technetium scans which were done at baseline and six 
months. All results were initially analysed by analysis of variance and Scheffe 
test. The appropriate test of significance (Student’s t-test, Mann-Whitney test 
or Wilcoxon test) was then employed when indicated.
In the aerobic group, there was a clear improvement in treadmill 
performance after three months (baseline 650.5s, three months 780.8s, 
p =  0.004); it was maintained at six months (846.9s, p <0.0001). In the 
power group, significant improvement was delayed until six months (baseline 
784.2s, three months 867.3s, six months 906.8s, p =  0.007). The control 
group showed no significant change (baseline 683.8s, three months 718.2s, six 
months 710.8s).
These improvements in exercise performance were not accompanied by 
significant changes in myocardial oxygen consumption as measured by 
submaximum and peak rate pressure product. Submaximum heart rate in the 
power group was lowered by training. There were no changes in the exercise 
electrocardiogram.
Body weight, body mass index and skin fold thickness showed variable 
responses. The power group showed the greatest fall in skin fold thickness, 
with no change in body weight and body mass index. This could have been due 
to muscle toning. The aerobic group gained weight, but their skin fold 
thickness also fell, and this may represent an increase in lean body mass. The
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control group gained weight with no change in skin fold thickness.
Lipids, lipoproteins and apolipoproteins were unchanged. There was a 
significant fall in fibrinogen level in the aerobic group, and a small fall in 
factor VII in the power group. This is in keeping with the inverse relationship 
found between physical activity and fibrinogen levels.
Global left ventricular function at rest and after cold pressor stress was 
not changed by exercise training. In the aerobic group, there was an 
improvement in regional ejection fraction in the anterior zone in those with 
previous anterior myocardial infarction. In the power group, there was shorter 
systolic length at rest, shorter fast filling time at rest and after cold pressor, 
following the training period.
Myocardial perfusion was assessed by thallium-201 scintigraphy and 
circumferential profile analysis. The control group had smaller degrees of 
abnormality in the anterior view than the exercise groups at baseline. This 
increased at six months, while that in the aerobic group changed little and that 
in the power group decreased. In subgroup analysis, those with anterior 
myocardial infarction in the aerobic group showed smaller degrees of 
abnormality in washout profiles on the six month scans than the other two 
groups. This was in the anteroseptal regions, the 45<> LAO and 65<> LAO views 
and global washout, but the 95% confidence intervals of these changes do 
include zero.
On twenty four hour ambulatory Hotter monitoring, the following 
changes were observed. Minimum and mean heart rates were significantly 
lower after both exercise training programmes. There were no changes in
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maximum heart rate, ventricular ectopic activity, or ST segment analyses for 
total ischaemic burden.
On M-mode echocardiography, no clinically significant changes occurred 
in cardiac dimensions. Paradoxical septal motion was observed in a number of 
patients. In some, it resolved with time and exercise training. Left ventricular 
mass was reduced by exercise training, contrary to previous studies.
In conclusion, mean heart rate, exercise performance and haemostatic factors 
were influenced positively by exercise training after coronary artery surgery. 
Power (strength) training was safe and beneficial in these previously untrained 
cardiac patients. The other aspects of cardiovascular function were not affected 
to any clinically relevant extent by aerobic or power exercise training.
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SECTION I
PLAN OF THESIS
The thesis is laid out in sections. The first part relates to introductory 
background information, rationale for the study, the protocol, statistics and 
calculation of the number of subjects required. The exercise programmes and 
interventions are discussed next.
In the second part (sections VII to XIV), the sections are self-contained 
with methods, results, discussion and review of the literature relating to that 
particular aspect of the study. Where relevant, links between the sections are 
discussed.
Finally in a general discussion the main findings are highlighted, 
limitations of the study are considered and suggestions for future studies are 
proposed. This is followed by the list of references and a list of abbreviations. 
The appendix is a copy of ARSAC permission for the use of radionuclides in 
the study.
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SECTION n
INTRODUCTION
CORONARY ARTERY BYPASS SURGERY
The main benefit of coronary artery surgery is the relief of angina. This 
is particularly pertinent in those in whom medical therapy has failed. 
Symptomatic relief is reported in up to 90% of patients in the first post­
operative year (Frick 1976; Mnayer et al 1977; Rogers et al 1990; Booth et al 
1991). It is the direct result of bypass of obstructive coronary arteiy lesions, 
myocardial revascularisation and relief of ischaemia.
Coronary artery bypass, grafting (CABG) had been performed in 1964 
with follow-up of the patient reported in 1973 (Garrett et al). Favaloro 
described the operative technique involving the use of reversed autologous 
saphenous veins (1968). There has been an exponential rise in CABG since 
then. (Killip 1988; Rutherford & Braunwald 1988; ACC/AHA guidelines 
1991). Techniques have improved and operative mortality has fallen to 
1 - 1.5% in low risk patients. The symptomatic benefit it confers should mean 
that previously disabled patients can resume normal activities, including full­
time employment, with socioeconomic gain. This expectation has not been 
borne out in practice (Oakley 1987; Channer et al 1988; Allen 1990).
In a selected subgroup of patients, coronary artery surgery (CAS) also 
prolongs life. In the Veterans’ Administration Coronary Artery Bypass Surgery 
Cooperative Study (1984), 686 patients were randomised to medical or surgical
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therapy. After sub-group analysis, patients with left main coronary artery 
stenoses, triple vessel disease and impaired left ventricular (LV) function fared 
better with surgery. After 11 years’ follow-up no distinct surgical advantage 
was found overall in those without left main stem disease, with survival of 58% 
in both medical and surgical groups (Rutherford & Braunwald 1988).
In the European Coronary Surgery Study (ECSS), 768 patients were 
randomised. Surgically treated patients with triple vessel disease survived 
better initially. All had good left ventricular function. At five years, survival 
in the surgical group was 92.4% and in the medical group, 83.1%, At 12 
years, the survival curves tended to converge, with 70.6% survival in the 
surgical group and 66.7% survival in the medical group (ECSS group 1982; 
Vamauskas & ECSS group 1988).
In the Coronary Artery Surgery Study (CASS), 780 patients were 
randomised. The patients were a low risk group with a good prognosis. At ten 
years, there was no survival advantage for surgery in the total group, with 
survival rate of 82% in surgical group and 79% in the medical group (Alderman 
et al 1990). Patients with proximal left anterior descending (LAD) lesions, or 
triple vessel disease and ejection fraction less than 0,50 had a better prognosis 
if treated surgically (Passamani et al 1985; Holloway & Schocken 1988; Myers 
et al 1989; Chaitman et al 1990).
These trials were started between 1972 and 1979. The differences in the 
results have been explained in various ways: different patient populations, 
decreasing operative mortality, improved operative techniques, improved 
medical management and new drugs. The general conclusions from the trials
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are nevertheless the same. Surgery improves prognosis in symptomatic patients 
with left main stem disease, triple vessel disease, proximal LAD disease, and 
impaired LV function. There is some evidence that those with abnormal resting 
ECG, positive exercise test, and older patients also improve (Hampton 1984; 
Ryan 1987; Gersh et al 1989). Symptomatic and prognostic benefit decrease 
with time. In the CASS, the proportion of asymptomatic patients in the 
surgically treated group fell from 66% to 63% and 47% at one, five and 10 
years’ follow-up (Rogers et al 1990).
Since these trials there has been a change in the type of patient 
undergoing CAS. They are older, have more severe disease, poor LV function 
and concomitant conditions such as diabetes (McIntosh & Garcia 1978; 
Christakis et al 1989; Califf et al 1989; Jones et al 1991). In general, patients 
with triple vessel disease and good LV function have five-year survival rate of 
90% and 10-year survival rate of 50 -70%  (Wheatley 1988).
CAS has not been shown to prevent subsequent myocardial infarction 
(Lipton et al 1986; Little et al 1990; Alderman et al 1990).
Graft failure occurs at the rate of 15-30% in the first year and at 1-3% 
per year thereafter, increasing sharply after 5-7 years to 3-12% per year. 
(Verstraete et al 1986; During & Hennekens 1990; Lipton et al 1990; 
Gavaghan et al 1991). Graft failure may be due to technical problems such as 
poor distal vessel run-off, thrombosis, intimai fibromuscular hyperplasia, or 
atheroma formation (Fetch 1991). Early failure is mainly the result of surgical 
difficulties and poor calibre vessels (FitzGibbon et al 1978) whereas late 
occlusions are due to atheroma (Fuster & Chesebro 1986). Attention to risk
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factor modification may help to reduce graft attrition (Fox et al 1987).
Re-operations may not yield ideal results and should be delayed if 
possible (de Fey ter et al 1985). Hacker et al (1988) suggest that repeat CAS 
should not be witheld for technical reasons as the potential benefit is similar to 
the that of primary operation. The immediate operative risk of 200 repeat 
operations was 7 - 12%, but survivors did well subsequently (Verheul et al 
1991). Patients for repeat CAS need to be carefully selected.
There has been a marked increase in the use of internal mammary artery 
(IMA) grafts, with associated excellent outcome in terms of graft function and 
prognosis (Tector et al 1981; Gibson & Loop 1986; Tector et al 1986; Lytle 
1988; Loop 1987). Internal mammary artery grafts are more resistant to 
occlusion than are saphenous vein grafts (Cameron & Walker 1990).
Ten-year patency rates of 90% are reported (Gibson & Loop 1986). Their use 
has improved the outlook of CAS patients. Five-year survival rate in 179 
patients with IMA grafts was 98.9% (Proudfit et al 1988). During 15 years’ 
follow-up of 748 patients of whom 532 had one or two IMA grafts, survival 
was better in those with IMA grafts than in those with vein grafts alone. They 
had less recurrence of angina, fewer myocardial infarctions and re-operations 
(Cameron et al 1986).
Anti platelet drugs are universally recommended after CAS to reduce the 
occurrence of occlusions, and have been subjected to several randomised studies 
(Chesebro et al 1982; Chesebro et al 1984; Brown et al 1985; Goldman et al 
1988; Gershlick et al 1988; Sanz et al 1990; Gavaghan et al 1991). It is 
thought that activated platelets are mediators of both early thrombosis and later
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atherogenesis. Most post-CAS patients in the United Kingdom are therefore on 
aspirin and/or dipyridamole.
It is not likely that CAS would directly affect the risk factors for CAD, 
such as hypertension, lipids, haemostatic factors and smoking. As part of the 
usual management of such patients, they are advised against smoking. 
Hyperlipidaemia is treated if present as patients with raised low density 
lipoprotein (LDL), and apolipoprotein B (apoB), and low high density 
lipoprotein (HDL) have a higher incidence of graft occlusion (Simons & Simons 
1987; Solymoss et al 1988). Disease in native vessels tend to progress quicker 
if the graft is occluded than if it is patent (Kroncke et al 1988). The long term 
management of post CAS patients should include risk factor modification, 
measures to enhance their quality of life and prevent graft attrition (Hoffmeister 
et al 1986; Kalan et al 1990).
The cardiovascular (CV) effects of CAS have been extensively studied. 
Exercise capacity, which may be dependent on graft patency, increases in 
conjunction with the relief of angina (Guiney et al 1973; Lapin et al 1973; 
Bartel et al 1973; Balcon et al 1974; Merrill et al 1975; Siegel et al 1975; 
McConahay et al 1977; Gohlke et al 1982; Talbot et al 1982; Allen 1990). The 
degree of ischaemia measured by ST segment depression during exercise, and 
on ambulatory ECG monitoring is reduced. It does not however predict 
outcome accurately (Quyyumi et al 1985; Crea et al 1987; Egstrup 1988; 
Gohlke-Barwolf et al 1990; Kennedy et al 1990; Kennedy 1990; Droste & 
Roskamm 1992; Patel et al 1993). The effect of CAS on arrhythmias is 
uncertain (Moller et al 1983; Rasmussen et al 1987; Yli-Mayry et al 1990;
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Huikurî et al 1990; Rotman et al 1990; Smith et al 1992). Left ventricular 
function studied by echocardiography, radionuclide and contrast 
ventriculography, may improve post-operatively especially after exercise 
(Chatteijee et al 1972; Wolf et al 1978; Kent et al 1978; Zir et al 1979; 
Kronenberg et al 1983; Austin et al 1983; Taylor et al 1983; Brundage et al 
1984; Tchervenkov et al 1985; Carroll et al 1985; Kawasuji et al 1988; 
Dilsizian et al 1988). Thallium scintigraphic scores are improved, as a direct 
result of myocardial revascularisation (Ritchie et al 1977; Verani et al 1978; 
Greenberg et al 1978; Kolibash et al 1979; Robinson et al 1979; Berger et al 
1979; Hirzel et al 1980; Rubenson et al 1982; Gibson et al 1983; Fioretti et al 
1988; Hamouratidis et al 1988). Thallium scintigraphy can be used in the 
prediction of graft occlusion (Sbarbaro et al 1979; Kolibash et al 1980; 
Wainwright et al 1980; Huikuri et al 1987).
EXERCISE REHABILITATION
The use of exercise rehabilitation for cardiac patients is gradually increasing, 
and should be recommended practice.
Pooled analyses of studies of exercise rehabilitation after myocardial 
infarction (MI) show a distinct benefit for exercise-trained patients, though the 
precise mechanism for this is uncertain. It is also associated with improved 
outcome in patients with angina and after CAS. In an overview of 22 trials of 
exercise rehabilitation post MI, O’Connor et al (1989) report a 20% reduction 
in overall mortality in exercise-based rehabilitation programmes due to a 
decreased risk of cardiovascular mortality and fatal infarction, operating over
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at least three years. There was also a reduction in sudden death rate during the 
first year post MI (Oberman 1989). May et al (1981) reported a 19% reduction 
in mortality with exercise training after MI. This compares with a reduction 
of 23.5% by beta blockers, 17.8% by lipid lowering drugs, 7.6% by anti­
platelet drugs and a 4% increase with antidysrhythmic therapy. In another 
pooled data report Oldridge et al (1988) showed a 24% reduction in total and 
a 25% reduction in cardiovascular mortality with exercise training after MI.
The effect of exercise rehabilitation on prognosis has not yet been 
studied in post-CAS patients. This would require a very large multicentre trial, 
as some studies have shown 79% ten year survival in CAS patients (CASS 
investigators), with even better results in those with IMA grafts as discussed 
earlier. Improvements on these figures would be difficult to show in a small 
study.
Improvement in quality of life has been shown in exercise rehabilitation 
after MI (Norris et al 1990; Oldridge et al 1991). There are those who are 
more doubtful about the psychological effects of exercise training (Langosch 
1988).
In the studies in which CAS patients were included, they derived as 
much benefit from exercise training as did patients with angina or MI, in terms 
of improved exercise capacity. However, since CAS patients have been studied 
mainly as part of a group of cardiac patients, it makes it difficult to determine 
their particular benefits specifically.
There are studies of exercise training after CAS which show that quality 
of life and rates of return to work are markedly improved by exercise
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rehabilitation (Murray & Seller 1982; Foster 1986; Hoad & Crawford 1990). 
In contrast others fail to show significant improvement in return to work rate 
after training (Danchin & Goepfert 1988). This factor is perhaps the one most 
influenced by extraneous and socioeconomic circumstances.
Exercise training in cardiac patients is usually based on aerobic 
exercises, such as running on the spot, step-ups,and trunk curls. These are also 
known as endurance, dynamic, isotonic or isokinetic exercises and involve the 
rhythmic movement of large muscle groups associated with increased 
ventilation, oxygen consumption and cardiac output. Aerobic training is of 
proven benefit in all groups of cardiac patients, with improved exercise 
capacity after a variable period of training.
Power or strength exercise training has not been studied in previously 
untrained post-CAS patients, and has only been reported in post-MI and other 
cardiac patients who have already undergone aerobic training. It is often 
discouraged in cardiac patients because of unfounded fears and lack of 
information on the physiological effects of such exercise. There is also 
confusion with static or isometric exercise such as sustained weight-lifting. 
That form of exercise causes a pressure rather than a volume load and therefore 
does not cause a sustained increase in cardiac output. The rise in blood 
pressure from static exercise is thought to be harmful in cardiac patients. It is 
important not to discourage cardiac patients from performing strength-training 
exercise. Many activities of daily living involve a power component eg. 
gardening, do-it-yourself, shopping and lifting. It is important to assess its 
effects in a controlled situation, in order to help clinicians to give appropriate
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advice to their cardiac patients.
Weight-training in a circuit is not strictly isometric. During circuit- 
training, there are rhythmic movements of large muscle groups to move a 
moderate weight load repetitively, with short periods of rest between each 
element of the programme. Like aerobic exercise, it should also cause an 
increase in ventilation, oxygen consumption and cardiac output. In addition, 
there may be increased skeletal muscle strength and mass.
It makes sense to compare the two forms of exercise directly in 
previously untrained patients after CAS.
The most compelling end-point of all is death. There is yet to be 
conclusive evidence demonstrating that exercise rehabilitation reduces 
mortality. This is because of flaws in study designs, small study sizes, 
inhomogeneous groups of patients, and non-uniform exercise protocols. Results 
of meta-analyses do indicate a survival advantage for patients who take part in 
exercise rehabilitation after myocardial infarction over those who do not, as 
discussed earlier.
Mortality is the most persuasive primary end point in exercise training 
and other interventional studies. This is not a practicable one for most 
investigators because it would require prolonged follow-up of a large number 
of patients to show any differences. In any case there are other important 
variables involved in morbidity which are of more value to the patient than is 
mortality. These include well-being, exercise capacity and risk of future 
cardiovascular events.
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Most CAS patients are familiar with the exercise test using treadmill or 
hicycle ergometer. It is therefore a useful method to assess the effects of 
exercise training in these patients. A valid primary end point in such a study 
is exercise performance. It is also a reflection of their physical well-being and 
ability to cope with daily activities.
EFFECTS OF EXERCISE TRAINING
Chronic exercise training in young rats causes myocardial hypertrophy, 
increased ratio of capillary to muscle fibres in myocardium, increased coronary 
artery size, development of collaterals in the coronary bed, improved cardiac 
performance, increased skeletal muscle mitochondria and respiratory enzymes 
and improved peripheral blood flow during exercise (Froelicher 1987a).
Cardiac output, stroke volume, left ventricular end diastolic volume and 
exercise capacity increase with endurance exercise training in normal subjects 
and in cardiac patients (Buttrick & Scheuer 1987; Hossack 1987; Oberman 
1988). Resting heart rate and rate pressure product at submaximum exercise 
is reduced after exercise training (Laslett et al 1985; Todd & Ballantyne 1986). 
Power exercise in wrestlers and weight trainers, can cause increased left 
ventricular wall thickness (Froelicher 1987b; Hanson & Nagle 1987).
There is substantial evidence in favour of the idea that exercise can 
prevent coronary artery disease (CAD) (Morris et al 1973; Paffenbarger & Hale 
1975; Morris et al 1980; Oberman 1985; Paffenbarger et al 1986; Slattery et 
al 1989; Morris et al 1990; Shaper & Wannamethee 1991). In those in whom 
CAD has already developed, exercise may be a means of retarding its progress.
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by modification of risk factors (Goldberg 1989). It is certainly a means of 
improving their quality of life (Laslett et al 1987; Shepard 1989).
Studies on exercise training in cardiac patients often combine those with 
different categories of disease - angina, myocardial infarction and post CAS. 
One of the most widely quoted is the PERFEXT study. In this, 146 patients 
were randomised to control (n = 74) and exercise (n = 72) groups. Coronary 
artery surgery patients formed a third of the group. They showed similar 
benefit as did the other patients after one year. In summary, these benefits were 
increased exercise time, thallium scores, and left ventricular function in the 
subgroup of patients with angina (Froelicher et al 1984).
Evidence to date supports the view that peripheral rather than central 
adaptations account for the improvement in exercise capacity that has been 
consistently demonstrated in exercise trained patients (Coplan et al 1986). This 
seems to occur even after short periods of training such as four weeks (Ignone 
et al 1988; Nordrehaug et al 1989). These peripheral adaptations serve to 
improve the efficiency of skeletal muscle. Studies that use cardiopulmonary 
exercise testing show that there is also improved cardiovascular and respiratory 
status, and that the effect is not merely one of habituation and better confidence 
(Ades & Grunvald 1990; Blumenthal et al 1991). There is growing speculation 
that by inducing ischaemia, exercise training results in the formation of a 
coronary collateral circulation. This has been suggested on perfusion scans 
(Todd et al 1991), but demonstration by angiography is lacking.
Studies of exercise training after CAS show that exercise capacity is 
increased (Stevens & Hanson 1984; Froelicher et al 1985; Froelicher 1987b;
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Hoad & Crawford 1990), some risk factors are reduced (Hedback et al 1990) 
and graft patency is increased (Nakai et al 1987) in the trained groups.
Whether or not exercise training can increase the benefits of CAS is an open 
question. Whether or not aerobic and power training cause different 
cardiovascular effects after CAS is unknown. Whether or not it is possible to 
influence known risk factors for CAD by exercise training after CAS is 
undetermined.
This study was undertaken to try to provide some answers to these 
questions.
It is a study of the effects of aerobic and power exercise training in 81 
men who had undergone coronary artery surgery six to 48 weeks prior to their 
enrolment. They were randomised to three groups:
1. control (no formal exercise training),
2. supervised, graduated, aerobic exercise three times weekly for six months,
3. supervised, graduated, power (strength) exercise training three times a week 
for six months.
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SECTION m
PROTOCOL
The following protocol was assessed and accepted by the Higher Degrees 
Committee at Glasgow University. There was initial criticism of the original 
number of patients of 60. The next section explains the modification in the 
protocol to increase the number of patients to 81.
PROPOSAL FOR THE DEGREE OF MD
"The effects of exercise training on cardiac function, lipids and coagulation in 
post-coronary artery bypass graft patients"
Introduction
Coronary artery bypass grafting (CABG) has been a significant advance 
in the management of patients with ischaemic heart disease. In their first year 
after CABG, 80-90% of patients report definite symptomatic improvement, if 
not cure. The prognosis is improved in patients with left main stem, triple 
vessel and proximal left anterior descending artery disease, especially in those 
with moderately impaired left ventricular function (EF 35-50%) and readily 
inducible ischaemia (on exercise testing).
However 10-30% of grafts occlude in the first year post-operatively, 
with or without a recurrence of angina. Exercise training provides added 
advantages to coronary artery surgery. Scientific evidence on the effects of 
exercise training post CABG is in short supply from the United Kingdom. Most 
reports on exercise training in heart disease are fi'om America, Scandinavia and 
Japan.
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Cardiac rehabilitation centres have been set up in only a few centres in 
the United Kingdom and there is scope for increasing their numbers. As 
coronary artery disease is the commonest cause of death in the West of 
Scotland, it would be good sense to invest in means of secondary prevention. 
This includes advice on diet and social behaviour, as well as exercise training 
sessions.
This study has therefore been designed to investigate the effects of 
endurance and power exercise on cardiac function, coagulation factors and 
lipids in men who have had coronary artery surgery.
Aims
1. To assess the cardiovascular effects of supervised exercise training in 
male patients post CABG. Effects on exercise tolerance, exercise induced 
ischaemia, myocardial perfusion, left ventricular systolic and diastolic function 
will be studied.
2. To determine the prevalence of silent myocardial ischaemia in post- 
CABG patients and to assess the effects of exercise training on silent 
myocardial ischaemia.
3. To determine possible factors contributing to graft occlusion in the 
short term.
4. To assess the effects of exercise training on lipid levels and 
haemostatic factors.
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Patients and Methods
Sixty male patients aged 30 70 years, who have had CABG in the previous 18 
months will be enrolled in the study.
They will be randomised to three groups: supervised graded endurance exercise 
training; supervised graded power exercise training; no exercise training. The 
programme will run for six months. Patients who are unable to perform the 
treadmill exercise test will he excluded.
At entry, at three months and at six months, patients will be evaluated 
as follows - clinical history and cardiovascular examination, resting ECG, chest 
X-ray, symptom-limited exercise ECG (modified Balke II protocol), 
echocardiography (Hewlett-Packard System), Thallium-201 myocardial 
perfusion scintigraphy scan (at entry and six months) gated Technetium 99 scan 
at rest and following cold pressor (entry and six months), assays of factor VII 
activity, fibrinogen, fibrinopeptide A, fasting lipids and apolipoproteins.
The training programme has been devised in collaboration with the 
Physiotherapy Department, Victoria Infirmary. Endurance exercises include 
running on the spot, step-ups, bridging, side flexion, back extension and trunk 
curls. Power exercises include pull down, push down, biceps curl, triceps curl, 
hamstrings and quadriceps curls and sit-ups. Training sessions will take place 
three times a week and last 30-40 minutes on each occasion. Attendance 
records will be kept. Each patient will be instructed on the exercises by a senior 
physiotherapist. The sessions will be supervised by a physiotherapist, cardiac 
rehabilitation sister and a doctor.
Any patient requiring treatment for angina will be given nifedipine
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initially. Further treatment and investigation will be carried out as indicated. 
Anticipated problems
Patient non-compliance, not only with exercise therapy, but also with 
other therapy will be overcome with counselling and encouragement. Drop­
outs, for medical and social reasons will no doubt occur, as has been the case 
in most trials of this nature.
Results
Patients in the exercise programmes will be their own controls. In 
addition, comparisons will be made between the groups. Differences in the 
measured variables will be assessed. Initial analysis of variance followed by 
paired "t" test or rank test, where appropriate, will be performed.
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SECTION IV
Calculation of number of subjects required
This was based on results from reported studies on exercise training in 
cardiac patients. Based on statistical power of 90%, with significance level of 
0.05, a total of 75 subjects are required in a two-group comparison (Altman 
1982). I have been unable to find any statistical formulae or nomograms 
pertaining to three groups.
There are statistical formulas that can be used to estimate the number 
required in each group based on standard tables (Kirkwood 1988).
Formula for number of subjects in each group (n):
(u+vŸxisdi +sd^
u = 1.28, V =  1.96, 
sd =  standard deviation 
X =  mean
Using the formula and results from previous work in our institution in 
patients with heart failure to calculate the number required in each group, n =  
53:
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(1.28+1.96)^x(178^+266^)
(710-568f
The standard deviations were large in that study, and reflect the large 
differences in exercise capacity among patients with heart failure. It was not 
possible to perform a pilot study in post-CAS patients, due largely to the 
restraints of time. Using results from a study of post-MI patients and the same 
equation, n ^  16:
(1.28+1.96)^x(lS^+20^)
26^
I had to combine statistical principles with logistics and expediency in 
reaching a decision to study a total of 81 patients. It took 32 months to follow 
up that number of patients. The tests that were done had to he arranged in 
conjunction with busy clinical departments and the patients involved.
In trials of exercise training after CAS involving between six and two 
hundred and ten patients, 19 29% increases in exercise capacity have been
reported (Oldridge et al 1978; Hartung & Rangel 1981; Dornan et al 1982; 
Waites et al 1983; Murray & Seller 1983; Stevens & Hanson 1984; Froelicher 
et al 1985; Nakai et al 1987) Most of these studies did not even have a control 
group. It was expected that the proposed study of 81 patients in three groups 
would show similar changes in exercise capacity.
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STATISTICAL ANALYSES
The results were analysed on an intention to treat basis, unless specified 
otherwise.
Results were analysed using SPSS/PC + version 4.0 statistical data 
analysis programme. Descriptive statistics were done initially, followed by 
tests of normality using normal probability plots for all the data. Within and 
between group differences in the measured variables were assessed by analysis 
of variance (ANOVA) with application of the Scheffe test for normal data, and 
Kruskal Wallis test for non-normal data. When this was significant i.e. p < 
0.05 and with Scheffe test indicating actual difference between two groups, the 
analysis was taken further.
Paired ’t ’ test or Wilcoxon test was done for within group data and 
unpaired ’t ’ test or Mann - Whitney U test was done for between group data. 
Two-tailed p values are noted where relevant.
The results are expressed as the mean with its 95% confidence interval or 
standard error, for normal data and as the median with 95% confidence interval 
or range for non normal data.
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SECTION V 
THE EXERCISE PROGRAMME
The programme was devised in conjunction with the Physiotherapy 
department to include movements involving all major muscle groups in 
exercises that are simple to perform.
The aerobic exercises were based on the Canadian Airforce XBX physical 
fitness programme. Aerobic exercises performed were arm circling, arm 
raising, step-ups, trunk rotation, star or stride jumps, crook-lying with trunk 
rotation and bridging, hip abduction while lying on side, side lying or standing 
trunk curls, trunk side flexion, and running on the spot.
Power exercises were based on a universal Multigym system. This 
consists of a group of apparatus in which weights are connected by 
appropriately placed pulley systems designed to allow movement of the weights 
in specific directions.
Power exercises performed were bench press, military press, biceps curl, 
upright row, pull down, push down, pulley row, quadriceps curl, hamstrings 
curl and sit ups.
Each patient ended the session with a ride on a stationary bicycle.
The exercise programme. used in the study is in line with 
recommendations of the American Society of Sports Medicine (1990) for 
exercise in the promotion of fitness in healthy persons. Persons with initial low 
levels of fitness, such as would be expected in cardiac patients, achieve more, 
in terms of maximal oxygen consumption (V02 max), than highly trained 
persons, after low to moderate intensity exercise programmes.
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The recommendations are; 20-60 minutes of any activity that uses large 
muscle groups and can be maintained continuously i.e. aerobic exercises, to be 
done 3 - 5  days a week, at 60 - 90% of maximum heart rate, or 50 - 85% of 
maximum oxygen uptake.
Resistance or strength training of moderate intensity sufficient to develop 
and maintain fat-free weight - one set of 8 - 12 repetitions of eight to ten 
exercises that condition the major muscle groups at least 2 days a week is the 
recommended minimum.
The patients attended sessions up to three times weekly in the same 
location and were supervised by a Physiotherapist, Cardiac Rehabilitation sister 
and a physician.
The duration of each session was 12-40 minutes depending on the 
patient’s stage of training. It was anticipated that by the end of the training 
period, each patient should have been exercising at his perceived maximum 
level of exertion.
In the aerobic group, the number of repetitions of each exercise was 
increased over time to increase the intensity of work performed in a graded 
manner.
In the power group each exercise was done, starting with the lightest 
weight (2 - 5kg), in 3 sets of 10 repetitions with 45s periods of rest between 
each element. The weight load was increased gradually, depending on 
individual’s progress and symptoms.
Heart rate and other cardiovascular monitoring were not done during the 
exercise sessions. Perceived exertion based on visual analogue scales has been
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shown to be an acceptable surrogate for heart rate monitoring in exercise 
rehabilitation programmes. Most studies do report using 70 - 85 % target heart 
rate or percentage of their maximum voluntary effort as a guide to the limits to 
which patients are exercised. I believe that symptomatic status during the 
training sessions can be used in a similar way to visual analogue scales. It was 
hoped that the men would continue unsupervised exercise in the community 
after the rehabilitation programme, relying on their symptomatic status rather 
than heart rate to decide on their limits of exercise. In retrospect, however, 
heart rate monitoring during the exercise sessions would have provided further 
information on the intensity to which the patients exercised.
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AEROBIC EXERCISE PROGRAMME
ARM CIRCLING
Stand with feet slightly apart. Abduct arms and rotate at shoulders, first 
forwards and then backwards. Start with 5 in each direction.
STEP UPS
Stand facing 20cm step. Step up and down at moderate pace, alternating left 
and right legs. Start with 10 repetitions.
TRUNK ROTATION
Stand with feet slightly apart, hands on hips. Rotate trunk to left and right 
alternately. Start with 5 to each side.
CROOK LYING TRUNK ROTATION
Lie on back, arms at side, with knees flexed. Rotate hips from side to side. 
Start with 5 to each side.
STAR JUMPS
Stand with feet together. Jump up ahducting legs and arms fully. Return to 
starting position. Start with 3 repetitions.
SIDE LYING HIP ABDUCTION
Lie on right side, right arm stretched above head, left arm supporting upper
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body at chest level, right knee flexed. Abduct left leg to 90<>. Return to 
starting position. Repeat on left side. Start with 5 on each side.
STANDING TRUNK CURLS
Stand with feet together, arms at side. Bend knees with arms stretched 
forwards, and lower the body towards mat. Return to starting position. Start 
with 3 repetitions.
CROOK LYING BRIDGING
Lie on back with knees flexed. Raise hips while keeping feet and shoulders on 
the mat. Return to starting position. Start with 5 repetitions.
ARM RAISING
Stand with feet together, arms at sides. Raise arms forwards above head, 
return to starting position. Start with 5 repetitions.
TRUNK SIDE FLEXION
Stand with feet slightly apart, arms at sides. Flex trunk to right, sliding the 
right hand down right leg. Return to starting position. Repeat on left side. 
Start with 3 on each side.
RUNNING ON THE SPOT
Raise feet at least 10-20cm off mat, while running on the spot for one minute.
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POWER EXERCISE PROGRAMME
BENCH PRESS
Lie on back on the bench, feet on the floor, with the apparatus behind head. 
Raise weights by pulling bar towards head. Return to starting position.
MILITARY PRESS
Kneel facing the apparatus. Raise weights by pushing the angled bar from chest 
level to above your head, fully extending your arms. Return to starting 
position.
BICEPS CURL
Stand facing the apparatus. Bend forearms to 90°, palms upwards, elbows 
tucked into sides. Raise weight by pulling the bar up, till arms are fully 
flexed. Return to starting position.
UPRIGHT ROW
Stand facing apparatus. With arms extended, palms downwards, pull the bar 
up towards your chin, and move elbows outwards at the same time to raise the 
weights. Return to startiug position.
PULL DOWN
Sit on stool, with apparatus behind body. Raise the weights by pulling the bar 
down toward shoulders. Return to starting position.
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PUSH DOWN
Stand facing the apparatus. Bend arms to 90<> with palms facing downwards. 
Raise the weights by pushing bar downwards until arms are fully extended. 
Return to starting position.
PULLEY ROW
Sit on the mat, legs fully extended facing the apparatus. Reach for the bar and 
raise the weights by pulling the bar towards the body. Return to starting 
position.
QUADRICEPS CURL
Sit on the edge of the bench with the cushioned bar at your feet and the 
apparatus behind body. Hold bar with flexed ankles and raise weights by 
extending the knees. Return to starting position.
HAMSTRINGS CURL
Lie prone on the bench, with the cushioned bar resting on back of ankles. 
Raise the weights by flexing at the knees. Stabilise upper body by holding onto 
the sides of the bench. Return to starting position.
SIT UPS
Lie supine on the mat, with legs fully extended. Grip fixed cushioned bar with 
flexed feet. Raise upper body and try to touch knees with your forehead and 
return to starting position.
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Attendance records were kept for each patient. The patients also recorded the 
level of the programme they had reached after each session. Their performance 
was assessed by the physiotherapist, their symptomatic status was assessed by 
the doctor, and they were then given appropriate advice about moving on to the 
next stage.
The patients in the power group attended 63% of the sessions; those in 
the aerobic group attended 64% of the training sessions.
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SECTION VI
INTERVENTIONS
Both exercise training groups attended the exercise sessions held in the 
same gymnasium supervised by the same physiotherapist, rehabilitation sister 
and doctor. The programme did not include specific instructions about diet or 
other changes in lifestyle. We did not record any such changes that may have 
taken place during the period of follow-up. General advice was available to the 
patients and would have been the same for all concerned.
The study was aimed at comparing the effects of different forms of 
exercise training i.e. "treatments" on selected cardiovascular factors. The 
primary end-point was exercise time on a treadmill.
Patients were assessed at baseline with two treadmill tests and the 
average of these was used as baseline treadmill performance.
Thereafter they were assessed at three and six months. History, clinical 
examination and weight, resting ECG, chest Xray, M-mode and 2D - 
echocardiography, Holter monitoring, lipid and lipoprotein analysis, 
haemostatic factor assays, were done at each assessment. Height was recorded 
at the first visit. Exercise thallium-201 scintigraphy and radionuclide 
ventriculography were done at baseline and six months.
THE SUBJECTS
There are only a few studies on exercise training after coronary artery 
surgery. These patients are forming a larger and larger proportion of cardiac
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patients, as the operation rates rise exponentially. It is necessary to study post- 
CAS patients as a single group, rather than as part of a mixed bag of cardiac 
patients. This would help to establish their particular response to exercise 
rehabilitation. In terms of its effects on lipids and coagulation factors, this 
may be of special relevance to this group of patients with respect to graft 
patency.
At the time of the study, the majority of patients requiring coronary 
artery surgery in the Victoria Infirmary were referred to a particular surgeon 
at the Western Infirmary. In that regard, the patients form a homogeneous 
group. The study was confined to men because it was more practicable in terms 
of available facilities for exercise training sessions.
The patients were recruited from Cardiology clinics in the Victoria 
Infirmary and asked to take part in the study. They gave their informed consent 
and were free to withdraw from the study at any time.
The study was approved by the Ethical Committee at the Victoria 
Infirmary, Glasgow.
Randomisation was done by using the method of opaque sealed envelopes 
containing the letters ’C% ’A’, or ’P’.
Those who dropped out before they had attended an exercise session 
were replaced, otherwise they were not. Eighty one male patients were asked 
to take part in the study. Four had dropped out by the end of the study period. 
Demographic details at baseline are shown in table 1. There were no 
significant differences between the groups.
Table 1
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DEMOGRAPHIC DETAILS AT BASELINE
Control Aerobic
Number 27
Mean age (years) 56.6
Grafts (mean) 3.2
IMA grafts 22
(no. of patients)
Time since 
surgery (weeks)
median (range) 12 (6-28)
Mean weight (SEM) 80.5
kg (2.1)
Previous MI 11
Smoking - current 4
previous 14
non 8
Work - employed 8
off work 7
retired 11
Drugs:
Aspirin 19
Dipyridamole 18
anti ischaemia 5
diuretic 5
ACE inhibitor 1
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56.5
3.0
17
12 (6-48) 
76.3 
(2.7)
17
3
15
9
6
9
12
15
13
2
2
2
Power
27
59.2
3,3
16
12 (6-44) 
72.6 
(2 .0)
15 
1
17 
6 
6 
6 
12
18
16 
1 
4
0
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Their ages ranged from 32 - 70 years. Fifty six percent had previous 
infarcts, and 60% were ex smokers. Seventy four percent were not in full-time 
employment, most were retired. The majority of patients had internal 
mammary artery grafts, and there was an average of 3 bypass grafts per patient. 
Most were enrolled around three months post-surgery, and were on anti-platelet 
drugs, as would be expected.
One patient in the control group was lost to follow up after eight weeks. 
Two patients in the power group dropped out after two weeks because of 
problems with their surgical scars; another moved away after five weeks. 
There were no drop outs in the aerobic group. The data that follow are on 77 
patients who completed the study.
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SECTION VII
CLINICAL EXAMINATION
At each assessment, the patients had a clinical examination consisting of 
resting pulse and blood pressure measurement, auscultation of heart and lungs, 
and measurement of body weight, body mass index and skin fold thickness. 
Blood pressure was measured manually using a mercury sphygmomanometer. 
Heart rate was measured from a resting ECG.
Body mass index was derived from the standard formula: weight/heighP. 
Skin fold thickness was measured with Harpenden calipers at four sites: biceps, 
triceps, scapula and abdomen. The biceps and triceps measurements were taken 
midway down each muscle, scapula measurement was taken halfway down the 
medial aspect of the scapula, and the abdominal measurement was taken at the 
anterior superior iliac spine. The sum of these was used as an measure of body 
fat. This method is a well recognised means of assessing body fat in nutritional 
and exercise training studies. With increasing obesity, a higher proportion of 
fat is deposited subcutaneously. A 10mm increase in the sum of four skin folds 
corresponds to an increase in fatness of 4.8% (Lohman 1981). The relative fat 
pattern does not change much after weight loss from food restriction, though 
the same may not be true of weight loss associated with exercise.
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Results
Heart rate and blood pressure readings are presented in the section on 
exercise test data.
Results for weight (WT), body mass index (BMI), and skin fold 
thickness (SFT) are in table 2.
The control group was heavier than the other two at all assessments. At 
baseline, this difference failed to reach statistical significance (ANOVA p = 
0.07). The average weight increased slightly in the eontrol and aerobic groups 
with time, while that in the power group remained almost static. Therefore, the 
mean weights at three and six months became significantly different (ANOVA 
p =  0.02 and 0.03 respectively). Applying t-tests shows the relevant 
differences clearly. Between control and power groups at three months and at 
six months 2p — 0.002 for each, and for the interval change at three months, 
2p =  0.013 (control group gained 1.3kg, power group lost 0.3kg). Between 
aerobic and power groups at three months, the interval change was significant 
with 2p =  0.016 (aerobic group gained 0.9kg, power group lost 0.3kg). There 
were no other differences reaching statistical significance. The changes had 
taken place by three months.
By definition, the patients were overweight, since their mean BMI 
exceeded 25. This is not surprising, considering the population being studied: 
middle-aged men from the West of Scotland with coronary artery disease. 
Body mass index followed a similar pattern to that of body weight. At three 
months, the control group increased BMI by 0.4, aerobic group increased by 
0.3 and power group decreased by 0.1, making the interval change at three
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months significant with 2p = 0.016 for control vs power and 2p =  0.024 for 
aerobic vs power. The difference remained for control and power groups at six 
months, 2p = 0.019.
Skin fold thickness at baseline was similar in the groups. The power 
group improved, with lower skin fold thickness values and a greater fall with 
time than occurred in the other two groups. At three months, ANOVA p =  
0.038 (control vs power 2p = 0.007, aerobic vs power 2p = 0.043). At six 
months, ANOVA p = 0.021 (control vs power 2p — 0.002, aerobic vs power 
2p = 0.032). The changes represent at the most 1 % reduction in fatness.
The weight gain in the control group is not reflected by a concomitant 
increase in skin fold thickness as would be expected. The aerobic group also 
gained weight but it was associated with a small drop in SFT. This is usually 
explained in terms of a gain in muscle tissue as a result of exercise training. 
It is supported by the pattern of lower SFT in the power group without much 
change in body weight. One could assume that the control group either also 
gained muscle tissue or gained fat in areas that were not measured in the study. 
Having said that, one must remember that the changes were really rather small 
and may not be of the same order of clinical as of statistical significance.
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Table 2
WEIGHT (kgT BODY MASS INDEX and SKIN FOLD THICKNESS
(mml mean (95% Cl)
CONTROL AEROBIC POWER
WTl 80.5 
(76.1 to 84.8)
76.3 
(70.7 to 81.9)
72.6 
(68.5 to 76.6)
WT2 81.8 
(77.4 to 86.1)
77.2 
(71.6 to 82.8)
72.3 
(68.2 to 76.4)
WT3 81.6 
(77.6 to 85.6)
77.1 
(71.4 to 82.8)
72.7 
(68-6 to 76.7)
BMIl 27.5 
(26.2 to 28.9)
26.9 
(25.6 to 28.3)
25.8 
(24.4 to 27.1)
BMI2 27.9 
(26.6 to 29.3)
27.2 
(25.9 to 28.6)
25.7 
(24.3 to 27)
BMI3 27.9 
(26.6 to 29.2)
27.2 
(25.8 to 28.6)
25.8 
(24.5 to 27)
SETT 47.5 
(41.5 to 53.4)
46.6 
(40.6 to 52.6)
40.4 
(36.8 to 44)
SFT2 48.9 
(43 to 54.8)
46.4 
(40.5 to 52.2)
39.7 
(36.8 to 42.6)
SFT3 47.4 
(42.3 to 52.5)
45.1 
(39.3 to 50.9)
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(35 to 41)
’r  baseline; ’2’ three months; ’3’ six months.
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SECTION VIII
THE EXERCISE TEST
Exercise tests were done using the Marquette Case II computerised 
system. The treadmill is connected to electrocardiographic (ECG) monitoring 
and display equipment. Leads II, VI and V5 are continuously displayed, with 
single complexes of the other leads shown alongside on screen. Full 12-lead 
electrocardiographs, with automatic ST segment analyses are printed every 
three minutes. The ST segment is measured 60ms from the I  point, and values 
exceeding 0.1 mV are considered positive for ischaemia. In addition to the 
automatic analysis, each exercise ECG is checked manually for artefact, such 
as that created by poor quality recordings, or movement.
The system records heart rate, exercise time, maximum ST segment 
depression and the time at which this occurred, estimated workload in metabolic 
equivalents (mets; 1 met =  3.5ml Oz/kg/min), percentage of target heart rate 
reached, and number of ventricular ectopics. The final report also displays 
leads in which 0.1 mV ST depression occurred. The number of ventricular 
ectopics is unreliable because of artefact, and has not been included in the 
results.
A modified Balke II protocol was used. This consists of three minute 
stages. The speed and gradient increase after the first stage from 3.2kph, 0 % 
to 4.8kph, 4 %.  The speed stays constant ft^om the second to the sixth stage, 
while the gradient increases by 4% per stage. At the seventh stage, the speed 
increases to 7.2kph and gradient remains at 20%. This protocol was chosen 
because most of the patients were already familiar with it. The modified Balke
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protocol is the one used for clinical assessments in our department and most of 
the patients would have had pre-surgery treadmill tests using it. In terms of 
workload, there is a gradual increase in this with each stage, and so is a 
physiologically sound means of testing exercise capacity.
Stage Speed tkphi Gradient Me
I 3.2 0 3
2 4.8 4 5
3 4.8 8 7
4 4.8 12 8
5 4.8 16 10
6 4.8 20 12
7 7.2 20 15
The exercise tests were done between 09.00h and ll.OOh. Resting ECG 
was done after the patient had been sitting for two to three minutes. The blood 
pressure was measured manually then and at two minutes into each stage of 
exercise, and entered into the computer.
Each patient had four exercise tests for the purposes of exercise test data 
and parameters during the programme: two at baseline, and one each at three 
and six months. The average of the two baseline tests was taken as baseline 
performance.
The tests were symptom-limited. A note was made of the symptom and 
also entered into the computer. A fall in systolic blood pressure of greater than
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lOmmHg from the previous reading, or significant ventricular arrhythmias were 
other reasons for stopping the test.
The following parameters were recorded for each patient at each 
assessment:
Resting heart rate (RHR), resting systolic blood pressure (RSBP), submaximal 
heart rate (SMHR), submaximal rate-pressure product (SMRPP), maximum 
rate-pressure product (MRPP), maximum heart rate (MHR), maximum treadmill 
time (MTT), maximum workload (MMET), maximum ST segment depression 
(MSTD), time to 1mm ST segment depression (TSTD) if  any, percentage of 
target heart rate achieved (PTHR) and heart rate at 5 minutes into recovery 
(FHR). Target heart rate is calculated as 220 minus age of patient.
These are measures of both physical fitness and residual myocardial 
ischaemia. A resting bradycardia and rapid recovery of heart rate after exercise 
are taken as indicative of a fit person. Low submaximal heart rate and rate- 
pressure product are also a measure of fitness. Submaximal heart rate and rate- 
pressure product were measured at the end of the first stage of the protocol. 
In this context, ’submaximal’ refers both to the stage reached in exercise 
testing, and indirectly, to the effort used. Almost all the patients completed 
stage 1 of the modified Balke protocol, and went on to exert maximal effort 
until symptoms limited their performance of the treadmill test. The maximum 
rate pressure product is commonly taken as an indication of myocardial oxygen 
demand at peak exercise (Kitamura et al 1972; Clausen 1976; Gobel et al 
1978). Maximum treadmill time and workload are indicators of fitness, 
severity of disease, and in some, motivation.
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It is difficult to be certain of the extent to which motivation is a factor, 
without the use of cardiopulmonary exercise testing, to provide an objective 
assessment of oxygen consumption, and treadmill time at the anaerobic 
threshold. Assuming that the patients’ characters did not change during the 
study, the uncertainty can be reduced by the fact that each patient acted as his 
own control during the programme so that the "motivation factor" remains 
constant.
ST segment depression is the indicator of ischaemia, and its absence on 
exercise testing is said to imply a good prognosis. In very simplistic terms, the 
greater the degree of ST depression the greater the ischaemia, and the quicker 
it comes on during exercise, the graver the outlook. This is the basis of the 
exercise test as it is commonly used in diagnostic and prognostic cardiology. 
There are however some doubts about the significance of ST segment changes 
during exercise tests after coronary artery surgery, with particular regard to the 
prognostic implications (Dubach et al 1989; Lavie et al 1991; Yli-Mayry et al 
1992). The simple statement mentioned above about ST segment depression 
may not hold true after coronary artery surgery. Certainly in this study, I 
witnessed several episodes of severe but asymptomatic ST depression, that 
made me wonder about the patency of the grafts and native coronary arteries 
in the patients involved.
The time to 1mm ST depression, if any, was recorded manually. If this 
was a transient occurrence, then it was subsequently ignored. If there was no 
ST depression during the test it was assumed to occur after the maximum 
exercise time, and was recorded as such, rather than at infinity, which would
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be impossible to fit into any analysis.
The heart rate five minutes into recovery was used as a measure of 
fitness; a recovery rate (RR) was derived as the difference between maximum 
heart rate and five minute heart rate divided by five (MHR -FHR/5), and 
expressed in beats/min. The higher the recovery rate, the fitter the patient. A 
recovery rate fraction (FRR) was calculated as the difference between maximum 
heart rate and five minute heart rate, divided by maximum heart rate 
(MHR - FHR/MHR), and expressed as a ratio. The higher the ratio, the fitter 
the patient.
Interval changes in submaximum (DSM) and maximum rate-pressure 
product (DM), maximum treadmill time (DTT) and maximum workload 
(DMET) were calculated for each group. Interval change from baseline to 3 
months is denoted ’1’, baseline to 6 months, ’2’. From 3 to 6 months the 
prefix ’in f  is used. This notation applies whenever interval changes are 
mentioned.
RESULTS
In all tables the suffix ’1’ is used for results at baseline, ’2 ’ for three months, 
and ’3’ for six months, unless otherwise specified. Results are shown as the 
mean with 95 % confidence intervals.
Symptoms
Common symptoms limiting the test were fatigue, dyspnoea, leg ache and chest 
pain. In a small number of cases the exercise test was stopped because of other 
complaints such as dizziness (tables 3 - 5 ) .
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TABLE 3
REASONS FOR STOPPING EXERCISE TESTS : CONTROL GROUP
Symptom/No.of
cases
Baseline 3 months 6 months
Dyspnoea 13 13 9
Fatigue 8 5 11
Leg ache 4 7 5
Chest pain 0 0 0
Other 1 1 1
TABLE 4
REASONS FOR STOPPING EXERCISE TESTS : AEROBIC GROUP
Symptoms/no. of 
cases
Baseline 3 months 6 months
Dyspnoea 7 9 6
Fatigue 7 8 10
Leg ache 8 6 5
Chest pain 4 4 5
Other 1 0 0
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TABLE 5
REASONS FOR STOPPING EXERCISE TESTS : POWER GROUP
Symptoms/no. of 
cases
Baseline 3 months 6 months
Dyspnoea 10 6 5
Fatigue 6 6 6
Leg ache 6 12 11
Chest pain 1 0 0
Other 1 1 0
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As would be expected, 99% were cured of chest pain by coronary artery 
surgery; only five patients stopped the test because of chest pain. Most were 
limited by dyspnoea and fatigue. This pattern did not change over the training 
period. I would have expected more patients to develop a recurrence of angina 
in that time; on the other hand, those in the aerobic group who had persistent 
angina were not cured of it by the programme. The numbers involved are too 
small for more meaningful comment to be made on this issue.
Exercise performance (table 6)
There were significant differences in exercise performance between the 
control and aerobic-trained groups at three and at six months (2p— 0.037 at 
three months; 2p= 0.002 at six months; 2p— 0.05 between three and six 
months). In the power group, their exercise performance at six months was 
better than that of the control group (2p= 0.031), and interval change at six 
months was in keeping with this (2p= 0.075).
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Table 6
EXERCISE PERFORMANCE IN THE THREE GROUPS AT EACH 
ASSESSMENT AND INTERVAL CHANGES (s)
CONTROL AEROBIC POWER P
MTTl 683.8 
(558.6 to 809.1)
650.5 
(549.7 to 751.3)
784.2 
(657.8 to 910.5)
NS
MTT2 718.2 
(585.3 to 851)
780.8 
(673.2 to 888.4)
867.3 
(743.6 to 991)
NS
MTT3 710.8 
(575.6 to 846)
846.9 
(746.5 to 947.3)
906.8 
(785.3 to 
1028.3)
*
0.031
DTTl 34.3 
(-1 to 69.6)
130.3 
(46.4 to 214.2)
83.1 
(0.9 to 165.3)
**
0.037
DTT2 27
(-40.4 to 94.4)
196.4 
(112.2 to 280.7)
122.7 
(37.7 to 207.6)
**
0.002
INTTT -7.3 
(-60.6 to 45.9)
66.2 
(13 to 119.3)
39.5 
(5.6 to 73.5)
**
0.05
Two tailed ’f  test: * power vs control; ** aerobic vs control
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The results for estimated maximum workload in metabolic equivalents (mets), 
follow a similar pattern to that of treadmill time, but the differences are more 
striking. Thus, the interval change at three months was significantly better 
between aerobic and control groups (2p =  0.009), and maintained at six months 
(2p =  0.002). Between three and six months, there was no significant change 
between those two groups (2p =  0.12). In the power group, the workload at 
six months was higher than that in the control group (2p= 0.03), interval 
change from baseline to six months was higher (2p= 0.064), as was the interval 
change from three to six months (2p= 0.05) (table 7).
These results support the view that exercise training improves exercise 
performance. In addition, the results suggest that aerobic exercise training in 
this group of post-CAS patients causes earlier benefit in treadmill performance 
than does power exercise training, when compared to a control group. 
However, there were no discernable differences in treadmill performance 
between the two types of exercise training at the end of the six month training 
period. This would imply that in the long run, the two types are equally 
beneficial, but that the effects of power training are slower in onset.
There were no differences in resting heart rate, resting systolic blood 
pressure, submaximum and maximum heart rates* time to ST segment 
depression, maximum ST segment depression, submaximum rate-pressure 
product, five minute heart rate, or percentage target heart rate between the 
groups at any time (tables 8 to 16).
The degree of ischaemia as measured by maximum ST segment 
depression during the exercise test did not change with exercise training. In no
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group, however, did it reach the critical 2mm, usually taken as the cut-off for 
an unequivocally positive exercise test. This merely indicates that the operation 
may have improved myocardial perfusion, but more evidence for this may come 
from the results of thallium myocardial perfusion scans.
The power-trained group achieved a higher maximum rate-pressure 
product compared to the control group (2p =  0.023), but there was no 
difference in that achieved by the two exercise groups or between the aerobic 
and control groups. When looked at as the interval change from baseline and 
from three months, the significant difference remains for the power and control 
groups (DM2 2p= 0.02; INTM 2p= 0.027). This is because in the control 
group, the maximum rate-pressure product fell with time, while in the aerobic 
group, it did not rise by much. This may be interpreted as the power group 
having a higher myocardial oxygen consumption at the end of the period of 
training, the aerobic group achieved only a modest increase while perhaps not 
surprisingly, the control group had a drop in myocardial oxygen consumption 
(table 17). The confidence intervals do overlap, and include zero for the 
exercise groups, making the clinical relevance of this finding doubtful.
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Table 7
ESTIMATED WORKLOAD IN THE THREE GROUPS AT EACH 
ASSESSMENT AND INTERVAL CHANGE BETWEEN THEM (mets)
CONTROL AEROBIC POWER P
value
MMETl 7.5 
(6.1 to 9)
7
(6.2 to 7.9)
8.6 
(7.3 to 10)
NS
MMET2 7.8 
(6.3 to 9.2)
8.4
(7.3 to 9.5)
9.3 
(8 to 10.5)
NS
MMET3 7.8 
(6.3 to 9.3)
9
(7.9 to 10.2)
10
(8.6 to 11.3)
*
0.03
DMETl 0.2 
(-0.2 to 0.7)
1.4
(0.7 to 2.1)
0.6 
(-0.2 to 1.5)
**
0.009
DMET2 0.2 
(-0.5 to 1)
2
(1.2 to 2.8)
1.3 
(0.4 to 2.3)
**
0.002
INTMET 0
(-0.6 to 0.6)
0.6
(0.1 to 1.2)
0.7 
(0.3 to 1.2)
*
0.05
Two ta iled ’t’ test: * power vs control; ** aerobic vs control
Table 8
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RESTING HEART RATE fheats/mînutel
CONTROL AEROBIC POWER
RHRl 80.6 77 82
(76.8-84.4) (71.5-82.4) (78.2-85,9)
RHR2 83.2 77.7 78.9
(77.6-88.7) (71.4-83.9) (74.3-83.4)
RHR3 80.2 79.8 79.3
(74.8-85.6) (72.6-87) (74-84.6)
Table 9
RESTING SYSTOLIC BLOOD PRESSURE fmmHgl
CONTROL AEROBIC POWER
RSBPl 131.2
(122.5-139.8)
130.4
(122.6-138.1)
128.1
(121-135.3)
RSBP2 127.3
(119.8-134.8)
125.2
(118.2-132.2)
128.8
(120-137.5)
RSBP3 122,1
(115.4-128.9)
125.2
(118.1-132.3)
125.8
(117.2-134.5)
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Table 10
HEART RATE AT SUBMAXIMUM EXERCISE (beats/mmutel
CONTROL AEROBIC POWER
SMHRl 104.1
(97.4-110.8)
106.7
(99.1-114.2)
106.2
(101.2-111.2)
SMHR2 104.1
(97.2-106.1)
99.5
(92.9-106.1)
98.2
(93.5-102.9)
SMHR3 99.7
(93.9-105.7)
99
(91.5-106.4)
97.7
(91.8-103.5)
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Table 11
RATR-PRESSIJRE PRODUCT AT SUBMAXIMUM EXERCISE fbeats/min 
mmHg>
CONTROL AEROBIC POWER
SMRPPl 15151.54
(13432.09-
16870.98)
15186.73
(13584,23-
16789.23)
17060.83
(12012.04-
22109,63)
SMRPP2 14206.58
(12922.41-
15490.74)
13145.19
(11776.65-
14513.73)
13381.25
(12246.67-
14515.83)
SMRPP3 13059.04
(12000.13-
14117.94)
13045.58
(11723.97-
14367.18)
13114.58
(11943.24-
14285.93)
Table 12
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MAXIMUM HEART RATE (beats/mini
CONTROL AEROBIC POWER
MHRl 149.5
(139.4-159.6)
144.8
(134.4-155.2)
154.8
(147.5-161.9)
MHR2 149.9
(139.4-160.5)
148.5
(137.9-159.2)
152.3
(144.1-160.6)
MHR3 145.4
(134.8-156)
150.9
(140.6-161.2)
157
(149.6-164.5)
Table 13
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TIME TO 1mm ST SEGMENT DEPRESSION (si
CONTROL AEROBIC POWER
TSTDl 526.2
(389.6-662.9)
543.5
(439.9-647.2)
538.6
(405.2-672)
TSTD2 534.4
(410.1-658.8)
525.3
(408.5-642.1)
609.6
(472.3-747)
TSTD3 579.4
(444.4-714.4)
695.5
(565.5-826.6)
641.7
(491.1-792.4)
Table 14
MAXIMUM ST SEGMENT DEPRESSION (mml
CONTROL AEROBIC POWER
MSTDl 1.23
(0.96-1-49)
1.19
(0.92-1.45)
1.44
(1.05-1.83)
MSTD2 1.24
(0.99-1.48)
1.4
(1.08-1.72)
1.58
(1.19-1.97)
MSTD3 1.13
(0.92-1.35)
1.24
(0.93-1.55)
1.52
(1.09-1.95)
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Table 15
HEART RATE FIVE MINUTES INTO RECOVERY PERIOD tbeats/minl
CONTROL AEROBIC POWER
FHRl 98.2
(92-104,5)
92.4
(85.3-99.5)
101.8
(96.8-106.7)
FHR2 97.8
(91.8-103.8)
95.2
(88.3-102.1)
97.8
(92.5-103.2)
FHR3 93.2
(85.2-101.2)
96.9
(85.7-108.2)
98.9
(92.6-105.2)
Table 16
PERCENTAGE TARGET HEART RATE ACHIEVED f
CONTROL AEROBIC POWER
PTHRl 92.2
(86-98.4)
87.9
(82.2-93.6)
95.7
(91.5-99.9)
PTHR2 92.4
(86.5-98.3)
90.4
(84.5-96.2)
95.3
(90.2-100.3)
PTHR3 91.4
(85.4-97.5)
92.1
(86.4-97.8)
97.5
(92.7-102.4)
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Table 17
MAXIMUM RATE-PRESSURE PRODUCT AND INTERVAL CHANGE
(beats/min mmHgl
CONTROL AEROBIC POWER P value
MRPPl 25079.8 
(22732.3 to 
27427.3)
23281.9 
(21156,4 10 
25407.4)
25646.3 
(23571.3 to 
27721.2)
NS
MRPP2 25212.1 
(22449 to 
27975.2)
23427.2 
(20821.2 to 
26033.1)
26003.1 
(23821.3 to 
28185)
NS
MRPP3 23181.2 
(20944.8 to 
25417.5)
23527.3 
(21028.9 to 
26025.7)
26568.1 
(24620,9 to 
28515.4)
0.023
DM1 132.3 
(-1722 to 
1986.6)
145.2
(-1797.3 to 
2087.6)
356.9 
(-1155 to 
1868.8)
NS
DM2 -1898.7 
(-3193.7 to - 
603.6)
245.4 
(-1371.7 to 
1862.5)
921.9 
(-1098.4 to 
2942.2)
0.02
INTM -2031
(-3720.6 to - 
341.3)
100.2
(-1496.2 to 
1696.5)
565
(-1057.4 to 
2187.4)
0.027
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Looking at fitness levels using recovery rate and the recovery rate 
fraction, the power group was fitter than the control group after six months 
(RR3 2p = 0.01; FRR3 2p =  0.032). There were no significant differences 
between the control and aerobic groups or between the two exercise-trained 
groups. There was a fall in the recovery rate in the control group, while that 
in the power group rose, and the aerobic group stayed static. Once again, there 
appears to be a gradation from control to aerobic to power. Those in the 
aerobic group improved their exercise performance early on, while the 
improvements in exercise performance in the power group were slower in 
onset. Both exercise-trained groups may have slightly improved their level of 
fitness. This is shown by increased exercise performance in the two groups, and 
better recovery rate, particularly in the power group (table 18).
Table 18
RECOVERY RATE Ibeats/minl and RECOVERY RATE FRACTION
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CONTROL AEROBIC POWER P
value
RRl 10
(8.9 to 11.3)
10.5 
(9.6 to 11.4)
10.6 
(9.6 to 11.6)
NS
RR2 10.2 
(8.9 to 11.6)
10.7 
(9.5 to 11.9)
11
(9.9 to 12.2)
NS
RR3 9
(7.3 to 10.7)
10.3 
(8.6 to 12)
11.8 
(10.6 to 13)
0.01
FRRl 3,3 
(3 to 3.6)
3.6 
(3.4 to 3.8)
3.4 
(3.2 to 3.7)
NS
FRR2 3.4 
(3.1 to 3.7)
3.6 
(3.3 to 3.8)
3.4 
(3 to 3.8)
NS
FRR3 3.2 
(2.7 to 3.6)
3.4 
(3.1 to 3.8)
3.7 
(3.4 to 4)
0.032
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DISCUSSION
Exercise performance on the treadmill was the primary endpoint of the 
study. This did improve with exercise training, and to a different degree with 
the two types of exercise.
In summary, the main findings fi-om the exercise test data were:
a) early and sustained improvement in treadmill time and workload in 
aerobically trained patients, with no changes in level of fitness or maximum 
myocardial oxygen consumption.
b) delayed improvement in treadmill time and workload in power trained 
patients, associated with increases in the level of fitness and maximum 
myocardial oxygen consumption.
There was a 20% increase in treadmill time in the aerobic group after 
three months’ training, with a further 10% increase at the end of six months, 
resulting in a 30% improvement in treadmill time at the end of training.
In the power group, there was an 11% increase after three months and a further 
5% increase after six months. The effect of power exercise training was 
therefore a 16% improvement in treadmill time. These compare with a 5% 
overall increase in the control group. Figure 1 shows the results of treadmill 
performance in graphical form. The asterisks represent the significant 
differences in exercise capacity discussed earlier.
There were small falls in resting heart rate (3 beats/minute) submaximum 
heart rate (8 beats/minute) and submaximum rate-pressure product (3946 
beats/minute mmHg) in the power group. Had these other markers of physical
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fitness been more prominent, they would have lent more support to the changes 
in recovery rate observed in the power group.
It is known that exercise training induces a training response’. This 
comprises a resting bradycardia, reduced heart rate and rate-pressure product 
at submaximum exercise, increased maximum exercise duration, maximum 
oxygen consumption and cardiac output and a shorter recovery time.
This effect is often described in exercise training studies (Ehsani et al 
1981; Ehsani et al 1982; Laslett et al 1985; Oberman 1988; Ades et al 1989; 
Wenger 1989). There may also be an increase in the exercise test workload at 
which ischaemia occurs (Ehsani et al 1981; Laslett et al 1985; Opasich et al 
1988).
The exercise trained groups in this study achieved this to a varying 
degree. Perhaps the intensity of training was not high enough to enable them 
to achieve all the elements of the training response. Oxygen consumption and 
cardiac output were not measured in this study.
The use of the treadmill to assess those undergoing power training may 
have been unfair. It is said that the effect of training is very specific (Jones 
1992). One could say that the assessment that was used tested endurance and 
not strength. This would mean that the aerobically trained patients would be 
at an advantage. It may have been fairer to incorporate an assessment of 
strength such as the one-repetition maximum test. Despite this possible 
limitation, the power group showed significant improvements in exercise 
capacity on a treadmill. The power exercise programme did include leg 
exercises, and the repetitive nature of the movements could have improved
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endurance. Specific tests of strength may have shown even greater benefits.
It has not yet been possible to deduce the mechanisms of the highly 
significant improvements in treadmill time and workload achieved by the 
aerobically trained patients. Nevertheless this can be translated into major 
gains in terms of physical capacity in the performance of everyday activities, 
which would occur early in the training programme.
I would suggest that aerobic training may be the preferred type of 
exercise early after coronary artery surgery, while for more protracted 
programmes, power exercise training could be introduced later on. An 
additional point in this regard concerns problems with surgical scars in patients 
using weight-training equipment soon (i.e. 6 to 12 weeks) after the operation. 
In this study, two patients had to drop out because of such problems. One had 
excessive pain in the scar, and the other had difficulty in healing of the lower 
end of the wound.
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Maximum treadmill exercise performance at each assessment(s) mean (SEM)
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STUDIES ON EXERCISE TRAINING AFTER CORONARY ARTERY 
SURGERY
To date, there have been reports on exercise training after coronary 
artery surgery in around 400 patients.
In a study of 45 subjects reported by Adams et al (1974), there were four 
CAS patients, 11 were post MI and the rest normal. The CAS patients achieved 
as much as post MI patients after aerobic training.
Six patients and six controls had a pre-operative exercise test and another 
16 weeks after surgery. After 32 months of exercise sessions 45 - 60 minutes 
daily, there were no significant change in resting heart rate or blood pressure. 
Maximum oxygen uptake increased by 28% in the exercise group and by 3% in 
the controls. Ninety percent of the total improvement in functional capacity 
had occurred by 4 months (Oldridge et al 1978).
In 51 patients eight to ten weeks after surgery, attending 16 minute 
training sessions three times a week, there was a significant improvement in 
duration of exercise and maximum work load after 8 weeks (Horgan et al 
1980).
In a non randomised study involving 27 post-CAS patients, there was a 
significant increase in maximum oxygen uptake and maximum heart rate after 
an in-patient programme of bedside exercise and early ambulation, followed by 
3 times weekly monitored callisthenics for 6 weeks (Soloff 1979).
Hartung and Rangel (1981) found that maximum oxygen uptake increased 
in 10 post-CAS patients who had 20 - 40 minutes aerobic exercise sessions 
three times weekly for three to six months.
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In the largest of the studies, Dornan et al (1982) reported on 210 males 
referred consecutively to a rehabilitation programme after coronary artery 
surgery. They had a submaximum exercise test at 8 weeks, followed by 12 
weeks training and a repeat exercise test. The patients were divided into those 
who were on drugs and those who were not. Age and extent of 
revascularisation did not appear to influence exercise tolerance. Both groups 
improved significantly after training, but those who were on drugs performed 
worse.
In a retrospective study of 22 patients, it was found that those who 
dropped out of a rehabilitation programme did worse in terms of exercise 
performance, employment status and re-hospitalisation rates (Waites et al 
1983).
In the PERFEXT study, post-CAS patients formed a third of the group, 
and they showed the haemodynamic benefits, such as higher maximum oxygen 
uptake, that were demonstrated in the other types of patients. This was 
particularly so in the subgroup with angina (Froelicher et al 1985).
All of these studies therefore show that exercise training does improve 
exercise capacity after coronary artery surgery.
As mentioned before, most of them included CAS patients as part of a 
larger group of cardiac patients. None of these previous studies addressed the 
effects o f power training.
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The present study was concerned with establishing the effects of exercise 
rehabilitation on a group comprising only surgical patients.
The main results of the exercise test data are in keeping with what has 
gone before. It also adds a new dimension and extends our knowledge by 
assessing the effects of power (strength) training after coronary artery surgery.
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STUDIES INVOLVING STRENGTH TRAINING IN CARDIAC PATIENTS
Power or strength training is usually recommended in cardiac patients 
only after a period of aerobic training has been completed (Crozier Ghilarducci 
et al 1989; Sparling et al 1990; McKelvie & McCartney 1990). There are 
limited reports on its effects in normal subjects and cardiac patients (Effton 
1989; Stewart 1989; Kelemen 1989; Hill & Butler 1991; Verrill et al 1992; 
Stewart 1992). Most would recommend circuit weight training as was used in 
this study (Kelemen et al 1986).
Nine stable aerobically trained cardiac patients had strength training 30 
minutes a day, three times a week for 10 weeks. They exercised at 80% 
maximal voluntary contraction at five stations. Heart rate and blood pressure 
were monitored during exercise. No signs or symptoms of ischaemia, abnormal 
heart rate or blood pressure responses occurred. Body weight, skin fold 
thickness, girth and maximal voluntary contraction were measured. Quadriceps 
girth increased by 11%. Maximal voluntary contraction increased by up to 
53% (Crozier Ghilarducci et al 1989).
Sixteen men in cardiac rehabilitation had circuit training at twelve 
stations as a supplement to their aerobic exercise for six months. Significant 
improvement in strength was observed, with 22 % increases for all 12 exercises. 
There were no changes in body weight or percent fat (Sparling et al 1990).
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Where direct comparisons have been made between aerobic and strength 
training, the physiological responses to the latter have been less alarming than 
expected (McCartney et al 1993).
Collins et al (1991) studied 15 men. During circuit weight training at 40, 
50, 60 and 70% of one repetition maximum, percent VO2 max was consistently 
lower than that predicted for dynamic exercise such as running or cycling, for 
a given percent of maximum heart rate. They concluded that using heart rate 
to prescribe the intensity of weight lifting exercise results in a lower level of 
aerobic metabolism than during dynamic exercise.
Twelve men with CAD exercised to fatigue at four stations in a circuit. 
The responses were compared to that on a treadmill. There was less ischaemia, 
lower peak heart rate and rate pressure product, similar peak systolic pressure, 
but higher diastolic pressure (Featherstone et al 1993).
After a six week period of aerobic exercise, 25 patients were divided into 
two groups. Thirteen patients continued with the aerobic programme for another 
six weeks. Twelve patients performed 15 minutes of aerobic exercise in 
addition to upper body circuit weight training. Peak heart rate and rate 
pressure product were similar, but peak systolic blood pressure was higher 
during aerobic exercise than circuit training. Treadmill time increased in both 
groups, but upper body strength increased only in the circuit weight training 
group (Butler et al 1992).
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Combined weight lifting and aerobic exercise training (10 patients) 
resulted in greater improvements in both cycle ergometer performance and one 
repetition maximum than did aerobic training alone (8 patients). After aerobic 
training the one repetition maximum increased by 4 - 13%, compared to 21 - 
43% after combined training; cycle ergometer power output increased by 2% 
and 15% respectively and cycling time also increased significantly more in the 
combined training group (McCartney et al 1991).
Power training therefore improves aerobic capacity. The results of the 
present study are in keeping with this view. Muscular strength is also 
improved by power training; this was not assessed in the study.
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SECTION IX
HAEMOSTATIC FACTORS
There have been many reports on the effects of acute exercise on 
platelets and their function, clotting factors and fibrinolysis in normals and in 
those with CAD. These have yielded varying results; increased platelet count 
and adhesiveness potentiation of coagulation by increased factor VIII levels, 
and enhanced fibrinolysis (latridis & Ferguson 1963; Menon et al 1967; 
Ferguson & Guest 1974; Davis et al 1976; Sarajas 1976; Speiser et al 1988). 
Prolonged aerobic exercise causes strong activation of the fibrinolytic system, 
slight increase in platelet count, and no change in platelet function, or in 
prothrombin time. Static exercise of short duration has no effect on platelet 
function, coagulation and fibrinolytic activity. Repeated bouts of maximum 
exercise with acidosis, causes a significant increase in platelet count and 
function, and fibrinolytic activity (Drygas 1988).
In contrast, little is known about the effects of chronic exercise training 
on haemostatic factors (Ferguson & Guest 1974; Sellier et al 1988; Connelly 
et al 1992; Wosornu et al 1992). The effects of physical conditioning on 
fibrinolysis are known. After training on a treadmill for ten weeks, the 
fibrinolytic response to venous occlusion is augmented (Williams et al 1980). 
Regular vigorous sporting activity enhances blood fibrinolysis by reducing 
plasminogen activator inhibitor capacity in normals, but not always in post-MI 
patients in a rehabilitation class (Estelles et al 1989). Marathon runners have 
greater increases in fibrinolytic activity compared with that achieved by joggers
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and previously sedentary persons (Ferguson et al 1987).
This part of the study was concerned with establishing the effects of the 
training programme on haematological factors that could influence subsequent 
cardiovascular events .
METHODS
Forty five millilitres (ml) of venous blood were drawn through 
indwelling cannulae, after an overnight fast. The first 30 ml were used for 
lipoprotein analysis. Haemoglobin, platelet count and haematocrit were all 
measured in five ml of blood in the standard way using a Coulter counter.
Five ml were for assays of factor VII and fibrinogen , and the remaining 
five ml for assay of fibrinopeptide A. The technicians performing the assays 
were not aware of the patients* groups. Samples were stored at -85oC in 
plastic containers and tested in batches. Factor VIIc and fibrinogen samples 
were stored for up to two weeks, fibrinopeptide A samples were stored for up 
to six weeks.
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Factor VIIc assay.
This was done by bioassay of the activity of VIIc in plasma, and 
measured by the amount of correction of the one-stage prothrombin time 
obtained when the patient’s plasma was added to factor Vll-deficient plasma. 
The reagents required are available commercially and include factor VII- 
deficient plasma, saline extract of brain, Owren’s buffer (pH 7.35), 0.025M 
calcium chloride, patient’s citrated platelet-poor plasma, and reference plasma 
containing lOOiu/dl of factor VII. After preparing serial dilutions of the 
reference plasma in Owren’s buffer, 0.1 ml of factor Vll-deficient substrate 
plasma, 0.1 ml of normal plasma dilution and 0.1ml of saline extract of brain 
are placed in a glass test tube in a water bath at 37oC. The mixture is 
incubated for 30s , and 0.1ml of 0.025M calcium chloride is added. The 
clotting time is recorded. Each dilution is so tested twice, and the average 
clotting time is plotted on a double-log graph paper against calculated plasma 
factor VII level. The 1 in 10 dilution of normal plasma is considered to contain 
1 unit of factor VII activity per ml. The patient’s plasma is similarly assayed, 
with dilutions tested depending on the approximate expected factor VII levels. 
The clotting time of the dilution of patient’s plasma is converted to factor VII 
activity by extrapolation from the standard graph.
The normal range is 60 - 150iu/dl.
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Fibrinogen assay
This is also a bioassay and a standard procedure. It is done using 
Multifibren (Behring) and a modification of the Clauss method. Multifibren 
consists of lyophilised alpha-thrombin from bovine plasma. The principle is 
that citrated plasma is clotted by the addition of a relatively large amount of 
thrombin, clotting time depending mainly on the fibrinogen content of the blood 
sample. Plasma is diluted 1 in 9 with barbital buffer solution (pH 7.6) and the 
assay performed within 15 minutes. 0.2 ml of citrated plasma solution and 0.2 
ml of Fibrintime are placed in a prewarmed test tube at 37oC, incubated for 
60s, and 0.2 ml of Multifibren added. The clotting time is recorded. The 
result is converted to g/dl using a standard table of values supplied in the kit. 
Reference curves are checked using supplied control plasma (lyophilised human 
plasma).
The normal range is 1.8 - 3.5g/dl.
Fibrinopeptide A assay
The assay is based on enzyme linked immunosorbent assay (ELISA) 
techniques (Boehringer Mannheim). Incubation of constant amounts of 
fibrinopeptide A (FPA) antibody with the sample leads to the formation of 
antigen-antibody complexes. The concentration of residual excess antibody is 
inversely proportional to the amount of FPA in the sample. To determine the 
concentration of antibody, aliquots of the incubation mixture are transferred
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into reaction vessels coated with excess FPA, for subsequent incubation. The 
wall-bound antigen-antibody complexes obtained form sandwich complexes with 
peroxidase labelled anti immunoglobulin G antibodies. The amount of these 
complexes provides a direct measure of FPA concentration in the sample. The 
sandwich complexes obtained are determined by enzymatic reaction of 
peroxidase with hydrogen peroxide/orthophenylene-diamine (a chromogen), and 
subsequent spectrophotometric measurement at 492nm. Due to the inverse 
relationship of bound enzyme activity and antigen concentration, the measured 
absorbances decrease as FPA concentration increases. The results are further 
evaluated by constructing a reference curve with standards of known 
concentration. Normal values are <  3 ng/ml.
RESULTS
The results presented are on 55 patients (71.4%) in whom the full 
complement of haematological results are available. In the remainder, some 
samples were clotted, or otherwise unsuitable for assay (e.g. delay in reaching 
the laboratory).
There were 20 patients each in control and power groups, and 15 in the 
aerobic group.
There were no significant changes in haemoglobin, haematocrit, or 
platelet count (table 19).
Fibrinopeptide A levels were positively skewed, and the results were 
therefore analysed by non-parametric methods. There were no significant
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changes in FPA with time, and the results are presented as median and range 
(table 20).
At baseline, 69% of controls, 74% of aerobic and 87.5% of power 
groups had levels in the normal range. At three months, these figures were 
50%, 81.5% and 79.2% respectively. At six months, they were 69.2%,59.3% 
and 70.8%. So apart from the control group at three months, the majority of 
patients had FPA levels in the normal range.
The abnormal values ranged from 3 to 66 ng/ml. In the aerobic group, 
a patient, A C ,  developed angina during the course of the study. His FPA 
levels were 0.5 ng/ml, 14 ng/ml and 44ng/ml at baseline, three and six months 
respectively. In the power group, J.C. developed angina after three months. 
His FPA level rose from 0.8ng/ml then to 18ng/ml at six months. From these 
two examples, one wonders if the levels could have been related to patients* 
symptoms or the underlying dynamics of their coronary circulation. Obviously, 
these are anecdotal in the context of this study, but still worthy of mention in 
the light of previous studies showing high FPA levels in patients with unstable 
angina (Eisenberg et al 1985; Theroux et al 1987). The true significance of the 
abnormally high FPA levels encountered in this study is not, however, entirely 
clear.
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Table 19
HAEMOGLOBIN.fg/dll HAEMATOCRIT (%)  AND PLATELET COUNT
CONTROL AEROBIC POWER
HBl 14.8 
(14.1 to 15.5)
14.7 
(14.3 to 15.1)
15.1 
(14.7 to 15.5)
HB2 14.7 
(14 to 15.3)
14.6 
(14.2 to 15)
15
(14.6 to 15.4)
HB3 14.6 
(13.9 to 15.4)
14.9 
(14.5 to 15.3)
15.1 
(14.7 to 15.5)
HCTl 43.5 
(41.5 to 45.4)
43.1 
(41.8 to 44.5)
44.5 
(43.2 to 45.8)
HCT2 43.2 
(41.5 to 44.9)
42.6 
(41.5 to 43.7)
43.7 
(42.3 to 45.1)
HCT3 42.5 
(40.6 to 44.5)
43.7 
(42.6 to 44.7)
43.8 
(42.5 to 45.1)
PLTl 286 
(257 to 315)
271 
(238 to 304)
273 
(245 to 301)
PLT2 290 
(259 to 321)
260 
(230 to 290)
254 
(226 to 282)
PLT3~ 299 
(256 to 341)
261 
(230 to 292)
255 
(230 to 280)
Table 20
FIBRINOPEPTTDE A LEVELS fng/mÜ
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CONTROL AEROBIC POWER
FPAl 0.65 (0.2-66) 0.9 (0.2-15) 0.8 (0.2-46)
FPA2 2.55 (0.2-41) 1.0 (0.2-45) 0.9 (0.3-44)
FPA3 1.5 (0.2-40) 1.2 (0.3-44) 1.0 (0.2-50)
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Results for fibrinogen levels are in table 21. There was a 12% reduction in 
fibrinogen levels in the aerobic group at the and of the study. This was evident 
at three months (p — 0.01), and was maintained at six months (p =  0.04). At 
six months, there was a 2% reduction in fibrinogen in the power group, and a 
4% reduction in the control group, but these did not achieve statistical 
significance.
*P* values for interval change in fibrinogen levels between the groups 
highlights the reduction in the aerobic group, (table 22) At three months, 
aerobic vs control p = 0  .0004, control vs power p = 0.07, aerobic vs power 
p =  0.0002. At six months, aerobic vs control p =  0.02, control vs power 
p =  0.09, aerobic vs power p =  0.05. The interval changes in fibrinogen level 
in the aerobic group at three months and at six months were both statistically 
significant (p =  0.01 and 0.04 respectively).
In this subgroup of patients, aerobic exercise caused an early and 
sustained fall in fibrinogen levels. Based on results of epidemiological surveys, 
this change would be considered a favourable one. It was not the purpose of 
the study to establish the mechanism for this. Smoking increases fibrinogen 
levels, but does not play a major part here since the majority of the patients 
were ex-smokers at the start of the study.
Factor VIIc levels rose with exercise training in the aerobic group, but 
fell very slightly in the power group, so that at the end of training, the 
difference in the two exercise groups was significant (power vs aerobic 
p =0.008; power vs control p=0.06) (table 23),
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Table 21
FIBRINOGEN LEVELS (g/dfi mean (SEMI
Baseline 3 months 6 months
CONTROL 3.48 (0.22) 3.87 (0.30) 3.34 (0.19)
AEROBIC 3.40 (0.21) 2.96 (0.16) 2.98 (0.16)
POWER 3.18 (0.12) 3.33 (0.13) 3.12 (0.12)
Table 22
INTERVAL CHANGE FROM BASELINE IN FIBRINOGEN LEVELS Ig/dll 
mean 195% CO
3 months 6 months
CONTROL 0.36 (-0.18 to 0.56) 0.15 (-0-42 to 0.12)
AEROBIC -0.43 (-0.63 to-0.23) 0.41 (-0.7 to -0.12)
POWER 0.15 (-0.05 to 0.35) -0.06 (-0-26 to 0.14)
Table 23
FACTOR VIIc LEVELS üu/dl) mean fSEM)
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Baseline 3 months 6 months
CONTROL 101.22 (4.31) 107.95 (4.5) 109.6 (4.8)
AEROBIC 100.4 (6.73) 108.2 (6.65) 113.67 (5.62)
POWER 105.8 (4.24) 107 (4.45) 104.4 (3.39)
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DISCUSSION
The Northwick Park Heart Study showed that factor VII and fibrinogen 
are independent risk factors for coronary artery disease (Meade et al 1986). 
The haemostatic system had previously been associated with CAD (Merskey et 
al 1960; Chakrabarti et al 1968; Stone & Thorp 1985) and with stroke 
(Wilhelmsen 1984). There have since been other epidemiological studies 
confirming the importance of the haemostatic system in arterial disease, 
transient ischaemic attacks, stroke, angina, myocardial infarction and peripheral 
vascular disease (Kannel et al 1987; Small et al 1988; Lee et al 1990; Qizilbash 
et al 1991; Yamell et al 1991; Elwood et al 1993; Meade et al 1993).
Fibrinogen levels are raised in inflammation, as it is an acute phase 
protein. It is also raised in smokers, older people, hyperlipoproteinaemia, 
hypertension, diabetes, obesity, and in sedentary persons (Meade 1987). All 
these are known risk factors for coronary artery disease.
High fibrinogen levels increase plasma viscosity, and platelet 
adhesiveness, therefore promoting a tendency to thrombosis. There is a linear 
relationship between the fibrinogen level and the risk of CAD, and this operates 
even within the physiological range (Meade et al 1985).
To date, there is no simple and safe drug known to reduce fibrinogen 
levels. Those tried so far are ticlopidine, nisoldipine, stanozolol, 
oxpentifylline, calcium dobesilate, propranolol, and the fibrates (Ernst 1991). 
None can be recommended solely for its fibrinogen-reducing properties. 
Exercise training might be a more innocuous method of trying to influence 
haemostatic factors.
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Factor VII levels correlate positively with dietary fat, plasma cholesterol 
and triglyceride levels. It is high in oral contraceptive users, older persons, 
obesity, diabetes. Factor VII activity is inhibited only slowly in plasma, 
because unlike other coagulation factors, it is not countered by natural 
inhibitory activity. Its assay is a good measure of coagulable potential. Its 
activity influences the rate of thrombin formation (Miller et al 1986).
As applied to CAD, hypercoagulability refers more to pro-coagulatory 
than to the anti-coagulatory influences. There is little information on this aspect 
in relation to exercise. Acute exercise has not been shown to affect fibrinogen, 
factors V, VII, or X levels (latridis & Ferguson 1963). Strenuous exercise has 
been shown to be associated with significantly lower fibrinogen concentrations 
than mild exercise, in a cross-sectional study, while more frequent strenuous 
exercise was associated with lower factor VII activity (Connelly et al 1992).
With regard to coronary artery surgery, this could have implications for 
preventing further cardiovascular events and improving graft patency. 
Although CAS prolongs life in selected patients, it does not prevent subsequent 
myocardial infarction, because revascularisation does not in itself halt the 
progression of atheroma. In addition, venous grafts are particularly prone to 
thrombosis and occlusion.
If it were possible to influence haemostatic factors favourably by means 
of exercise, it would provide another mechanism for secondary prevention in 
CAD.
Thrombin is a potent platelet aggregating agent and vasoconstrictor. 
Thrombin activity, as measured by fibrinopeptide A (FPA) levels, is increased
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in patients with unstable angina, myocardial infarction and sudden death 
(Meade et al 1984; Eisenberg et al 1985; Theroux et al 1987; Willensky et al
1989). Thrombin is difficult to measure directly, because of its very short half- 
life. Fibrinopeptide A, which is cleaved from fibrinogen by thrombin, is a 
reliable indicator of thrombin activity. In the Northwick Park Heart Study, an 
in vivo correlation between factor VII activity and fibrinopeptide A was shown 
(Miller et al 1986; Meade 1987).
Haemoglobin concentration, haematocrit and platelet count all contribute 
to plasma viscosity and the propensity to blood sludging up and clotting 
especially in large vessels.
Fibrinogen and factor VIIc are now accepted as independent risk factors 
for CAD. That high levels are associated with an increased incidence of CAD 
has been shown by several epidemiological studies. As is the case for lipids, 
the search for non-pharmacological ways of altering the levels of these 
haemostatic factors is worthwhile. No drug has been found to do this 
innocuously.
As such, the finding that aerobic exercise training for six months caused 
a 12% reduction in fibrinogen levels is an exciting one. It would represent a 
substantial reduction in cardiovascular risk for the patients. The relation 
between fibrinogen levels and cardiovascular risk is a linear one. For every 
fall of O.lg/1 in fibrinogen concentration, there is a 15% reduction in 
cardiovascular risk (Connelly et al 1992). Thus the fall of 0.41g/l in the 
aerobic-trained group at the end of six months, translates into a 61.5% 
reduction in risk.
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In their cross-sectional study, Connelly et al (1992) found that fibrinogen 
levels were lower in those who took strenuous exercise (2.7g/l) compared to 
those who took mild or no exercise (2.77g/l). In that study and in others of 
similar nature, questionnaires were used to assess the extent to which the 
subjects exercise, and would be prone to errors of reporting, particularly 
overestimation of strenuous activity in those reporting that. The authors felt 
that this would have led to an underestimation of the actual difference in 
fibrinogen concentrations between the exercise levels. In all these studies, 
there has been an inverse relationship between level of exercise and fibrinogen 
concentration. In some, but not all, the differences reached statistical 
significance, and were independent of smoking.
Reports of longitudinal follow up of fibrinogen and factor VII in cardiac 
patients after exercise training are scanty. There is a report from Russia of a 
fall in fibrinogen with training in a group of cardiac patients (Dudaev et al 
1986).
Other risk factors for ischaemic heart disease that work through an effect 
on fibrinogen levels are smoking, old age, obesity, diabetes, stress at work, and 
retarded growth during infancy. In women, use of the oral contraceptive pill 
and the menopause are additional factors. Cessation of smoking definitely 
reduces plasma fibrinogen levels (Meade 1987). It would now appear that 
exercise training also does the same.
Factor VIIc levels are low in those undertaking strenuous exercise 
frequently, thereby suggesting that it also is influenced by exercise (Connelly 
et al 1992). Perhaps the patients in my study did not achieve the level of
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exercise required to lower factor VII concentrations, hence the result obtained 
of an increase in the aerobic-trained group and a very small fall in the power- 
trained group.
The patients were not given specific dietary advice. Dietary variations 
could have been a factor in the differences seen in factor VIIc levels.
The rise in factor VIIc levels in the aerobic group is disappointing and 
may be thought to offset the benefit of low fibrinogen levels. The relationship 
between fibrinogen and non-fatal ischaemic heart disease is linear, but that for 
factor VIIc is as yet unknown.
The reduction in risk of ischaemic heart disease associated with vigorous 
exercise in leisure time is possibly mediated partly through reductions in the 
levels of these haemostatic factors. Exercise has not been shown to affect total 
cholesterol levels consistently, but is known to increase high density lipoprotein 
cholesterol levels, another risk factor in ischaemic heart disease. The next 
chapter section addresses this issue.
Haemoglobin, haematocrit and platelet numbers were not affected by the 
exercise training programme. I was unable to perform more sophisticated tests 
of platelet and red cell function and aggregability, and of blood rheology. 
These may have provided further insights into exercise training and blood 
coagulability, and are worth exploring in the future.
Fibrinopeptide A is a marker of thrombin activity and active clotting. 
Levels are raised in unstable angina and acute myocardial infarction. This 
study did not demonstrate any change in FPA levels after exercise training in 
a group with relatively stable coronary artery disease. This is perhaps not that
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surprising. One would not expect ongoing clot formation in these men. None 
of the patients developed myocardial infarction during the study, although as 
mentioned earlier, two patients had an unstable phase. In addition, there was 
a wide variation in the FPA levels even within patients making it impossible for 
between group changes to shine through.
The results shown here have been published (Wosornu et al 1992). They 
are impressive and worthy of further investigation. The differences between 
and within the groups reached very high levels of statistical significance. In 
the case of haemostatic factors in post-CAS patients, this implies high levels of 
clinical significance as well.
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SECTION X
LIPIDS & LIPOPROTEINS
Lipids and their subfractions are known risk factors for coronary artery 
disease. High total cholesterol (TC), high low density lipoprotein (LDL) and 
low high density lipoprotein (HDL), especially HDL subfraction 2, are 
associated with risk of death from cardiovascular causes. This has been shown 
in several primary prevention studies (Miller et al 1977; Gordon et al 1981; 
Stamler et al 1986; Martin et al 1986; Canner et al 1986; Frick et al 1987; 
Manninen et al 1988; Holme 1990). Secondary prevention studies have 
conHrmed these findings with good evidence of regression of CAD following 
treatment of dyslipidaemia (Amtzenius et al 1985; Blakenhorn et al 1987; 
Passamani 1987; Carlson & Rosenhamer 1988). For every 1% reduction in 
cholesterol, an estimated 2.5% reduction in CAD incidence occurs (Holme
1990). In the Lipids Research Clinics Coronary Primary Prevention Trial 
(1984), there was a 19% reduction in risk of CAD death or non-fatal 
myocardial infarction in the treated group. The effects of triglycerides and 
very low density lipoproteins (VLDL) are less clear, but they are being 
implicated more and more in CAD and in graft occlusion (Scwandt 1990). In 
addition, raised triglyceride levels are associated with hypercoagulability 
(Meade 1987). A high proportion of patients undergoing CAS have abnormal 
lipid profiles (Thompson & Sapsford 1985; Billington et al 1989). Attention 
should be directed at correcting these abnormalities.
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High baseline cholesterol levels are associated with reduced graft 
patency, as shown by angiographic and post mortem studies (Campeau et al 
1984; Campeau & Sniderman 1985; Bourassa et al 1986; Neitzel et al 1986). 
Coronary atherosclerosis regresses with treatment of hyperlipidaemia (Kane et 
al 1990; Brown et al 1990; Loscalzo 1990; Barth & Amtzenius 1991; Watts et 
al 1992). Progression of atherosclerosis correlates best with total cholesterol 
and LDL levels, while regression correlates with HDL levels (Barth & 
Amtzenius 1991). In the Cholesterol Lowering Atherosclerosis Study, 
aggressive diet and dmg therapy (colestipol and niacin) caused significant 
changes in cholesterol levels (43% reduction in LDL, 37% increase in HDL), 
and slowed the rate of development and progression of atheroma in coronary 
arteries and vein grafts (Blakenhom et al 1987).
Apolipoprotein A-1 (Apo-Al) is the major protein component of HDL. 
Apolipoprotein B (Apo-B) is a structural protein of chylomicrons, VLDL and 
LDL (Ball & Mann 1986). They have been shown to be better indicators of the 
risk of CAD than HDL and LDL. A high level of Apo-B and a low level of 
Apo-Al indicate an increased risk of CAD (Kostner 1987; Durrington et al
1988).
In normal persons after exercise training, plasma cholesterol falls by 4 
13% and triglycerides by 9 - 42% (Sellier et al 1988). Increases in HDL have 
also been found (Huttunen et al 1979; Danner et al 1984; Blumenthal et al
1991).
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Exercise training improves lipoprotein profiles in patients with CAD and 
after myocardial infarction (Erkelens et al 1979; Streja & Mymin 1979; 
Ballantyne et al 1982; Heath et al 1983; Schuler et al 1988; Agren et al 1989; 
Baardman et al 1990). In a meta-analysis of 15 trials involving 490 males, 
trained on average for four 45-minute sessions per week for 25 weeks, there 
was a reduction in total and LDL cholesterol, choIesterol/HDL ratio, and an 
increase in HDL. The total cholesterol level decreased from 5.99 to 5,71 
mmol/1; LDL from 3.75 to 3.62 mmol/1; cholesterol/HDL ratio from 5.7 to 
5.0; and HDL increased from 1.06 to 1.16 mmol/1 (Vu Tran & Brammell 
1989).
Decreases in body weight associated with exercise training exert some 
influence on the changes in lipid levels in some but not all of the trials (Vu 
Tran & Weltman 1985; Krauss 1989). Training must be of sufficient intensity 
and duration to be effective in improving lipoprotein profiles.
The mechanisms by which exercise training modifies lipid levels are 
uncertain. Increased lipoprotein lipase activity in skeletal muscle, adipose 
tissue and liver has been suggested (Kiens & Lithell 1989; Weintraub et al
1989). Exercise may also induce increased insulin sensitivity (Jennings et al 
1986). Exercise increases the supply of triglyceride-rich lipoproteins to 
lipoprotein lipase, by enhancing muscle blood flow. This causes increased 
lipolysis and generation of nascent HDL in muscle capillaries (Ruys et al 1989; 
Lewis 1990).
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To assess the effects of exercise training on lipoprotein levels after 
coronary artery surgery, the patients in the present study had lipid levels 
measured at baseline, three and six months.
METHODS
Thirty millilitres of venous blood for lipid analysis were taken after an 
overnight fast. The serum samples were stored at 4°C for up to three days, and 
tested in batches. The technicians performing the assays were not aware of the 
patients' groups.
Total cholesterol and triglyceride were assayed by automated analysis using 
enzymatic colorimetric tests (Boehringer Mannheim). For cholesterol, after 
estérification and oxidation, the resultant colour was measured at 500nm, For 
triglyceride, the reaction involved hydrolysis, with subsequent enzymatic 
determination of the liberated glycerol, also by colorimetry at 500nm.
Normal ranges: cholesterol <5.2mmol/l; triglyceride <2.3mmol/l
Lipoproteins were measured by beta-quantification. They can be selectively 
precipitated by adding combinations of sulphated polysaccharides and divalent 
cations to plasma. Five millilitres of plasma in a thermoplastic ultracentrifuge 
tube is overlayered with normal saline. The tube is sealed with a cap and spun 
at 35,000rpm at 4<>C for 18 hours. Two fractions are obtained. The top 
fraction contains VLDL, and the bottom fraction contains HDL and LDL. The
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LDL can be precipitated with heparin and manganous chloride, leaving HDL 
in solution. The individual fractions are analysed to obtain a measure of the 
lipoprotein levels. Total cholesterol, triglyceride, cholesterol in bottom 
fraction, HDL in bottom fraction, and cholesterol in the top fraction (VLDL) 
can be measured directly. Then LDL can be calculated as bottom cholesterol 
minus HDL cholesterol. A calculated VLDL can also be obtained as total 
cholesterol minus bottom fraction. The measured VLDL (from the top fraction) 
should agree with the calculated VLDL by ±  0.35.
HDL subfraction 2 and 3 masses were estimated by rate zonal 
ultracentrifugation with ultraviolet scanning (Beckman Instruments). Serum 
with its optical density specially adjusted, is centrifuged at 42,000 rpm for two 
hours. Under these conditions, HDL is buoyant and so floats through the 
centrifuge cell at a rate which is a function of its density. As it does so 
absorbance at 280nm is monitored periodically by the ultraviolet scanning 
equipment. This shows a decrease in absorbance at the periphery of the cell. 
After the allotted time, the cell is scanned, and the change in absorbance within 
two specified flotation intervals (3.5 to 9 and 0 to 3.5) is recorded. This is 
compared to a template with previously determined boundaries for the specified 
flotation intervals, and the height at which they cross the absorption curve is 
measured in millimetres. The differences between the two flotation intervals 
are calculated and this is converted, using specific molar absorptivities, to give 
concentrations of HDL2 and HDL3.
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Apolipoprotcins Al and B were measured by immunochemical assay (Orion 
Diagnostica). It is based on measurement of immunoprécipitation in the liquid 
phase. In conditions of antibody excess (anti-sera to Apo-Al and Apo-B), the 
amount of precipitate is proportional to the apolipoprotein concentration in the 
serum. The measurements are performed by analysers at wavelength of 340nm. 
The absorbances are converted to sample concentrations by referring to standard 
graphs, and reference solutions supplied in the kit.
Reference ranges; Apo-Al 0.20 - 2,50g/l; Apo-B 0.15 - 2.00g/l.
RESULTS
There were sixty nine complete sets of data and these are presented in this 
section. The results are presented as mean and its 95% confidence interval for 
each group at each assessment (tables 24 to 33). As in other tables, suffix ’1’ 
denotes baseline, '2 ’ three month, and ’3’ denotes six month assessment. 
Levels are in mmol/1 unless otherwise specified.
Table 24
TOTAL CHOLESTEROL
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CONTROL AEROBIC POWER
TCI 6.51 
(6.05 to 6.98)
6.2
(5,72 to 6.68)
6.56 
(6.19 to 6.92)
TC2 6.41 
(5.95 to 6.87)
6.12 
(5.74 to 6.51)
6.26 
(5.90 to 6.62)
TC3 6.18 
(5.69 to 6.66)
6.19 
(5.80 to 6.79)
6.39 
(5.98 to 6.79)
Table_25
TRIGLYCERIDE
CONTROL AEROBIC POWER
TRIGl 2.09 
(1.66 to 2.51)
2.01 
(1,6 to 2.42)
1.98 
(1.59 to 2.36)
TRIG2 2.34 
(1.81 to 2.88)
2.21 
(1.79 to 2.63)
1.86 
(1.55 to 2.17)
TRIG3 2.16 
(1.66 to 2.66)
2.06 
(1.66 to 2.46)
1.94 
(1.62 to 2.27)
Table_26
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VERY LOW DENSITY LIPOPROTEIN
CONTROL AEROBIC POWER
VLDLl 0.99 
(0.79 to 1.19)
1.04 
(0.7 to 1.37)
0.90 
(0.73 to 1.06)
VLDL2 1.09 
(0.81 to 1.36)
1.04 
(0.81 to 1.28)
0.89 
(0.74 to 1.04)
VLDL3 1.01 
(0.76 to 1.26)
1.04 
(0.83 to 1.25)
0.85 
(0.73 to 0.98)
Table 27
LOW DENSITY LIPOPROTEIN
CONTROL AEROBIC POWER
LDLl 4.36 
(3.99 to 4.73)
4.06 
(3.65 to 4.47)
4.43 
(4.15 to 4.7)
LDL2 4.25 
(3.86 to 4.64)
3.96 
(3.64 to 4.28)
4.28 
(3.99 to 4.56)
LDL3 4.04 
(3.67 to 4.4)
3.97 
(3.64 to 4.31)
4.30 
(3.96 to 4.65)
Table 28
HIGH DENSITY LIPOPROTEIN
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CONTROL AEROBIC POWER
HDLl 1.16 
(1.06 to 1.26)
1.22 
(1.12 to 1.32)
1.24 
(1.13 to 1.33)
HDL2 1.09 
(1.01 to 1.17)
1.15 
(1.07 to 1.23)
1.16 
(1.04 to 1.28)
HDL3 1.12 
(0.98 to 1.25)
1.15 
(1.07 to 1.23)
1.23 
(1.11 to 1.35)
Table_29_
HDL/TOTAL CHOLESTEROL RATIO
CONTROL AEROBIC POWER
RATIOl 0.18 
(0.16 to 0.2)
0.2
(0.18 to 0.23)
0.19 
(0.17 to 0.21)
RATI02 0.17 
(0.16 to 0.19)
0.19 
(0.17 to 0.21)
0.19 
(0.17 to 0.21)
RATI03 0.18 
(0.16 to 0.2)
0.19 
(0.17 to 0.21)
0.2
(0.18 to 0.22)
Table 30
HDL SllBFRACTlON 2
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CONTROL AEROBIC POWER
HDL2(1) 58.4 
(46.9 to 69.9)
68.0 
(52.4 to 83.4)
61.9 
(48.7 to 75.1)
HDL2(2) 58.5 
(47.1 to 69.9)
64.1 
(51.9 to 76.4)
62.1 
(47.8 to 76.4)
HDL2(3) 62.7 
(49.2 to 76.1)
63.0 
(49.7 to 76.2)
65.5 
(50.8 to 80.2)
Table 31
HDL SUBFRACTION 3 (mg%>
CONTROL AEROBIC POWER
HDL3(1) 224.5 
(203.3 to 245.6)
225.9 
(200.5 to 251.3)
240.4 
(222.3 to 258.4)
HDL3(2) 221.8 
(202.8 to 240.8)
222.9 
(207.7 to 238.2)
225.2 
(200.2 to 250.2)
HDL3(3) 219.7 
(202.0 to 237.4)
227.9 
(207.9 to 247.9)
235.9 
(212.8 to 259.0)
Table 32
APOLIPOPROTEIN Al (g/11
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CONTROL AEROBIC POWER
APOAl(l) 1.13 
(1.05 to 1.22)
1.16 
(1.09 to 1.23)
1.25 
(1.07 to 1.43)
APOAl(2) 1.12 
(1.03 to 1.21)
1.14 
(1.08 to 1.21)
1.22 
(1.04 to 1.40)
APOAl(3) 1.14 
(1.05 to 1.22)
1.09 
(1.03 to 1.15)
1.21 
(1.10 to 1.31)
Table 33
APOLIPOPROTEIN B (g/n
CONTROL AEROBIC POWER
APOBl 1.22 
(1.09 to 1.36)
1.13 
(1.01 to 1.25)
1.17 
(1.07 to 1.26)
APOB2 1.20 
(1.08 to 1.33)
1.11 
(1.00 to 1.22)
1.11 
(1.00 to 1.22)
APOB3 1.13 
(1.01 to 1.25)
1.14 
(1.02 to 1.26)
1.15 
(1.05 to 1.26)
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DISCUSSION
The total cholesterol and LDL levels were higher than is ideal in post- 
CAS patients, but it is not a surprising finding among patients with established 
coronary artery disease in the West of Scotland. Average levels of total 
cholesterol reported in Scottish studies are 6.48 to 6.95 mmol/1 (Scottish 
Society of Physicians 1971; Isles et al 1989).
There were no statistically significant changes in any of the lipid and 
lipoprotein levels at any time.
There are several possible explanations for this lack of effect of the 
exercise programmes on lipoprotein levels in these men.
The patients in the exercise programmes may not have exercised 
sufficiently hard and long to cause such changes. This is borne out by their 
failure to achieve a full training effect. It has been suggested that 
improvements in lipoprptein profiles with training may be due to the training 
effect. They were found to correlate best with changes in VO2 max, and are 
maximal in patients with initially low VO2 max, high LDL and low HDL (Heath 
et al 1983). However high density lipoprotein has been shown to increase after 
thirteen weeks of exercise training without changes in diet, smoking or the 
achievement of training effect (Streja & Mymin 1979). It is therefore not clear 
exactly what the relation is between lipid changes and cardiovascular fitness. 
Some investigators suggest that exercise increases the production of HDL 
cholesterol from peripheral muscles (Ruys et al 1989).
Most of the reported studies make no mention of the level of fitness 
achieved by the patients.
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In a previous study from the Victoria Infirmary, nineteen men post 
myocardial infarction were trained for six months by aerobic exercise. There 
was a reduction in LDL and triglycerides, and an increase in HDL, apoAl and 
HDL2, compared with no change in twenty three control patients. There was 
no change in total cholesterol levels, and no relationship was found between 
treadmill performance and lipid levels (Ballantyne et al 1982).
In a cross-sectional study of exercise training after MI from Seattle, the 
only reported change was an increase in HDL in the 83 trained post-myocardial 
infarction patients (1.2 mmol/1) compared to 103 controls (1.03 mmol/1) 
(Erkelens et al 1979).
After a year of high intensity exercise training in eighteen patients with 
stable coronary artery disease, total cholesterol, LDL, VLDL, and triglycerides 
fell in association with increased work capacity and a reduction in stress- 
induced ischaemia (Schuler et al 1988). In another group, HDL increased after 
three months of exercise training, but there was no effect on total cholesterol 
and LDL. There was a high correlation between HDL and estimated maximum 
oxygen uptake (Hartung et al 1981).
Seventy seven cardiac patients, nine of whom had coronary artery 
surgery, underwent three months of cardiac rehabilitation comprising physical 
fitness, psychosocial wellbeing and risk factor modification. The control group 
showed no changes in lipids, but total cholesterol fell from 7.1 to 6.8 mmol/1 
in the rehabilitation group. It remained high in those with initial values above 
6.5 mmol/1. There was no change in HDL, LDL and cholesterol/HDL ratio. 
Those who followed the diet strictly had greater reductions in cholesterol levels
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(Baardman et al 1990). AU these studies showed only minor changes in lipids.
In this study, the aerobic group had gained an average of a kilogramme 
in weight by the end of training. As mentioned earlier in most studies where 
exercise training was associated with changes in lipid levels, there was 
decrease in weight in the trained patients. It would appear that the slight 
weight loss and reduction in skin fold thickness in the power group were not 
enough to influence lipid levels. In a meta-analysis of ninety five trials on 
exercise training. Vu Tran & Weltman (1985) report that changes in body 
weight are relevant to lipoprotein levels. Thus, those in which there was no 
change in body weight, total cholesterol fell by 0.19 mmol/1 and LDL levels 
fell by 0.08 mmol/1. The reductions in lipids were more significant with 
reductions in body weight - 0.34 mmol/1 and 0.29 mmol/1 respectively; with 
increases in weight, cholesterol and LDL increased by 0.07 mmol/1 each.
Specific dietary advice or intervention were not included in the 
rehabilitation programme in this study. This was in order to assess the effects 
of the two types of exercise training without the influence of other 
interventions. It is therefore impossible to judge to what extent, if any, each 
group of patients altered its dietary habits. One would have thought though 
that, if anything, the patients would have adopted healthier eating habits.
In a study of only post-CAS patients (Agren et al 1989), eighteen 
underwent exercise training for twelve weeks. Preoperative, post operative, 
post-training and one year lipoprotein levels were compared with those in 
nineteen control patients. There were no changes in body weight with training, 
and a constant diet was encouraged. Training was by cycling for sixty minutes
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three times a week. Plasma cholesterol did not change. Triglycerides 
decreased by 23 % in the training group after two months. In the control group, 
there was a slow spontaneous decrease in triglyceride levels, so that by one 
year there was no significant difference between the two groups. High 
triglyceride levels are associated with hypercoagulability. Lowering 
triglyceride levels after coronary artery surgery may therefore reduce the risks 
of thrombosis and graft occlusion. Initial mean LDL levels were high and did 
not change. Initial mean HDL levels were low. At two months after surgery, 
HDL levels rose in both groups, but did so more with training. In the trained 
group, there was a 20% increase in the first 26 weeks, and 23% by one year. 
In the control group, the HDL level rose by 10-15% post operatively, and at 
one year were 20% higher than preoperative values. At that time, there was no 
difference between the two groups. ApoAl increased by 5% in both groups 
two months after operation, and by 10% at one year. ApoB did not change in 
the trained group, but the control group showed an early increase of 6%. 
Coronary artery surgery itself seems to influence lipid levels. The exercise 
trained group showed some additional benefits which were not sustained at one 
year. That study had a different slant from the present one: it included 
preoperative assessments and was thus able to determine the effects of the 
operation itself.
Sixteen untrained men with abnormal lipid levels had twenty weeks of 
strength training. Despite 50% increase in upper body strength and 37% 
increase in lower body strength measured by the one repetition maximum test, 
there were no changes in lipids or lipoprotein levels (Kokkinos 1991).
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In strength trained athletes, some reports suggest a fall in HDL cholesterol or 
a rise in the ratio of total cholesterol to HDL cholesterol. However various 
factors such as age, body weight, diet and anabolic steroid use could also 
influence the lipid levels in these studies. (Hurley 1989; McKelvie & 
McCartney 1990) In a previous study by Hurley et al (1988), weightlifting 
training caused an increase in HDL cholesterol and a decrease in LDL 
cholesterol with no change in percent body fat.
Previous studies of weight lifting training in untrained healthy middle- 
aged men caused reductions in total cholesterol to HDL cholesterol ratio, and 
LDL cholesterol levels. This was accompanied by a reductions in body fat 
(McKelvie & McCartney 1990).
The conclusion remains that the exercise training programmes used in 
this study failed to influence lipid levels after coronary artery surgery in these 
men. This suggests that for the purposes of influencing lipoprotein profiles, 
it would seem appropriate to include dietary intervention and aggressive drug 
treatment, if necessary, in such patients. In so doing the chances of 
development and progression of atherosclerosis in the future would be reduced.
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SECTION XI
ASSESSMENT OF LEFT VENTRICULAR FUNCTION:
GATED TECHNETIUM EQUILIBRIUM BLOOD POOL ANGIOGRAPHY
This technique is widely used in the measurement of left ventricular 
function at rest, and in response to stress (Burow et al 1977; Wackers et al 
1979; Port et al 1981; Borer et al 1984). The patient’s red blood cells are 
labelled in vivo with 800 MBq of 99m technetium 20 minutes after the injection 
of stannous pyrophosphate, which is used to increase the binding of technetium 
to the red blood cells. A parallel hole general purpose collimator acquires a 
scan of the left ventricle. The patient rests supine with the camera positioned 
35 - 45o LAO with lOo caudal tilt to give maximum separation between left 
and right ventricles and the atria. The heart rate is monitored and the R wave 
is used to gate the scan into 16 parts within each R R interval. An R-R interval 
window of 20% is used so that any beats outside of this, e.g. ectopics, are 
excluded from the analysis. The acquisition time is six minutes, with an 
average count number of 100,000 per second. The acquired beats are stored in 
frame mode in a 64 x 64 matrix to produce a summated representative cycle.
The stress test chosen for this study was the cold pressor test. This has 
previously been used and validated in the Victoria Infirmary (Northcote & 
Cooke 1987). Exercise radionuclide ventriculography is generally preferred as 
a stress test, since it has been shown to indicate the presence of severe coronary 
artery disease quite clearly (Borer et al 1977). In patients with CAD, ejection 
fraction falls with exercise; it rises in normal persons. The cold pressor test
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is also useful in detecting CAD and left ventricular dysfunction (Wainwright 
et al 1979; Manyari et al 1982; Vojacek et al 1982; Rootwelt et al 1982; 
Buonanno et al 1983). The cold pressor test can cause a fall in ejection fraction 
even in normal persons, but this is more pronounced in patients with CAD: 
5-8% and 8.6% respectively (Wasserman et al 1983). For the purposes of the 
present study, it was simply a matter of determining the effects of training on 
left ventricular function in patients with established coronary artery disease who 
had had coronary artery surgery. The cold pressor test was deemed an adequate 
and reproducible test for the follow up of these patients.
The patient’s right forearm is immersed in a mixture of crushed ice and 
water at 4«>C, and the scan is repeated. The acquisition time for this is five 
minutes.
In the Nuclear Medicine department, Victoria Infirmary, the coefficient 
of variance for resting ejection fraction in normals is 5%. Two separate mean 
ejection fi'actions differed by 1.2 ±  6.2%. For patients with coronary artery 
disease, the coefficient of variance for ejection fraction response to cold pressor 
is 9% (Northcote & Cooke 1987).
The Stanford automatic left ventricular function analysis programme is 
used for image analysis to construct a time activity curve from which indices 
of left ventricular function can be derived (figure 2). Global ejection fraction, 
regional ejection fraction, fast filling time and length, fast ejection time and 
length, systolic time and length can be calculated.
The method was originally described by Goris et al (1981). The 
automatic programme performs a comprehensive analysis of left ventricular
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function. It constructs functional images of stroke volume, regional ejection 
fraction, amplitude, and phase. The edge detection algorithm is based on a one 
dimensional La Placian filter applied to the end-diastolic image vertically, 
horizontally, and along both diagonals. A search is made for the first edge 
which completely encloses the left ventricle, which is located by calculation of 
the x-y coordinates of the centre of gravity of an amplitude image constructed 
by the system. The programme transforms the data to frequency domain, and 
retains the zero, first, second, and third harmonics, as well as the diastolic 
image. The left ventricle is located on the left edge of the stroke volume 
image, and the edges of the ventricle are identified on the diastolic image. A 
left ventricular area of interest is created and used for interpolative background 
subtraction. The area of interest is also used to create a 100-point volume 
curve using the frequency components. It is from this curve that the system 
calculates ejection fraction. Time and length for fast filling, fast ejection, and 
systole and dV/dt are derived fi-om the curve.
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Since a number of the patients had had previous infarcts, this needs to 
be considered in the analysis of regional left ventricular function, and the 
effects that training might have on this. Detecting wall motion abnormalities 
in response to stress tests tends to add little to the sensitivity of rest scans. But 
any changes in regional left ventricular function after an intervention can be 
considered to be a result of that intervention. Thus for the follow up of 
patients with exercise training, it might be a useful test.
I sought permission from the Department of Health and Social Security 
to use radiopharmaceuticals in the study. This relates to this section using 99m 
technetium, and to the next part, using thallium 201. Permission was granted 
for nuclear cardiology scans in sixty patients under the supervision of Professor 
N Mackay who is an ARSAC certificate holder. Copies of the relevant 
documents form the appendix.
In order to reduce their exposure to radiation to a minimum, the patients 
had scans at baseline and after the intervention period; the three month 
assessment was omitted.
RESULTS
Fifty seven patients had a full set of scans for analysis. Of the 
remainder, 1 scan was not suitable for analysis due to errors in scanning or 
processing, 2 patients had incomplete scans due to inability to tolerate the cold 
pressor test. The fifty seven were made up of 16 controls, 25 in the aerobic 
group, and 16 in the power group. The results of global ejection fi^action are 
presented first followed by those regional ejection fraction. The results
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reported in % and expressed as the mean with its 95% confidence interval. 
Baseline parameters of global ejection fraction in the three groups did not differ 
from each other significantly (table 34).
In patients with significant coronary artery disease, the ejection fi-action 
falls during the cold pressor test. The influence of the cold pressor test on the 
other parameters have not been established.
In these patients, there was a trend towards lower ejection fraction in all 
the groups during the cold pressor test. The value in the power group was 
significantly higher than that in the other two groups, ANOVA p == 0.04. The 
other parameters were not aflected by the cold pressor test at baseline 
(table 35).
After the training period, the resting systolic length was significantly 
shorter in the power group as compared to the other two groups,
(ANOVA p =  0.01). Aerobic and power training in these patients had no 
effect on resting ejection fraction or that in response to cold pressor.
There was a trend towards shorter systolic length in response to cold 
pressor (ANOVA p = 0.07) and towards shorter fast filling time at rest and 
in response to cold pressor in the power group (ANOVA p ~  0.08 and 0.06 
respectively) (tables 36 and 37).
The interval changes between baseline and six months in the different 
parameters are shown in the tables 38 and 39. Changes achieving statistical 
significance are marked by asterisks in the tables.
As mentioned earlier, the actual ejection fi-action during cold pressor at 
baseline was higher in the power group than in the others . T h e ’t’ test was
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used to assess the difference.
Between aerobic and power groups 2p = 0.008; and between control and 
power groups, 2p = 0.05. There was no difference between control and 
aerobic groups in baseline ejection fraction during cold pressor (2p = 0.8). 
The differences in ejection fraction shown in the table did not achieve statistical 
significance.
The data on systolic length and fast filling time were not normally 
distributed, therefore the Mann-Whitney U test was used in their further 
analysis, to determine the exact differences between the groups.
For resting systolic length at six months, the difference between the 
power and aerobic group was significant at 2p= 0.03, and between power and 
control groups at 2p =  0.01. The difference between control and aerobic 
groups was not statistically significant, 2p = 0.14.
The only interval change in the other parameters of global ejection 
fraction reaching statistical significance was a fall in fast filling time during 
cold pressor in the power group (ANOVA p — 0.04)
Between control and aerobic groups, the difference was not significant 
2p = 0.08; between aerobic and power groups, 2p = 0.3; and between power 
and control groups, 2p= 0.04.
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Table 34
BASELINE RESTING PARAMETERS OF GLOBAL EJECTION FRACTION
CONTROL AEROBIC POWER
EF 51.5 
(40.4 to 62.7)
49.6 
(41.1 to 58.2)
59.2 
(54.6 to 63.8)
FET 17.6 
(15.9 to 19.4)
19.9 
(17.0 to 22,8)
17.9 
(14.9 to 21.0)
-VM/SV 4.5 
(4.1 to 4.9)
4.5 
(4.2 to 4.8)
4.4 
(3.9 to 4.8)
PEL 35.4 
(31.9 to 38.9)
37.4 
(33.2 to 41.6)
36.3 
(32.8 to 39.8)
ST 39.9 
(37.0 to 42.9)
41.8 
(38.3 to 45.4)
41.6 
(38.6 to 44.5)
SL 50.7 
(44.4 to 56.9)
48.1 
(42.5 to 53.7)
45.2 
(39.7 to 50.7)
FFT 68.3 
(61.5 to 75.1)
68.4 
(62.2 to 74.6)
62.2 
(57.4 to 66.9)
+VM/SV 3.5 
(3.2 to 3.9)
3.6 
(3.3 to 4.0)
3.5 
(3.1 to 3.8)
FFL 38.7 
(32.8 to 44.7)
37.0 
(32.4 to 41.6)
33.5 
(27.5 to 39.5)
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ABBREVIATIONS IN TABLES 34 - 37
EF: ejection fraction
FET: fast ejection time
-VM/SV: rate of systolic shortening
EEL: fast ejection length
ST: systolic time
SL: systolic length
FFT: fast filling time
+ VM/SV: rate of diastolic lengthening
FFL: fast filling length
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Table 35
BASELINE EJECTION FRACTION PARAMETERS DURING COLD 
PRESSOR TEST
CONTROL AEROBIC POWER
EF 45.7 
(33.9 to 57.5)
44.1 
(36.4 to 51.4)
58.6* 
(51.1 to 66.2)
FET 18.9 
(14.5 to 23.4)
19.7 
(15.6 to 23.8)
19.4 
(15.5 to 23.3)
-VM/SV 4.4 
(3.8 to 5.1)
4.2 
(3.9 to 4.6)
4.0 
(3.6 to 4.4)
PEL 38.3 
(33.2 to 43.5)
42.2 
(37.2 to 47.1)
41.3 
(37.8 to 44.7)
ST 43.1 
(38.2 to 48.0)
46.5 
(42.0 to 51.1)
45.1 
(41.1 to 49.0)
SL 46.3 
(38.8 to 53.9)
54.1 
(47.7 to 60.6)
48.1 
(40.9 to 55.3)
FFT 65.3 
(58.2 to 72.4)
73.9 
(68.1 to 79.7)
67.4 
(62.0 to 72.9)
+ VM/SV 3.7 
(3.3 to 4.3)
4.2 
(3.7 to 4.7)
3.6 
(3.1 to 4.0)
FFL 34.2 
(27.5 to 41.1)
32.0 
(26.5 to 37.4)
36.6 
(29.8 to 43.5)
126
Table 36
RESTING PARAMETERS OF GLOBAL EJECTION FRACTION AFTER 
TRAINING
CONTROL AEROBIC POWER
EF 52.9 
(40.3 to 65.4)
50.0 
(42.4 to 57.6)
55.6 
(48.5 to 62.7)
FET 18.4 
(15.5 to 21.3)
19.6 
(17.0 to 22.1)
21.3 
(15.0 to 27.5)
-VM/SV 4.3 
(3.9 to 4.7)
4.2 
(3.9 to 4.6)
4.4 
(3.9 to 4.8)
FEL 35.7 
(32,1 to 39.3)
37.1 
(33.9 to 40.3)
36.8 
(30.9 to 42.6)
ST 40.1 
(37.1 to 43.0)
41.9 
(38.5 to 45.3)
41.3 
(35.8 to 46.7)
SL 52.5 
(43.9 to 61.1)
47.1 
(42.2 to 52.0)
39.3 * 
(35.3 to 43.1)
FFT 69.8 
(61.9 to 77.7)
65.5 
(60.4 to 70.6)
60.0 
(55.2 to 64.8)
+VM/SV 3.2 
(2.8 to 3.6)
3.6 
(3.2 to 3.9)
3.5 
(3.1 to 4.0)
FFL 36.9 
(29.8 to 44.0)
35.8 
(31.5 to 40.2)
30.3 
(25.7 to 35.0)
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Table 37
EJECTION FRACTION PARAMETERS DURING COLD PRESSOR AFTER 
TRAINING
CONTROL AEROBIC POWER
EF 48.2 
(37.2 to 59.2)
45.1 
(38.1 to 52.0)
55.2 
(46.1 to 64.3)
FET 18.3 
(14.4 to 22.1)
18.8 
(15.6 to 22.1)
19.8 
(15.8 to 23.9)
-VM/SV 4.4 
(4.0 to 4.8)
4.1 
(3.7 to 4.4)
4.4 
(3.8 to 4.9)
FEL 37.9 
(32.6 to 43.2)
41.7 
(37.5 to 45.9)
36.6 
(32.2 to 40.9)
ST 44.9 
(40.6 to 49.1)
45.5 
(42.2 to 48.7)
42.2 
(38.6 to 45.7)
SL 57.6 
(47.5 to 67.7)
55.7 
(49.6 to 61.7)
45.6 
(37.4 to 53.9)
FFT 75.9 
(67.7 to 84.1)
73.9 
(68.0 to 79.8)
64.9 
(58.7 to 71.1)
+VM/S
V
3.7 
(3.2 to 4.3)
4.1 
(3.7 to 4.5)
3.5 
(3.2 to 3.9)
FFL 39.4 
(30.9 to 47.9)
35.4 
(30.2 to 40.6)
30.6 
(25.5 to 35.6)
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Table 38
INTERVAL CHANGES IN EJECTION FRACTION AT REST AND IN 
RESPONSE TO COLD PRESSOR
CONTROL AEROBIC POWER
DEFI -5.8 
(-11.5 t o -0.1)
-5.5 
(-9.2 t o -1.8)
-0.6 
(-5.8 to 4.6)
DEF2 -4.7 
(-10.0 to 0.7)
-4.9 
(-8.8 to -1.1)
-0.4 
(-7.4 to 6.5)
DEF3 1.3
(-4.0 to 6.7)
0.4 
(-4.4 to 5.1)
-3.6 
(-9.6 to 2.4)
DEF4 2.4 
(-3.4 to 8.3)
1.0
(-3.6 to 5.5)
-3.4 
(-10.5 to 3.7)
ABBREVIATIONS
DEFI: Difference in baseline resting and cold pressor ejection fraction 
DEF2: Difference in six month resting and cold pressor ejection fraction 
DEF3: Interval change in resting ejection fraction 
DEF4: Interval change in cold pressor ejection fraction
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Table 39
INTERVAL CHANGES IN OTHER PARAMETERS OF GLOBAL EJECTION 
FRACTION
CONTROL AEROBIC POWER
DFETl 0.8 
(-2.3 to 3.9)
-0.3 
(-3.0 to 2.3)
3.3
(-3.6 to 10.2)
DFET2 -0.7 
(-7.8 to 6.5)
-0.9 
(-5.9 to 4.2)
0.4 
(-5.8 to 6.6)
DDSl -0.2 
(-0.7 to 0.4)
-0.3 
(-0.6 to 0.1)
0
(-0.4 to 0.4)
DDS2 0
(-0.7 to 0.7)
-0.2 
(-0.6 to 0.3)
0.4 
(-0.3 to 1.0)
DFELl 0.3 
(-4.8 to 5.5)
-0.3 
(-4.5 to 3.9)
0.4 
(-5.2 to 6.0)
DFEL2 -0.4 
(-5.5 to 4.7)
-0.5 
(-6.2 to 5.2)
-4.7 
(-11.1 to 1.7)
DSTl 0.1 
(-4.2 to 4.4)
0.1 
(-4.3 to 4.4)
-0.3 
(-4.8 to 4.2)
DST2 1.8
(-4.6 to 8.2)
-1.0 
(-6.7 to 4.5)
-2.9 
(-8.8 to 3.0)
DSLl 1,8
(-6.2 to 9.8)
-1.0 
(-7.8 to 5.7)
-5.9 
(-11.7 t o -0.2)
DSL2 11.3 
(-0.8 to 23.3)
1.6
(-4.1 to 7.2)
-2.5 
(-13.7 to 8.7)
DFFPl 1.5
(-6.2 to 9.2)
-2.9 
(-9,6 to 3.8)
-2.1 
(-7.6 to 3.3)
DFFT2 10.6 
(1.3 to 19.9)
0
(-5.1 to 5.0)
-2.5 * 
(-11.6 to 6.6)
DDDl -0.3 
(-0.8 to 0.1)
0.1 
(-0.5 to 0.4)
-0.1 
(-0.4 to 0.6)
DDD2 0
(-0.5 to 0,5)
-0.1 
(-0.7 to 0.6)
0
(-0.5 to 0.5)
DFFLl -1.8 
(-7.1 to 3.5)
-1.2 
(-6.7 to 4.3)
-3.2 
(-10.8 to 4.4)
DFFL2 5.1
(-2.7 to 13,1)
3.4
(-3.2 to 10.0)
-6.1 
(-15.0 to 2.9)
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ABBREVIATIONS
DFETl: Interval change in fast ejection time at rest
DFET2: Interval change in fast ejection time during cold pressor
DDSl : Interval change in -VM/SV at rest
DDS2: Interval change in -VM/SV during cold pressor
DFELl : Interval change in fast ejection length at rest
DFEL2; Interval change in fast ejection length during cold pressor
DSTl: Interval change in systolic time at rest
DST2: Interval change in systolic time during cold pressor
DSLl : Interval change in systolic length at rest
DSL2: Interval change in systolic length during cold pressor
DFFTl: Interval change in fast filling time at rest
DFFT2: Interval change in fast Riling time during cold pressor
DDDl: Interval change in + VM/SV at rest
DDD2: Interval change in +  VM/SV during cold pressor
DFFLl: Interval change in fast filling length at rest
DFFL2: Interval change in fast filling length during cold pressor
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DISCUSSION
In most studies, coronary artery surgery has been shown to have a 
neutral effect on resting left ventricular function, as measured by radionuclide 
or contrast ventriculography. This is perhaps not surprising. Coronary blood 
flow even through stenosed arteries, may be adequate for resting left ventricular 
contractility which need not alter with revascularisation. It becomes critical 
when demand increases. In contrast therefore, in most studies, coronary artery 
surgery has been shown to improve left ventricular function during exercise 
and stress.
In one of the earlier studies using angiocardiography, Chatteijee et al 
(1972) found that in five patients with stenoses of the left coronary system, left 
ventricular ejection fraction at rest was depressed before surgery, and improved 
post-operatively. One patient with right coronary artery disease showed no 
change in ejection fraction. Hamby et al (1974) studied 104 patients with 
patent grafts one year after CAS, and concluded that reversibility of left 
ventricular function depends on clinical state and pre-operative LV function, 
such as the presence of wall motion abnormalities. In 30 patients studied 
before and five months after CAS, Brundage et al (1977) concluded that the 
most important determinant of LV function after CAS is the state of the native 
coronary circulation at repeat cardiac catheterisation. Wolf et al (1978) studied 
37 patients with biplane left ventriculography before and 13 months after CAS. 
They found that LV function and segmental dysfunction were related to graft 
patency. This is similar to findings by Rees et al (1971) in 14 patients. Eight 
had patent grafts and improved LV function, the remainder did not. In 51
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patients studied before and one to two years after CAS, LV function was 
unchanged in 72%, deteriorated in 3% and there was a 5% incidence of new 
wall motion abnormalities (Zir et al 1979).
In one of the earlier studies using radionuclide ventriculography, Kent 
et al (1978), studied 23 patients before and two to six months after CAS. 
There was no change in resting ejection Fraction. In the 17 patients with the 
most symptomatic benefit, exercise ejection fraction improved from 39 + 3% 
to 59 ±  4%. In six, there was no change or a fall in ejection fraction during 
exercise. Exercise induced LV dysfunction improved. In 14 patients studied 
before, eight days and three months after CAS, there was no change in resting 
ejection fraction. Exercise ejection fraction increased more at eight days, and 
persisted at three months (Austin et al 1981). Ejection fraction fell with 
exercise pre-operatively, but not 23 weeks after CAS in 36 patients. The 
results were most impressive in those with pre-operative evidence of exercise 
induced LV dysfunction (Kronenberg et al 1983). Resting ejection fraction and 
regional wall motion score were unchanged by CAS in 56 patients studied 
before and six weeks post-operation. Exercise ejection fraction increased from 
64% to 72% and exercise induced wall motion abnormalities were abolished 
(Taylor et al 1983). Where resting ejection fraction was measured in the early 
post operative period (24 hours and one week), it was found to have improved 
fi-om 49 + 2% to 56 + 2% in 53 patients. This held true regardless of the pre­
operative ejection fraction, and was associated with a decrease in end diastolic 
volume, suggesting improved myocardial contractility (Tchervenkov et al 
1985). Austin et al (1981) suggested that studies of LV function post CAS
133
should be delayed till at least three months presumably to allow perioperative 
factors such as excess adrenergic drive to subside. Dilsizian et al (1988) 
suggest that subclinical LV dysfunction due to ischaemic or hibernating 
myocardium is improved by revascularisation. In their study of 31 patients, 
both resting and exercise ejection fraction improved after CAS; 27 patients had 
patent grafts. On the other hand. De Nardo et al (1989) found no change in 
global ejection fraction in 34 patients, despite the development of paradoxical 
septal motion in 14 of the patients.
A few studies have considered the effects of CAS on diastolic function. 
In 23 patients LV compliance improved in the 15 with patent grafts. The post­
operative biplane ventriculography was done 19 weeks after CAS (Miller et al 
1975). In 24 patients with stable angina, ejection fraction increased in response 
to exercise after CAS. Left ventricular end diastolic pressure was reduced, but 
still rose with exercise (23 to 37 mmHg pre-op, 17 to 25 mmHg post-op). 
Early diastolic peak filling rate was greater after CAS, 1260 ml/s pre- 
operatively, 950ml/s post-operatively (Carroll et al 1985). Kawasuji et al 
(1988) found no change in resting ejection fraction in the four weeks after 
CAS. Ejection fraction at peak exercise increased, as did peak ejection rate. 
Peak filling rate, and peak filling rate during the first third of diastole were 
unchanged.
Studies on the effects of exercise training on left ventricular function in 
patients with CAD have also shown inconsistent results. In normals, there is 
an increase in end diastolic volume and peak cardiac output after training 
(Clausen 1976; Rerych et al 1980).
134
In the PERFEXT study, there was no significant change in ejection 
fraction, end diastolic volume, stroke volume or cardiac output after the one 
year training programme. The exercise group had lower percentage changes in 
end systolic volume at varying workloads (Froelicher et al 1984).
In 25 patients with CAD, Ehsani et al (1986) showed that after a year of 
progressive and intense aerobic training, there was a rise in ejection fraction 
during maximal supine bicycle exercise (52 ±  3% vs 58 ±  3%, p < 0.01). 
This was so despite a higher rate pressure product and systolic blood pressure. 
Resting ejection fraction was unchanged. There was smaller end systolic 
volume during exercise, but no change in end diastolic volume. Before 
training, ejection fraction decreased from rest to exercise in 15 patients, was 
unchanged in three and increased in seven. After training, ejection fraction 
decreased from rest to exercise in four, was unchanged in two and increased in 
19. They suggest that there was improved contractile function after training. 
Overall, there was also an improvement in exercise induced regional wall 
motion abnormalities. Measured VOj max increased by 37% in the trained 
group- The control group of 14 patients showed no changes. In a report on 11 
patients using the same training programme, stroke volume during upright 
exercise requiring 35 -65% VO  ^max was 18% higher after the training period. 
Mean blood pressure was unchanged , therefore left ventricular stroke work
increased (Hagberg et al 1983).
After six to twelve months of exercise training in 53 patients, there was 
no change in resting and peak ejection fraction. Ejection fraction at pre 
training peak exercise increased from 50 + 17% to 54 ±  17%, p — 0.002.
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There was a correlation with the magnitude of training bradycardia, but not 
with the degree of left ventricular impairment before training. The end systolic 
volume at equivalent workload was smaller after training. The relation to 
training bradycardia suggests that lower myocardial oxygen demand contributed 
to the higher submaximal ejection fraction (Williams et al 1984).
Similar results were found by Jensen et al (1980) in 19 patients. Resting 
and maximal ejection fraction did not change with six months' training, but 
there was an increase in submaximal ejection fraction.
DeBusk and Hung (1982) report an slight increase in submaximal 
ejection fraction after 12 weeks’ training in 21 post-infarct patients, with no 
change in resting or maximal ejection fraction.
Verani et al (1981) found that 12 weeks of training increased resting 
ejection fraction from 52 + 4% to 57 ±  4% in 16 patients with CAD. In 15 
patients with recent MI, after six months training, there was no change in 
resting or exercise ejection fraction (Cobb et al 1982). Stroke volume 
increased by 10% after one year of high intensity exercise training in 37 post- 
M1 patients, whilst 42 who had low intensity exercise showed no changes, not 
even in exercise performance (Paterson et al 1979).
The form of stress used here was the cold pressor test. It was described 
in the 1930s (Hines &  Brown 1936) and the haemodynamic responses to it were 
studied in the 1960s with varying results (Boyer et al 1960; Greene et al 1965). 
More recently, Buonanno et al (1983) showed that the cold pressor test invokes 
the sympathetic nervous system, with a rise in systolic pressure, heart rate, 
double product, and left ventricular end diastolic pressure. There is an increase
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in myocardial oxygen consumption due to increased afterload. Vasoconstriction 
also increases peripheral vascular resistance. Left ventricular ejection as 
measured by fast ejection length and systolic time is prolonged by cold pressor, 
and peak rate of left ventricular ejection is reduced and delayed.
There have not been any reported studies on the effects of coronary 
artery surgery on the performance of the cold pressor test, nor was that part of 
this study. Given that both the cold pressor test and exercise increase the 
demands on the myocardium, I think that it is reasonable to extrapolate from 
the studies on exercise radionuclide ventriculography. It has been shown that 
exercise stress is more sensitive than cold pressor in detecting CAD (Rootwelt 
et al 1982; Manyari et al 1982). Wherever possible therefore, exercise stress 
tends to be used in the detection of CAD. The cold pressor test is useful in the 
follow-up of such patients, and is an alternative to exercise when this cannot 
be performed for mobility and technical reasons. In the presence of CAD, the 
ejection fraction tends to fall with cold pressor stress as it does with exercise 
(Vojacek et al 1982). It was reasonable to use the cold pressor test in studying 
the effects of exercise training on ejection fraction. None of the studies 
mentioned above have used it.
In a study from this department of 40 patients with angina, 20 had 
aerobic training for one year. The exercise group showed an improvement in 
ejection fraction during cold pressor test from 48 ± 8.4% to 54.9 ± 10.1%, 
while in the control group it fell from 49.4 ±  14.2% to 45.1 ±  12.1% (p < 
0.01). There was no change in resting ejection fraction. The fall in ejection 
fraction with cold pressor was less in the exercise group after training
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(control -6 ± 6.9%, exercise -2.4 ±  8.4%).
Before addressing the results of the present study, the meaning of the 
parameters that were measured in this section should be discussed. Global 
ejection fraction depends on heart rate, preload, afterload and intrinsic 
myocardial contractility. It is a widely used but composite measure of left 
ventricular function. In equilibrium radionuclide angiography, it is the 
difference between end diastolic and end systolic counts divided by end 
diastolic counts, in the left ventricular region of interest. The other parameters 
are mathematically derived from a time/activity curve of left ventricular 
function (figure 2). Fast ejection reflects systole and fast filling, diastole. A 
brief period of isovolumetric contraction marks end diastole and a brief period 
of isovolumetric relaxation marks end systole. Fast ejection length is between 
the end of isovolumetric contraction and end systole. At end systole, fast 
filling begins. Fast filling ends with diastasis. As well as the lengths of fast 
ejection and fast filling, the maximum rate of change of volume during those 
periods (DVs/Dt and DVd/Dt) and the time at which these maximum changes 
occur (FET and FFT) are measured automatically from the time/activity curve 
and its first derivative. Systolic length (SL) is not obtained from systole; it is 
FFT minus FET, the time from maximum rate of volume change in systole to 
maximum rate of volume change in diastole.
In a study of normal persons using isoprenaline and propranolol, Sapru 
et al (1980) found that left ventricular ejection and filling times and rates are 
sensitive indicators of changing inotropic state. In CAD, peak filling rate is 
reduced and time to peak filling is prolonged, and in some studies this is
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proportional to disease severity (Bonow et al 1981; Polak et al 1982; Reduto 
et al 1982; Mancini et al 1983; Miller et al 1983; Dymond et al 1984).
There have been no reported studies comparing the effects of aerobic and 
power exercise training on measures of left ventricular systolic and diastolic 
function after coronary artery surgery.
In this study there were no changes in rest or stress ejection fraction nor 
in the ejection fraction response to cold pressor in any of the groups. Indeed 
the values were rather consistent. Power and aerobic training had no influence 
on most of the derived measures of left ventricular contractile function.
The only statistically significant changes were in the power group. 
There was shorter systolic length at rest (p = 0.01) and during cold pressor 
(p — 0.05) after the training period. Fast filling time was also shorter in the 
power trained group. This may suggest improved efficiency of contraction, but 
the clinical and physiological relevance of these isolated responses are unclear. 
As well as that, since neither translates into improved global ejection fraction, 
perhaps other determinants of ejection fraction such as heart rate and blood 
pressure which were not analysed in this part of the study might have been 
helpful in unravelling the significance (if any) of the isolated changes that 
occured in the power group.
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REGIONAL EJECTION FRACTION
Regional ejection fraction abnormality is a marker of CAD. It is derived 
in the same way as is global ejection fraction (Maddox et al 1979). In the 
present study, the left ventricle is divided into eight equal segments, numbered 
1 to 8, in a clockwise direction starting from 12 o’clock (figure 3). The end 
diastolic and end systolic counts in each region are used to determine the 
regional ejection fraction.
In the tables, the letters A to D are used to indicate the type of scan, 
such that A represents baseline resting scan, B, six month resting scan C, 
baseline cold pressor scan D, six month cold pressor scan.
There are no reported studies of the effects of exercise training on 
regional ejection fraction.
Twenty seven of the patients in whom a full set of scans was available 
for analysis had not had previous myocardial infarctions. The analysis of 
results of regional ejection fraction takes account of this.
The results are shown as comparisons made between the two resting 
scans and between the two cold pressor scans, rather than between resting and 
cold pressor scans at each assessment. In this way, the two types of scan 
become two separate tests of regional ejection fraction. In the previous section, 
it was shown that the cold pressor test did not make any difference to 
parameters of global ejection fraction, and indeed there was no significant
PEGIONAl EJECTION 
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Figure 3: R egional e j e c t i o n  f r a c t io n :  l e f t  v e n tr ic u la rseg m en ts .
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rest to stress changes in regional ejection fraction either.
Results are expressed as mean with the SEM, and ’p ’ values mentioned 
in the text or shown in the table if indicated. They are first presented for the 
groups as a whole (tables 40 and 41).
In looking at the interval changes within groups, the interval change in 
resting and cold pressor scans in region 7, and resting scan in region 8 reached 
significance, with ANOVA p =  0.02, 0.04, and 0.004 respectively (table 42).
In region 7 at rest, the difference was between power and control groups 
with 2p =  0.034. There was a reduction in ejection fraction in the power group 
and an increase in the control group. In region 7 after cold pressor, the 
difference was between aerobic and control, with 2p — 0.021, a reduction in 
the aerobic group and a rise in the control group. In region 8 at rest there were 
significant differences between both exercise trained groups and the control 
group, with 2p — 0.012 in aerobic vs. control, and 2p = 0.003 in power vs. 
control. Again, it was the control group that showed an improvement in 
ejection fraction in that region. Interestingly, the atria and great vessels overlie 
regions 7 and 8, therefore these findings may well be spurious, and unlikely to 
be of clinical relevance.
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Table 40
REGIONAL EJECTION FRACTION AT REST: BASELINE AND SIX 
MONTHS, mean (SEM) %
CONTROL AEROBIC POWER
lA 42.7 (3.8) 44.5 (3.8) 48.9 (2.8)
IB 48.1 (4.5) 40.8 (3.0) 44.3 (3.8)
2A 63.6 (4.6) 59.9 (4.1) 64.5 (3.4)
2B 63.8 (4.6) 59.6 (3.2) 57.8 (5.7)
3A 66.6 (4.5) 59.6 (3.7) 64.4 (4.2)
3B 61.3 (4.7) 61.1 (3.6) 61.78 (4.3)
4A 57.6 (6.0) 52.6 (4.5) 58.5 (4.2)
4B 54.7 (6.7) 54.2 (4.9) 59.4 (5-1)
5A 49.9 (6.3) 44.9 (5.0) 57.8 (3.9)
5B 49.1 (7.8) 47.8 (5.8) 54.5 (3.5)
6A 34.6 (4.3) 28.7 (3.8) 40.9 (2.4)
6B 32.1 (5.9) 29.9 (4.0) 36.3 (4.1)
7A 22.5 (3.8) 21.6 (3.9) 34.1 (3.5)
7B - 28.3 (4.7) 24.3 (3.5) 25.7 (3.0)
8A 24.1 (3.7) 29.6 (4.0) 38.1 (4.4)
8B 33.0 (4.3) 25.6 (3.1) 30.3 (3.6)
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Table 41
REGIONAL EJECTION FRACTION AFTER COLD PRESSOR; BASELINE 
AND SIX MONTHS mean (SEM)%
CONTROL AEROBIC POWER
1C 37.3 (4.9) 38.0 (4.6) 48.6 (4.0)
ID 45.6(4.1) 40.3 (3.1) 47.3 (4.6)
2C 57.6 (4.8) 51.4 (5.2) 60.8 (4.5)
2D 59.9 (4.3) 52.6 (4.2) 57.4 (5.7)
3C 58.9 (4.8) 47.4 (5.8) 62.6 (4.5)
3D 59.6 (4.3) 55.7 (4.4) 59.0 (7.0)
4C 52.8 (6.6) 48.0 (4.8) 61.6 (4.1)
4D 51.8 (6.4) 50.6 (4.5) 56.7 (5.8)
5C 42.8 (7.5) 42.6(4.1) 61.1 (3.6)
5D 45.5 (8.0) 43.7 (5.2) 52.4 (4.2)
6C 29.4 (5.7) 28.7 (3.5) 41.9 (3.9)
6D 35.3 (7.6) 30.6(3.1) 43.4 (4.8)
7C 16.1 (4.1) 26.5 (3.1) 35.3 (4.3) *
7D 28.4 (6.6) 21.9 (2.7) 35.6 (5.4)
8C 25.8 (5.4) 31.2 (3.4) 38.7 (5.0)
8D 32.3 (4.6) 26.2 (3.0) 35.6 (4.8)
* ANOVA p = 0.007
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Table 42
STATISTICALLY SIGNIFICANT INTERVAL CHANGES IN REGIONAL 
EJECTION FRACTION mean (SEM)%
CONTROL AEROBIC POWER
REGION 7 rest 5.8 (2.8) 2.7 (3.1) -8.4 (3.9)
REGION 7 cp 12.3 (5.9) -4.6 (3.4) 0.4 (5.2)
REGION 8 rest 8.9 (3.9) -4.0 (2.8) -7.8 (3.4)
Table 43
DISTRIBUTION AND SITES OF MYOCARDIAL INFARCTION IN EACH 
GROUP
CONTROL AEROBIC POWER
NONE 9 10 8
ANTERIOR 1 7 2
INFERIOR 2 7 6
SITE
UNKNOWN
4 1 0
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The data are now analysed with reference to previous myocardial 
infarction.
Twenty seven patients had not had myocardial infarctions. The 
distribution and sites of infarction in each group are shown in table 43.
The following tables show regional ejection fraction at rest and after cold 
pressor in patients with no history of previous myocardial infarction (tables 44 
and 45), anterior myocardial infarction (tables 46 and 47) and inferior 
myocardial infarction (tables 48 and 49).
In those with no previous myocardial infarction, there were no 
significant differences between or within the groups.
In comparing those with anterior myocardial infarction and those with 
no previous myocardial infarction, there was a significant difference within the 
aerobic group (no MI n = 10, anterior myocardial infarction n = 7) in the 
following regions:
baseline resting scans region 1, (55.3 vs 27.1, 2p = 0.002) region 3, (70.3 vs 
44.7, 2p = 0.006) region 4, (63.7 vs 32.3, 2p — 0.015) region 6, (39.7 vs 
13.9, 2p =  0.009) region 7, (33.6 vs 5.4, 2p = 0.003) region 8 (42.3 vs 12.1, 
2p = 0.002); six month resting scans region 1 (50.3 vs 29.4, 2p == 0.002) and 
region 2, (68.6 vs 29.4, 2p = 0.082).
As expected, those with anterior myocardial infarction had lower 
regional ejection fractions at baseline than those with no previous myocardial 
infarction. This difference disappears with time and training, and those with 
anterior myocardial infarction appear to ’catch up’ with those with no previous 
myocardial infarction. In region 1, the difference remains and it appears in
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region 2. This could signify an improvement in ejection fraction in the anterior 
zone of the left ventricle, denoted by regions 3 to 6, in those with anterior 
myocardial infarction brought about by aerobic exercise training. 
Alternatively, there could have been a deterioration in regional ejection fraction 
in those with no previous myocardial infarction. The atria and great vessels lie 
over regions 7 and 8, and partly over region 1 so the significance of changes 
in those regions are less clear.
These interval changes do not actually achieve statistical significance, 
since some patients in each of the two groups improve while others deteriorate. 
Thus, although the absolute values of ejection fraction in the regions mentioned 
above differ significantly, the mean interval changes do not (table 50). 
Nevertheless, the direction of change is positive in those with anterior 
myocardial infarction and negative in those with no previous myocardial 
infarction. No firm conclusions can be reached, but the suggestion is that 
aerobic exercise training could influence the ejection fraction in the anterior 
zone of the left ventricle in patients with previous anterior myocardial 
infarction. The type of graft did not make any difference. This would imply 
that there had been an improvement in myocardial perfusion to that region, and 
that despite the infarction, there was residual viable tissue.
The numbers in the control and power groups are too small to contribute 
to the question. Those with inferior myocardial infarction showed no 
significant changes.
There were 5 patients with myocardial infarction at unspecified sites, 4 
in the control group, and 1 in the aerobic group. In this small subgroup of
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patients, there was again no significant difference in regional ejection fraction 
between or within the two groups.
In the previously mentioned study from this department, there were 
significant improvements noted in regions 3, 4 and 6 in the exercise groups 
between baseline and 12 month cold pressor scans. There was a small 
improvement in the control group due mainly to a reduction in resting regional 
ejection firaction.
It is interesting that the same regions also showed an improvement 
among a subgroup in the present study, though it was in the resting scan and 
not the stress scan as had been found in the previous study.
148
Table 44
REGIONAL EJECTION FRACTION AT REST IN PATIENTS WITH NO
PREVIOUS MYOCARDIAL INFARCTION (n = 27) mean (SEM)%
CONTROL AEROBIC POWER
lA 47.9 (4.8) 55.3 (6.7) 50.3 (4.5)
IB 50.1 (7.3) 50.3 (4.2) 46.6 (5.6)
2A 69.2 (5.4) 68.6 (7.0) 68.4 (5.4)
2B 70.0 (6.7) 65.7 (4.0) 70.3 (6.9)
3A 73.8 (5.5) 70.3 (4.9) 69.4 (4.5)
3B 66.8 (7.1) 69.3 (4.0) 71.0 (3.7)
4A 69.9 (6.4) 63.7 (5.9 64.1 (6.2)
4B 64.9 (8.9) 60.6 (7.2) 64.8 (4.5)
5A 60.8 (5.7) 55.2 (6.7) 63.8 (5.4)
5B 65.6 (8,9) 55.3 (8.3) 53.3 (5.0)
6A 42.3 (4.9) 39.7 (5.6) 38.6 (4.4)
6B 43.6 (7.9) 36.8 (5.4) 33.8 (3.0)
7A 28.8 (5-3) 33.6 (6.1) 32.3 (5.2)
7B 35.8 (7.1) 31.7 (5.9) 24.6 (2.1)
8A 29.0 (5.2) 42.3 (6.4) 36.8 (8.4)
8B 36.9 (6.5) 32.9 (4.8) 28.8 (5.5)
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Table 45
REGIONAL EJECTION FRACTION AFTER COLD PRESSOR IN PATIENTS
WITH NO PREVIOUS MYOCARDIAL INFARCTION (n = 27) mean (SEM) %
CONTROL AEROBIC POWER
1C 41.3 (7.3) 43.5 (6.8) 43.4 (6.7)
ID 50.0 (6.2) 44.0 (4.0) 50.9 (2.5)
2C 64.9 (5.9) 53.6 (7.8) 56.1 (8.3)
2D 60.9 (6.8) 59.2 (4.2) 68.0 (5.9)
3C 67.1 (6.3) 56.7 (7.9) 65.4 (4.9)
3D 64.4 (6.3) 63.9 (5.0) 71.4(4.5)
4C 65.4 (8.7) 54.4 (7.6) 63.9 (6.3)
4D 63.3 (8.8) 57.5 (6.7) 63.8 (5.4)
5C 56.6 (9.8) 48.8 (9.3) 62.0 (6.2)
5D 57.4 (10.4) 55.6 (5.5) 51.3 (4.7)
6C 39.9 (6.1) 30.0 (6.2) 36.3 (6.0)
6D 41.8 (9.4) 37.0 (4.7) 42.1 (5.4)
7C 21.3 (5.1) 26.4 (4.9) 30.8 (6.3)
7D 35.3 (6.5) 25.5 (4.6) 33.9 (5.9)
8C 31.7 (7.5) 34,9 (6.1) 33.9 (9.1)
8D 38.3 (5.1) 28.1 (5.3) 32.4 (4.9)
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Table 46
REGIONAL EJECTION FRACTION AT REST IN PATIENTS WITH
ANTERIOR MYOCARDIAL INFARCTION (n = 10) mean (SEM)%
CONTROL AEROBIC POWER
NUMBER 1 7 2
lA 25.0 27.1 (3.3) 45.0 (5.0)
IB 34.0 29.4 (3.5) 38.0 (0)
2A 45.0 44.3 (4.7) 48.5 (2.5)
2B 54.0 49.6 (7.3) 48.0 (6.0)
3A 57.0 44.7 (6.0) 64.0 (11.0)
3B 58.0 50.4 (7.7) 54.0 (0)
4A 24.0 32.3 (9.2) 55.5 (5.5)
4B 30.0 38.6 (10.3) 67.0 (11.0)
5A 12.0 27.3 (9.3) 62.5 (3.5)
5B 16.0 28.1 (12.6) 58.5 (8.5)
6A 11-0 13.9 (6.3) 37.0 (2.0)
6B 12.0 15.3 (8.9) 33.0 (1.0)
7A 8.0 5.4 (5.2) 22.0 (2.0)
7B 20.0 10.7 (5.8) 18.0 (2.0)
8A 2.0 12.1 (4.5) 30.5 (3.5)
8B 9.0 13.9 (4.1) 35.0 (1.0)
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Table 47
REGIONAL EJECTION FRACTION AFTER COLD PRESSOR IN PATIENTS
WITH ANTERIOR MYOCARDIAL INFARCTION (n = 10) mean (SEM)%
CONTROL AEROBIC POWER
NUMBER 1 7 2
1C 22.0 23.9 (9.5) 50.0 (1.0)
ID 36.0 32.1 (7.7) 41.5 (28.5)
2C 45.0 37.4 (11.3) 70.5 (9.5)
2D 57.0 39.4 (11.1) 42.5 (34.5)
3C 40.0 24.9 (12.7) 68,5 (8.5)
3D 65.0 46.7 (9.4) 39.5 (34.5)
4C 14.0 31.0 (10.2) 69.5 (8.5)
4D 47.0 41.7 (8.9) 44.0 (18.0)
5C 6.0 27.7 (8.1) 68.0 (13.0)
5D 7.0 29.4 (9.4) 49.5 (6.5)
6C "3.0 22.7 (7.3) 44.0 (16.0)
6D 2.0 21.6 (6.1) 32.0 (3.0)
7C -6.0 22.7 (6.4) 39.5 (21.5)
7D 3.0 16.1 (4.6) 20.5 (13.5)
8C 13.0 22.4 (6.3) 41.0 (7.0)
8D «  ..... 21.4 (6.4) 25.5 (24.5)
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Table 48
REGIONAL EJECTION FRACTION AT REST IN PATIENTS WITH
INFERIOR MYOCARDIAL INFARCTION (n = 15) mean (SEM)%
CONTROL AEROBIC POWER
NUMBER 2 7 6
lA 32.0(13.0) 46.3 (4.6) 48.3 (11.7)
IB 43.5 (14.5) 37.0 (5.7) 43.3 (7.3)
2A 59.5 (24.5) 64.6 (6.9) 64.7 (4.3)
2B 62.0 (11.0) 57.1 (3.4) 44.5 (9.4)
3A 57.0 (24.0) 58.0 (6.7) 57.8 (8.9)
3B 55.0 (17.0) 56.7 (6.7) 51.8 (8.6)
4A 37.0 (24.0) 54.4 (4.8) 52.0 (6.9)
4B 36.0 (29.0) 56.3 (7.1) 49.8 (11.4)
5A 24.0 (32.0) 45.1 (7.2) 57.3 (3.0)
5B 28.0 (28.0) 53.1 (8.3) 54.8 (6.8)
6A 24.5 (17.5) 27.7 (5.8) 45.2 (1.6)
6B 14.5 (8.5) 34.0 (5.6) 40.7 (10.6)
7A 10.0 (8.0) 21.7 (5.6) 40.5 (5.4)
7B 15.0 (10.0) 26.3 (4.8) 29.7 (7.4)
8A 17.5 (14.5) 27.6 (5.1) 42.3 (3.9)
8B 26.5 (12.5) 28.6 (5.5) 30.7 (6,8)
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Table 49
REGIONAL EJECTION FRACTION AFTER COLD PRESSOR IN PATIENTS
WITH INFERIOR MYOCARDIAL INFARCTION (n = 15) mean (SEM)
CONTROL AEROBIC POWER
NUMBER 2 7 6
1C 25.5 (18.5) 44,7 (7.9) 55.0 (5.2)
ID 41.0 (16,0) 40.9 (4.8) 44.5 (9.9)
2C 47.5 (20.5) 59.6 (8.6) 63.7 (4.2)
2D 52.0 (7.0) 52.3 (5.8) 48.3 (12.1)
3C 46.5 (11.5) 53.4 (8.2) 56.8 (10.1)
3D 48.0 (4.0) 48.7 (8.9) 49.0 (13.9)
4C 31.5 (17.5) 53.7 (6.1) 56.0 (6.8)
4D 33.5 (16.5) 44.9 (7.7) 51.5 (12.7)
5C 24.0 (30.0) 48.0 (7.9) 57.5 (4.0)
5D 38.5 (38.5) 37.0 (11.6) 64.8 (9.8)
6C 20.0 (22.0) 32,1 (5,9) 48.8 (4.6)
6D 46.0 (46.0) 29.7 (5.1) 49.0 (10,5)
7C 4.0 (13.0) 29.7 (6,5) 39.8 (5.7)
7D 50.0 (43.0) 21.9 (5.4) 43.0 (11.3)
8C 2.5 (9.5) 35.9 (5,4) 44.3 (5.4)
8D 38.0 (25.0) 27.3 (4.5) 43.2 (8.7)
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Table 50
INTERVAL CHANGES IN RESTING REGIONAL EJECTION FRACTION IN 
AEROBIC GROUP: NO MI VS ANTERIOR MI
REGION NO MI ANTERIOR
MI
'2p'
1 -5.0 (7.8) 2.3 (3.7) 0.41
2 -2.9 (5.8) 5.3 (4.6) 0.29
3 -1.0 (3.8) 5.7 (3.9) 0.24
4 -3.1 (5.3) 6.3 (4.5) 0.20
5 0.1 (4.7) 0.9 (6.2) 0.92
6 -2.9 (3.0) 1.4 (5.2) 0.48
7 -1.9 (6.3) 5.3 (3.0) 0.32
8 -9.4 (5.3) 1.7 (3.5) 0.10
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SECTION XII
MYOCARDIAL PERFUSION: REST AND EXERCISE THALLIUM-201 
SCINTIGRAPHY
Exercise thallium-201 scintigraphy was used in assessing myocardial 
perfusion. This technique is well established. In the myocardium, thallium 
201 acts like potassium and is taken up avidly by well-perfused parts (Strauss 
et al 1975). In coronary artery disease, obstructive lesions may prevent the 
uptake of the radionuclide by affected parts of the myocardium particularly 
under conditions of stress. At rest, these parts are adequately perfused, and 
any defects that were present during the stress test may disappear. This is the 
basis of the reversible perfusion defect used in the diagnosis of coronary artery 
disease (Bailey et al 1977; Ritchie et al 1977; Hamilton 1979; Grunwald et al 
1981; McKillop 1982; Verani 1983). In myocardial infarction, the perfusion 
defects present during stress tend to remain also at rest, and form the 
irreversible or fixed perfusion defect (Pohost et al 1977; Hamilton et al 1977). 
After coronary artery surgery, or other means of myocardial revascularisation, 
one would expect that perfusion defects due to obstructive coronary lesions 
would be abolished and that the extent of fixed defects may be reduced. This 
depends on the completeness and maintenance of revascularisation, the 
emergence of new lesions, including graft occlusion, and the progression of 
existing lesions, including reinfarction. The maintenance of revascularisation 
could be due to changes brought about by exercise training.
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METHODS
The patients had additional treadmill exercise tests using a modified 
Balke protocol as previously described, at baseline and at the end of their 
training period. An indwelling venous cannula was inserted in the left 
antecubital fossa. This was used to obtain the samples needed for 
haematological and lipoprotein assays, and then flushed with 10ml normal 
saline prior to starting the treadmill test. The patients had been fasting for at 
least 12 hours. On these occasions, they were asked to exercise until they 
estimated that they were one minute from their maximum exercise. At that 
point, 80 MBq of thallous-201 chloride was injected into the cannula, and 
flushed with a further 20 ml normal saline. At the end of exercise, the patient 
was quickly transported in a wheelchair to the scanning room. This was 
accomplished within 10 minutes in the majority.
A Technicare Sigma 410 gamma camera with a large field of view crystal 
and general purpose collimator, connected to an AD AC CGR 7310 computer 
was used to acquire the thallium-201 scans. The scans were obtained in 
anterior, 45o left anterior oblique (LAO), and 65o LAO positions, (figures 4 
to 6). 350,000 counts were acquired in each position. The time taken to 
acquire these preset counts was recorded. The spleen was masked with a lead 
shield. Data were acquired and stored in a 128 x 128 x 8 bit matrix on the 
computer.
(a)
(b)
a e i a  *nt c mvoc
( O R I G I N A L >
Figure 4. Planar thalliumstress (a) and after rest (b) scan anterior view after
Figure 5. Planar thallium scan: 45o LAO view afterstress (a) and after rest (b)
(a)
(b)
Figure 6. Planar thallium scan: 65o LAO view afterstress (a) and after rest (b).
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Three hours later, the patient returned for further scans, taken in the 
same views. Each scan was obtained in the time it had taken to obtain the 
corresponding view earlier in the day.
There were therefore six scans, three stress and three rest or 
redistribution scans for processing. This was done using commercially 
available software and analysis programmes.
The initial processing included background subtraction of non-cardiac 
activity (which was principally due to pulmonary uptake). Subtraction of non­
cardiac activity was done by interpolative background subtraction, as described 
by Goris et al (1976) and modified by Beck et al (1979). The stored image is 
recalled onto the monitor, and a lightpen is used to outline the boundaries of 
the left ventricle, thus creating a left ventricular area of interest (AOI). The 
interpolative background subtraction then takes place, and the process is 
repeated for each image. The programme generates a horizontal reference 
plane i.e. a three-channel profile, across the centre of the AOI. A new set of 
pixel values (interpolated values) is assigned to the reference plane. A 
background-computed image is determined as a fraction of the radioactivity in 
the myocardial region relative to the reference plane. Then, a background 
corrected image is created by subtracting the computed background image from 
the original unprocessed one.
The production of raw stress, redistribution and washout profiles is done 
next. The profiles consist of the maximum number of counts along radii 
originating at the centre of the left ventricle. Each radius is separated by 6<> 
from the next. The number of counts along the radius is smoothed using a three
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point smooth.
The programme quantitates the spatial distribution of thallium in the 
myocardium on each pair of stress and redistribution images. The centre and 
apex of the left ventricle are marked by the operator on each pair of images, 
using a light pen. The system then creates sixty radii extending from the 
centre, placed at 6° intervals, with the first radius at 90o anticlockwise from 
the apex. The system searches for the pixel in each radius with the maximum 
number of counts, within the inner and outer search boundaries of the 
myocardium. It then averages the pixels and displays the image, with inner and 
outer boundaries, and hottest pixel marked. Once this is accepted by the 
operator, each pixel is averaged with the two adjacent pixels on each radius, 
and the stress and redistribution images are displayed on the screen.
The calculated count profiles can then be plotted, with the highest count 
value on either image being assigned a value of 100%. All other pixels are 
assigned a value relative to this. The horizontal axis of the graph represents 
count location in the myocardium, with the apex always at the 90o position. 
The vertical axis shows the percentage of the maximum counts in the 
myocardium. Stress and redistribution curves are plotted on the same graph. 
The percent washout curve is also plotted, with percent washout calculated as 
Stress image count value minus Redistribution image count value divided by 
Stress image count value, multiplied by 100%.
Profiles generated in this way provide information on the relative 
distribution of thallium around the circumference of the heart (Burow et al 
1979) . The stress profile will show up ischaemic areas as those of initially low
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uptake of thallium, with a tendency to normalise after rest. In normals, the 
stress and redistribution curves will run parallel to one another. Washout 
curves are particularly relevant in patients with balanced triple vessel disease, 
or after intervention. Uptake of thallium may be uniform in all areas in these 
cases, and therefore plots of relative counts may show no abnormality. Slow 
clearance of thallium from ischaemic areas may result in redistribution profiles 
which are higher than expected.
The addition of normal values to the curves provides further 
enhancement of the above programme and analysis. Maddahi et al (1981) have 
published normal values for stress and washout curves, which identify lower 
limits of normal corresponding to two standard deviations below the mean for 
his group of normal individuals. Abnormal curves can be compared with these 
values to show up areas which fall below the normal range. For the detection 
of coronary artery disease, the technique has a sensitivity of 93% and 
specificity of 91%. It was therefore deemed suitable for the assessment of 
myocardial perfusion in post-CAS patients.
A computer programme had been developed in the Nuclear Medicine 
Department at the Victoria Infirmary, on a BBC Master computer to 
superimpose the normal curves from Maddahi’s study onto the profiles 
generated from the patients, and to quantitate any abnormality. Before this is 
done, a further smoothing of the profiles is carried out. The programme has 
the feature of automatic alignment of stress and redistribution profiles using 
cross-correlation. The facility for the operator to override the automatic 
alignment is available. This may be necessary in the presence of gross
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localised perfusion defects.
A printout of the counts for stress, redistribution and washout profiles 
generated from the AD AC computer is obtained. The stress and redistribution 
data are entered by hand into the BBC computer, and stored. The stress image 
is used later as the reference for the cross-correlation routine. The raw data are 
smoothed using a three point smooth, and then normalised to the new maximum 
of the stress profile. The redistribution profile is cross-correlated with the 
stress profile, and the results of these calculations are displayed on the screen. 
The stress and redistribution profiles are then plotted in the position of 
maximum cross-correlation. The operator can either accept the automatic 
alignment, or manually adjust it. This is then stored, and can be printed out. 
The washout profile is calculated and along with the stress profile, it is 
compared with the normal range of data (figures 7-9).
Each image is divided into four segments, and for a segment to be 
considered abnormal, at least one area of 18 degrees or more in either of the 
profiles has to extend below the normal limit. For a study result to be 
considered abnormal at least two abnormal segments have to be present in the 
entire study. The outflow tracts are not included in the analysis.
The use of normal values generated from a different population may not 
be ideal, but their incorporation into our analysis provides a guide as to the 
extent of abnormality and differences between the two scans in each patient.
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Figure 9: Stress, redistribution and washout curves, 65o LAOview.
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RESULTS
Fifty six patients had complete sets of scans for analysis. There were 18 
in the control group, 23 in the aerobic group and 15 in the power group. The 
imbalance in the training groups was due to more patients being randomised to 
the aerobic than to the power group in the middle part of the study, with the 
thallium scans being performed on a consecutive basis. There were errors 
during the acquisition of baseline scans in the remaining four patients.
Three sets of scans from each group were analysed twice to determine 
the intra-observer variation. This was thought to be relevant because the full 
analysis involved several steps. The differences in the results were negligible. 
The anterior views were identical; in the 45° and 65o LAO views, there were 
6 “ 12o differences in the degrees of abnormality in the stress profiles.
The degrees of abnormality in the stress and washout profiles before and 
after training were compared between the groups.
Results are presented first as regional stress data in each individual, with 
the mean and SEM (tables 51 to 59). As is expected following 
revascularisation, some stress scans were normal. Subsequent tables show 
mean total degrees of abnormality in stress profiles for each view and mean 
global stress in the three groups (table 60). Washout data are presented as 
mean degrees of abnormality of regional washout, mean washout in each view 
and mean global washout in the three groups (tables 61 and 62).
A number of patients had previous myocardial infarction, causing fixed 
perfusion defects. It may be suggested that if exercise training has any effect 
on myocardial vascularity, even such fixed defects may be altered, especially
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as they may represent stunned or hibernating myocardium.
In the previous section, those with anterior myocardial infarction had 
improved anterior regional ejection fraction after aerobic training. Results of 
their thallium scans were therefore analysed as a subgroup to see if this was 
related to myocardial perfusion as was speculated. Significant differences were 
found after training in degrees of abnormality in the washout curves, but not 
in the stress curves.
The aerobic group tended to have lower degrees of abnormality in 
washout in the anterior zone after training than the power group. The control 
group had intermediate values. The significant results are in table 63. None 
of the other values achieved statistical significance.
A fair number of the patients had normal anterior views, resulting in low mean 
degrees of abnormality in each region.
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Abbreviations used in the tables arc:
ALS/W: anterolateral stress/washout 
AS/W: apical stress/washout 
IS/W: inferior stress/washout 
PLS/W: posterolateral stress/washout 
lAS/W : inferoapical stress/washout 
SS/W: septal stress/washout 
INS/W: 65o LAO inferior stress/washout 
APS/W: 65o LAO apical stress/washout 
ASS/W: Anteroseptal stress/washout 
ANTS/W: anterior view stress/washout 
FVS/W: 45o LAO view stress/washout 
SVS/W: 65o LAO view stress/washout
1 =  first scan
2 = second scan
MI code: 1 == none 2 — anterior 3 = inferior 4 = site unknown
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There were significant differences between the groups only in ISl 
(ANOVA p =  0.02) and IS2 (ANOVA p = 0.04), with the control group 
having a lower perfusion abnormality in that region than the exercise groups on 
both scans. This suggests that there was no change in regional perfusion with 
exercise training in these patients who appear to have been adequately 
revascularised by coronary artery surgery.
There was a significant difference only in the anterior view, with the 
control group having a smaller perfusion defect than the aerobic group on both 
scans. The control group did increase the perfusion defect more than the 
aerobic group, and in the power group, there was a reduction in the perfusion 
defect. These interval changes did not reach statistical significance. There was 
therefore no overall change in global stress perfusion with exercise training in 
these patients.
A further analysis was done of patients with no history of myocardial 
infarction. This did not yield any differences between the groups.
The overall low degrees of abnormality implies that revascularisation had been 
very successful in these patients.
The lack of effect of exercise training on myocardial perfusion is perhaps 
a reflection of its existing adequacy.
In a further analysis of the stress data, only patients with positive scans 
in any of the three views were considered. This did not add to the above results 
in that there was no significant differences within or between the groups at any 
time.
Table 51
CONTROL GROUP: ANTERIOR VIEW STRESS DATA
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PAT. ALSl ALS2 ASl AS2 ISl IS2 Ml
1 0 0 0 0 0 0 4
2 0 0 0 0 0 0 1
3 0 0 0 0 0 0 4
4 0 36 0 0 0 0 1
5 0 0 0 0 0 0 1
6 36 18 0 24 72 66 3
7 0 0 30 24 78 48 2
8 0 30 0 0 0 0 4
9 42 0 0 0 0 0 1
10 0 0 0 0 0 0 3
11 0 0 0 0 0 18 1
12 78 90 12 60 0 36 2
13 0 36 0 0 0 0 1
14 0 0 0 0 0 0 1
15 0 0 0 0 0 54 1
16 0 0 0 0 0 0 1
17 0 24 0 0 0 24 1
18 18 18 0 0 0 0 1
MEAN 9.66 14 2.33 6.0 8.3 13.66
SEM 5.0 5.5 1.8 3.7 5.7 5.2
Table 52
CONTROL GROUP: 45o LAO VIEW STRESS DATA
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PAT. PLSl PLS2 lASl IAS2 SSl SS2 Ml
1 0 0 0 0 54 54 4
2 0 0 0 0 48 36 1
3 0 0 0 0 66 72 4
4 0 18 0 0 54 42 1
5 0 0 0 0 0 0 1
6 36 66 24 30 30 54 3
7 36 0 18 36 90 66 2
8 0 0 0 0 0 0 4
9 0 0 0 0 0 48 1
10 0 0 0 0 30 60 3
11 0 0 0 0 0 24 1
12 0 0 0 0 96 90 2
13 0 60 0 0 18 60 1
14 0 0 0 0 96 96 1
15 0 0 0 0 0 66 1
16 0 0 0 0 78 96 1
17 0 0 0 0 60 0 1
18 0 0 0 0 66 102 1
MEAN 4.0 8.0 2.33 3.66 43.6 53.6
SEM 2.7 4.8 1.6 2.5 8.3 7.6
Table 53
CONTROL GROUP: 65o LAO VIEW STRESS DATA
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PAT. INSl INS2 APSl APS2 ASSl ASS2 MI
1 0 0 0 0 0 0 4
2 0 48 0 30 0 0 1
3 0 0 0 0 24 0 4
4 0 54 0 0 0 0 1
5 36 0 0 0 0 0 1
6 78 72 30 30 0 0 3
7 48 60 60 60 42 0 2
8 60 36 0 0 0 0 4
9 48 42 0 0 0 0 1
10 78 54 0 0 0 0 3
11 0 48 0 0 0 0 1
12 0 0 48 24 60 72 2
13 36 0 0 0 0 0 1
14 0 0 0 0 0 0 1
15 24 0 0 0 0 0 1
16 30 54 0 0 0 0 1
17 0 0 0 0 0 0 1
18 0 18 0 6 0 18 1
MEAN 24.3 27 7.6 8.3 7.0 5.0
SEM 6.7 6.4 4.3 3,9 4.1 4.1
Table 54
AEROBIC GROUP: ANTERIOR VIEW STRESS DATA
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PAT. ALSl ALS2 ASl AS2 ISl IS2 MI
1 48 0 42 0 0 0 4
2 54 0 0 0 84 72 3
3 0 0 0 0 0 0 1
4 18 18 60 24 24 0 3
5 0 0 0 0 84 84 3
6 0 36 0 42 48 78 1
7 42 30 0 0 0 0 1
8 0 0 0 0 0 0 1
9 0 24 0 36 18 90 3
10 18 36 0 0 0 0 2
11 0 24 0 36 36 90 1
12 0 0 0 0 90 90 3
13 0 42 0 0 18 24 3
14 90 84 60 54 18 18 2
15 24 24 36 36 90 90 1
16 0 0 0 0 84 54 2
17 0 0 0 0 36 0 1
18 0 0 0 0 0 36 1
19 18 60 0 12 48 18 2
20 0 30 0 0 66 0 1
21 18 0 42 0 66 54 1
22 36 72 0 12 0 0 2
23 60 0 0 0 0 0 1
MEAN 18.5 20.9 10.4 10.9 35.2 34.7
SEM 5.3 5.3 4.3 3.6 7.2 7.9
Table 55
AEROBIC GROUP; 45o LAO VIEW STRESS DATA
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PAT. PLSl PLS2 lASl IAS2 SSl SS2 MI
1 0 0 0 0 36 0 4
2 0 0 0 0 0 0 3
3 0 0 0 0 0 0 1
4 72 0 18 0 30 0 3
5 60 78 36 6 0 0 3
6 78 0 0 0 0 0 1
7 0 0 0 0 84 84 1
8 36 36 6 0 36 0 1
9 24 0 0 0 0 0 3
10 0 0 0 0 60 102 2
11 0 0 0 0 0 48 1
12 36 72 24 0 18 0 3
13 18 18 0 0 30 84 3
14 18 0 12 60 102 90 2
15 0 0 0 0 0 0 1
16 0 0 0 0 30 48 2
17 0 0 0 0 30 0 1
18 0 0 0 0 0 30 1
19 18 36 54 60 90 90 2
20 0 0 0 0 84 66 1
21 0 0 0 36 90 102 1
22 0 0 0 0 60 42 2
23 0 0 0 0 66 0 1
MEAN 12.3 10.4 6.5 7.0 36.8 34.2
SEM 4.3 4.8 2.9 3.8 7.4 8.4
Table 56
AEROBIC GROUP: 65o LAO VIEW STRESS DATA
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PAT. INSl INS2 APSl APS2 ASSl ASS2 MI
1 54 0 60 0 0 0 4
2 72 78 0 12 0 0 3
3 0 0 0 0 0 0 1
4 0 90 48 60 30 18 3
5 90 90 6 12 0 0 3
6 48 24 0 0 0 0 1
7 0 48 0 0 0 0 1
8 30 72 0 24 0 0 1
9 54 60 0 6 0 0 3
10 18 18 0 0 0 0 2
11 72 54 12 0 0 0 1
12 24 72 0 0 0 0 3
13 54 24 0 0 0 36 3
14 36 24 60 60 90 90 2
15 0 0 0 0 0 0 1
16 0 36 0 0 0 0 2
17 36 54 0 0 0 0 1
18 0 0 0 0 0 0 1
19 60 30 60 60 30 84 2
20 0 0 0 0 0 0 1
21 0 66 0 0 0 0 1
22 0 0 0 0 66 84 2
23 0 0 0 0 0 0 1
MEAN 32.1 34.7 11.2 8.9 8.9 12.8
SEM 6.7 6.2 4.8 3.8 4.8 6.2
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Table 57
POWER GROUP: ANTERIOR VIEW STRESS DATA
PAT. ALSl ALS2 ASl AS2 ISl IS2 MI
1 0 0 0 0 0 30 1
2 0 0 0 0 0 24 1
3 0 0 0 0 72 0 3
4 0 0 0 0 78 78 3
5 0 0 0 0 0 0 1
6 0 0 0 0 0 0 2
7 0 48 0 60 0 24 3
8 0 0 42 24 66 36 1
9 0 0 0 0 0 0 3
10 54 24 0 0 0 0 1
11 0 0 0 0 24 0 1
12 90 72 60 0 60 18 2
13 0 0 0 0 0 0 3
14 0 0 0 0 0 0 4
15 0 0 0 0 0 0 1
MEAN 9.6 9.6 6.8 5.6 20.0 14.0
SEM 6.8 5.6 4.7 4.2 8.1 5.7
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Table 58
POWER GROUP: 45o LAO VIEW STRESS DATA
PAT. PLSl PLS2 lASl IAS2 SSl SS2 MI
1 0 0 0 0 0 0 1
2 0 0 0 0 18 60 1
3 0 36 0 6 0 0 3
4 0 0 0 0 0 0 3
5 0 0 0 0 0 0 1
6 0 0 0 0 0 54 2
7 0 66 0 0 0 24 3
8 0 0 66 36 90 54 1
9 0 0 0 0 0 0 3
10 72 0 0 0 66 60 1
11 0 0 0 0 0 0 1
12 30 24 0 0 78 102 2
13 0 0 0 0 0 48 3
14 0 0 0 0 0 0 4
15 0 0 0 0 0 0 1
MEAN 6.8 8.4 4.4 2.8 16.8 26.8
SEM 5.1 4.9 4.4 2.4 8.3 8.6
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Table 59
POWER GROUP: 65o LAO VIEW STRESS DATA
PAT. INSl INS2 APSl APS2 ASSl ASS2 MI
1 0 0 0 0 0 0 1
2 18 18 0 0 0 0 1
3 90 78 12 24 0 0 3
4 48 36 6 0 0 0 3
5 18 30 0 0 0 0 1
6 24 18 18 0 0 0 2
7 90 54 6 0 0 0 3
8 0 0 0 0 0 0 1
9 18 24 0 0 0 0 3
10 78 72 0 0 0 0 1
11 60 48 24 6 0 0 1
12 36 0 0 18 60 78 2
13 0 0 0 0 0 0 3
14 0 0 0 0 0 0 4
15 24 24 0 0 0 0 1
MEAN 33.6 26.8 4.4 3.2 4.0 5.2
SEM 8.4 6.8 1.9 1.9 4.0 5.2
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Table 60
TOTAL STRESS PERFUSION ABNORMALITY IN ALL GROUPS
CONTROL AEROBIC POWER
ANTSl * 20.3 (9.2) 64.1 (10.2) 36.4 (15.5)
ANTS2 ** 32.0 (11.6) 66.5 (11.4) 29.2 (10.8)
FVSl 50.0 (9,9) 55.6 (9.8) 28.0 (14.4)
FVS2 61.0 (8.8) 51.6 (11.6) 38.0 (10.8)
SVSl 39.0 (10.7) 52.4 (12.0) 42.0 (10.2)
SVS2 40.3 (9.3) 56.3 (10.5) 35.2 (8.7)
GLOBALSl 109.3 (25.7) 172.2 (24.6) 106.4 (32.1)
GLOBALS2 133.3 (22.7) 174.5 (25.6) 102.4 (23.9)
* ANOVA p=  0.02. ** ANOVA p=  0.04
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Table 61
DEGREE OF ABNORMALITY IN REGIONAL WASHOUT IN ALL GROUPS
CONTROL AEROBIC POWER
ALWl 62.6 (7.9) 67.3 (6.5) 67.2 (7.9)
ALW2 74.3 (6.2) 77.7(4.1) 70.0 (7.2)
AWl 40.3 (4.9) 43.8 (4.1) 44.4 (6.2)
AW2 43.0 (5.1) 54.5 (3.1) 46.8 (5.2)
IWl 55.3 (7.8) 73.6 (5.1) 67.2 (7.5)
IW2 69.6 (7.2) 66.3 (5.7) 70.0 (6.5)
PLWl 2.3 (2.3) 16.7 (5.9) 9.6 (5.7)
PLW2 12.3 (5.7) 12.3 (4.8) 13.6 (7.4)
lAWl 2.3 (2.3) 9.6 (3.5) 7.2 (4.6)
IAW2 12.7 (4.2) 11.2 (4.2) 10.0 (5.6)
SWl 13.0 (5.9) 9.1 (4.3) 6.0 (3.3)
SW2 14.3 (4.9) 15.1 (5.3) 14.4 (8.3)
INWl 7.3 (3.1) 7.3 (3.8) 5.6 (3.4)
ÏNW2 13.0 (5.9) 19.6 (6.3) 16.0 (7.8)
APWl 6.3 (4.4) 3.1 (2.2) 5.6 (3.8)
APW2 10.0 (4.3) 4.9 (2.9) 12.8 (5.3)
ASWl 11.3 (5.6) 8.6 (4.2) 16.8 (7.5)
ASW2 11.3 (4.0) 16.9 (6.6) 21.6 (8.8)
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Table 62
DEGREE OF ABNORMALITY IN WASHOUT PER VIEW AND GLOBALLY 
IN ALL GROUPS
CONTROL AEROBIC POWER
ANTWl 159.4 (19.1) 184.7 (12.5) 176.1 (20.1)
ANTW2 188.1 (16.7) 198.5 (11.4) 184.1 (17.6)
FVWl 17.7 (9.4) 35.5 (12.1) 22.8 (9.6)
FVW2 39.3 (12.3) 38.6 (11.6) 38.0 (20.6)
SVWl 25.0 (11.7) 19.0 (8.2) 28.0 (13.3)
SVW2 34.3 (12.8) 41.5 (12.0) 50.4 (21.4)
GLOBALWl 202.1 (32.8) 239.2 (24.8) 226.9 (30.8)
GLOBALW2 261.8 (33.9) 278.6 (28.2) 272.5 (51.4)
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Table 63
THALLIUM WASHOUT IN PATIENTS WITH ANTERIOR MYOCARDIAL 
INFARCTION - SIGNIFICANT RESULTS
CONTROL AEROBIC POWER ANQVA
PLW2 57.0 (27.0) 0(0) 81.0 (9.0) 0.002
SW2 45.0 (9.0) 24.0 (11.1) 90.0 (0) 0.025
APW2 21.0 (21.0) 1.2 (1.2) 54.0 (6.0) 0.008
ASW2 24.0 (24.0) 4.8 (4.8) 90.0 (0) 0.002
FVW2 138.0 (54.0) 40.8 (18.0) 231.0 (9.0) 0.007
SVW2 84.0 (84.0) 30.0 (18.4) 222.0 (18.0) 0.024
GLOBALW2 453.0 (147.0) 276.0 (37.3) 693.0 (27.0) 0.01
DSVW 30.0 (30.0) 2.4 (38.9) 210.0 (30.0) 0.04
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DISCUSSION
There have been many studies on exercise and resting thallium-201 
scintigraphy before and after CAS (Ritchie et al 1977; Verani et al 1978; 
Kolibash et al 1979; Robinson et al 1979; Berger et al 1979; Sbarbaro et al 
1979; Hirzel et al 1980; Pfisterer et al 1982; Gibson et al 1983). They have 
confirmed that myocardial perfusion is improved by bypass surgery. In 1978, 
Verani et al showed that 9 out of twenty three patients had normal thallium 
scans, and 19 had improved scans post-operatively. Ten years later, using 
exercise thallium tomography in 25 patients, Fioretti et al (1988) found that 
transient defects were reduced from 11 to 5 segments per patient, and even 
persistent defects were reduced from 8 to 4 segments per patient after CAS.
It is generally agreed that thallium-201 scintigraphy is a more sensitive 
and specific investigation than exercise electrocardiography in the setting of 
CAS. In 1977, Ritchie et al studied 20 patients by rest and exercise thallium 
imaging postoperatively. In addition, nine had resting scans and 11 had resting 
and exercise scans preoperatively. Patients with no new perfusion defect had 
87% graft patency, those with a new defect had 54% graft patency, suggesting 
that pre and post operative thallium scans may nonivasively predict graft 
patency. In a study of 55 patients pre CAS and two weeks and one year post- 
CAS, Pfisterer et al (1982) found a sensitivity, specificity and overall accuracy 
of 80%, 88%, and 86% respectively for detecting graft occlusion. Hirzel et al 
(1980) reported that 31 patients with normal postoperative scans had 81 % graft 
patency, 16 patients in whom perfusion defects had not changed after surgery 
had 38% patency, and seven patients with worse perfusion defects after surgery
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had 15% patency.
Segments showing total redistribution preoperatively are more likely than 
those with partial redistribution or persistent defects to become normal 
postoperatively. Ninety three percent of such segments were normal after 
surgery, compared with 73% with partial redistribution, and 45% with 
persistent defects, in a study of 47 patients (Gibson et al 1983).
As with other aspects of exercise rehabilitation, most reported studies on 
thallium scintigraphy are in patients with angina or previous myocardial 
infarction with CAS patients forming a small, if any, part of the group.
The results obtained here are in keeping with several previous reports, 
which conclude that thallium scans and scores are unchanged by exercise 
training in patients with coronary disease or previous myocardial infarction 
(Foster 1986). It had been thought that exercise training would encourage the 
development of collateral vessels and thus improve myocardial perfusion. 
Verani compared et al (1981) exercise thallium scans before and after twelve 
weeks aerobic exercise training in 16 patients. There were no controls. 
Patients exercised to the same level before and after training. Pairs of scans 
were assessed blindly as to a change in perfusion, and then anatomical regions 
of individual scans were given a score of 0-4, in a semi-quantitative analysis. 
Three patients improved, three were worse, and ten unchanged.
Tubau and colleagues (1982) used circumferential profile analysis of 
thallium scans before and after a mean duration of training of 5.6 months in 17 
patients. Five patients improved, one was worse, and 11 unchanged.
The PERFEXT study was a randomised controlled trial of 146 patients
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(Froelicher 1987c). The exercise group undertook one year of aerobic training. 
Side by side analysis of paired thallium scans was used, with any changes 
scored on a 0-3 scale. There were no significant changes found. Regional 
scoring was done on a 0 10 scale. The exercise group showed a small 
improvement in perfusion but this was dependant on the presence of angina. 
Subgroup analysis of these thallium data was done, using circumferential 
profile analysis (Sebrechts et al 1986). Global indices were statistically 
different between the control and trained groups, but regional analysis failed 
to identify any one vascular territory as being the source of this improvement. 
The study did not really add to that reported by Froelicher.
The lack of effect could be related to low intensity and short duration 
of exercise training used in the studies, for there have been one or two training 
programmes resulting in improved myocardial perfusion.
Eighteen patients with angina and hyperlipidaemia were studied before 
and after one year of exercise training and low fat diet. There were 18 matched 
controls. Thallium scans were done after maximal exercise. The trained group 
achieved a higher exercise level than at baseline. Degrees of circumference of 
left ventricle with reversible ischaemia were measured from reconstructed 
cross-sectional images of stress and redistribution scans. Stress induced 
myocardial ischaemia in the trained group was reduced by 54%, even though 
they achieved a higher workload (Schuler et al 1988).
Sixteen patients with chronic stable angina showed a 34% reduction in 
number of degrees of ischaemia on circumferential profile analysis after one 
year of aerobic exercise training. (Todd et al 1991). There was no change in
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17 control patients. View and segmental data showed that the improvement was 
mainly in left anterior descending artery territory. Thallium scans were again 
done at maximal exercise and the trained patients achieved a higher cardiac 
workload. This study was conducted in this department and has been referred 
to in other sections of this work.
The PERFEXT study included 53 patients with previous CAS, 28 in the 
exercise intervention group, and 25 controls (Froelicher et al 1985). The mean 
time from surgery was two years. The exercise group had more evidence of 
ischaemia than the control group at baseline: exercise-induced angina (32% vs 
24%), ST depression (46% vs 32%), thallium ischaemia (44% vs 26%), left 
main coronary disease (25% vs 8%), thallium ischaemia score (3.7 vs 1.4 
units). This would suggest that they had incomplete myocardial 
revascularisation. The results of thallium-201 scintigraphy before and after 
exercise training were the same as that reported for the whole PERFEXT group. 
There was a trend towards improved thallium scans in the exercised patients 
with angina. Interval change in immediate scores was -0.1 Atwood severity 
units in controls, -0.8 in exercisers, 0.4 in controls with angina, and 1.6 in 
exercisers with angina. Interval change in ischaemia scores in controls was 0, 
in exercisers 1.0, controls with angina -1.2, exercisers with angina -2.1.
Slow myocardial thallium washout rate has been found to increase the 
sensitivity of thallium stress tests (Maddahi et al 1981; Sklar et al 1982; 
Gerwitz et al 1983), identifying patients with left main stem and triple vessel 
disease (Maddahi et al 1986) and in correctly localising the diseased vascular 
territory (Abdulla et al 1985). Washout rates improve the diagnostic reliability
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of thallium scans in the assessment of graft patency (Zimmerman et al 1988). 
Changes in washout would therefore reflect changes in myocardial ischaemia. 
The analysis of degrees of abnormality in washout profiles in this study did not 
yield any relevant findings in the group as a whole. In subgroup analysis of 
those with anterior MI, the aerobic group fared better after training than the 
power, and to a lesser extent, the control groups. This result should be 
interpreted cautiously. It is an indirect assessment of perfusion, not supported 
by changes in stress profiles. It is based on subgroup analysis involving nine 
patients. Highly statistically significant differences did occur in several areas 
and this consistency makes the finding worthy of mention. Thallium washout 
is affected by various factors including heart rate, activity prior to and timing 
of redistribution scan, blood glucose and myocardial uptake in relation to other 
organs (Abdulla et al 1985; Kaud et al 1986; Angello et al 1987).
There are several possible explanations for the lack of more convincing 
change in the thallium indices measured in the present study.
The most likely one is that there was little improvement to be made on 
myocardial perfusion in these patients. The vast majority of patients were free 
of angina during the study. The inclusion of patients with previous myocardial 
infarction in this study may have reduced the chances of demonstrating 
reversible perfusion defects, and any improvement or otherwise induced by 
exercise training. Alternatively, one could speculate that the training 
programmes were not rigorous enough or that any changes were too minor to 
be demonstrated by thallium scanning, and the analysis used.
Newer techniques such as quantitative single photon emission computed
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thallium-201 tomography (SPECT) may have identified subtle changes in 
perfusion. It has been found to improve localisation of coronary stenoses, 
predict multivessel disease and determine perfusion defect size accurately 
(Maddahi et al 1989; Mahmarian et al 1990). Almost half the patients had 
normal anterior views at baseline, indicating that revascularisation had been 
adequate, and not likely to improve further. There have been suggestions that 
delays in scanning after exercise reduce the detection of transient defects 
(Rothendler et al 1985). The anterior view was taken first, and any changes 
might have been identified readily in that view. That was the only view with 
differences in stress scan abnormalities between the three groups.
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SECTION XIII
TWENTY FOUR HOUR AMBULATORY HOLTER MONITORING.
Twenty four hour ambulatory Hotter monitoring was used in the study 
to determine the effects of the training programmes on ventricular ectopic 
activity, minimum, mean and maximum heart rate and total ischaemic burden. 
Ventricular ectopic activity was measured in terms of the total number of 
ectopics per twenty four hours, and the maximum Lown grading in that period. 
Total ischaemic burden was assessed by maximum ST segment depression, 
heart rate at onset of maximum ST depression, duration of ST depression 
greater than 0.1 mV from baseline occurring 80 ms after the J point and 
episodes of such ST depression.
Each patient had Holter monitoring done at baseline and after six 
months. The Oxford Medilog 4000 (MARS) ambulatory electrocardiographic 
recorder was used. This is a frequency modulated recorder with a frequency 
response of 0.05 to 40 hertz and a signal to noise ratio of over 30 decibels. 
Each complex is processed in real time and stored on a cassette tape. By 
playing the cassette through the Oxford Medilog MARS replay system, the 
information can be retrieved. Recorder heads were cleaned before each use, 
new batteries were used for each recording and cassettes tapes were 
demagnetised before use, to help achieve high quality. To this end also, the 
patient's chest was shaved if necessary, and rubbed with an abrasive paste to 
remove the stratum corneum. Five electrodes were placed as follows:
1. manubriosternal angle 2. left anterior axillary line, just below the clavicle
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3. the sixth rib in the left anterior axillary line 4. the right fourth 
costochondral joint 5. the sixth rib in the right anterior axillary line. 
Electrodes 1 and 3 record lead CM5, electrodes 2 and 4 record modified lead 
II, and electrode 5 is the ground electrode. An impedance meter was used to 
ensure that the resistance between electrodes was less than 5 kilo ohms. 
Artefact due to lead movement was reduced by creating stress loops in the leads 
before attaching them to the patient with surgical tape, and an elastic vest. The 
recorder was worn in a pouch on a waist belt. A 1 mV calibration signal was 
fed into the recorder and ECG signal recorded on a conventional ECG machine 
to ensure adequate quality before the actual recording was started.
Patients were asked to carry on with their normal activities as much as 
possible during ambulatory monitoring. Each had a diary card on which to 
record details of events, also marked by the event button. None had recordings 
done during periods of exercise training.
The cassette was analysed automatically by the Oxford Medilog MARS 
replay system. This produced trend graphs of heart rate, ST segment analysis 
(figure 10), ventricular ectopic activity, hourly summary of maximum and 
minimum heart rates, and arrhythmias. Samples of all types of complex and 
their relative frequency were also shown, (figure 11) Since the time of each 
significant event is shown, a manual check can be done to exclude artefacts 
from the analyses.
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Figure 10; Holter monitoring mean heart rate and ST level,
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The Lown ventricular ectopic grading system is shown here.
Figure 12
LOWN VENTRICULAR ECTOPIC GRADING SYSTEM 
Grade 0 - None
Grade lA - Isolated, less than 30 per hour
Grade IB - Isolated, more than 30/hr, less than 1/min
Grade 2 - Frequent, more than 30/hr
Grade 3 - Multiform
Grade 4A - Repetitive; couplets
Grade 4B - Repetitive; salvoes
Grade 5 - Early ectopics ( R on T)
195
RESULTS
The results are on fifty four patients in whom baseline and six month 
Holter tapes were fully completed and could be analysed.
A. Heart rate responses
The results for minimum, maximum, and mean heart rate are shown in 
figures 13 to 19.
There was no consistent change in maximum heart rate over the training period.
The minimum heart rate in the exercise groups was significantly lower 
after training than in the control group at the following times of day:
time ANOVA p value
O.OOh 0.01
3.00h 0.03
4.00h 0.05
S.OOh 0.03
lO.OOh 0.008
ll.OOh 0.02
12.00h 0.03
13.00h 0.04
16.00h 0.04
17.00h 0.02
19.00h 0.02
21.00h 0.04
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The mean heart rate was calculated as the total beats per 24 hours 
divided by 1440. There was a lower mean heart rate in the power group after 
training, falling from 78.8 (SEM 2.3) beats/min to 73.6 (SEM 1.5) beats/min 
(p = 0.008). This was significantly lower than the controls’ 81.0 (SEM 2.2) 
beats/min (p — 0,01), but not significantly different from that in the aerobic 
group which was 74.5 (SEM 2.2) beats/min. The difference between the 
aerobic and control groups also reached statistical significance, p = 0.05.
Thus exercise training using both modalities conferred a tendency 
towards a lower minimum heart rate to the patients. This additional benefit 
operated particularly mid-morning, lunch-time, early evening, and noctumally. 
At other times, there was a trend towards lower minimum heart rates, but it did 
not reach statistical significance.
B. Ventricular ectopic activity.
The total number of ventricular ectopics per day did not change within 
or between the groups. Table 64 shows the median number of ventricular 
ectopics per day in each group at baseline and at six months. The data were not 
normally distributed, and there was a wide range. Analysis of the number of 
ventricular ectopic beats per hour did not change the interpretation of the 
results.
Table 65 is maximum Lown grade at each assessment.
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TABLE 64
Ventricular ectopic beats per day 
median (range)
BASELINE SIX MONTHS
CONTROL 177 (0 - 878) 54 (0 - 4146)
AEROBIC 67 (1 - 2577) 43 (0 - 5471)
POWER 66 (0 - 33847) 65 (3 - 5097)
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TABLE 65
L o w n  g r a d e  a t  e a c h  a s s e s s m e n t  ( n u m b e r  o f  p a t i e n t s )
CONTROL AEROBIC POWER
LOWN a b a b a b
0 2 1 0 1 1 0
la 8 9 13 11 7 9
lb 2 3 3 2 3 4
2 2 1 2 1 3 2
3 0 0 1 4 1 1
4a 0 0 2 2 3 2
4b 0 0 0 0 1 1
5 0 0 0 0 0 0
a - baseline b - six month assessment
The table is self-explanatory. The majority of patients had low grade 
ventricular ectopic activity, which was not altered by exercise training.
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C. ST segment analysis.
The following parameters were measured and analysed : 
minimum ST level (MINST mm)
heart rate at the onset of minimum ST level (HRST beats/min) 
duration of ST depression greater than 1mm (DURST s) 
number of episodes of significant ST depression (EPIST)
The results are shown in the tables 66 to 68.
In these tables, suffix ’1’ denotes baseline, ’2’ denotes six month assessment. 
The results are presented for each individual and then summarised for the group 
with mean, SEM and median values. There were no significant changes in 
these measurements in the three groups. In addition, there was no circadian 
pattern in these parameters.
Table 66
ST SEGMENT ANALYSIS - POWER GROUP
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PAT MINS
T1
MINS
T2
HRST
1
HRST
2
DURS 
T 1
DURS 
T 2
EPIST
1
EPIST
2
1 2.36 1.84 88 100 320 140 6 4
2 2.96 3.24 130 134 100 130 4 3
3 2.48 1.48 120 126 10 30 1 3
4 1.20 1.48 68 72 10 250 1 3
5 1.28 1.60 90 94 10 20 1 2
6 2.00 1.16 128 86 50 20 3 1
7 1.04 0.80 54 84 10 0 1 0
8 0 0 100 78 0 0 0 0
9 1.04 1.28 120 122 5 5 1 1
10 1.44 1.04 130 118 20 5 2 1
11 2.24 1.56 130 120 100 50 1 2
12 1.36 0.40 98 120 5 0 1 0
13 1.12 0.80 106 106 5 0 1 0
14 0 0 58 70 0 0 0 0
15 0 56 0.52 92 54 0 0 0 0
16 0.20 1.00 118 134 0 10 1 1
17 0.68 0.48 118 120 0 10 0 1
18 3.00 2.48 110 110 310 80 21 5
19 0.64 0.72 114 98 0 0 0 0
MN 1.27 1.38 107 107 59.6 73.9 2.5 2.1
SEM 0.27 0.23 6 7 23.9 33.7 0.67 0.59
MD 1.5 1.36 103 108 15.0 7.5 2.0 1.0
Table 67
ST SEGMENT ANALYSIS - AEROBIC GROUP
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PAT MINS
T1
MINS
T2
HRST
1
HRST
2
DURS
T
1
DURS
T
2
EPIST
1
EPIST2
20 0.88 1.08 104 82 0 10 0 1
21 148 0.32 96 142 35 0 3 0
23 2.84 2.40 126 124 160 340 4 7
24 0.40 0.92 70 120 0 0 0 0
25 0.88 0.88 132 102 0 0 0 0
26 0.88 1.28 88 86 0 5 0 1
27 0.60 1.04 128 140 0 5 0 1
28 0.92 1.04 56 58 0 5 0 1
29 3.68 1.00 142 84 70 10 3 1
30 0.56 0.24 108 60 0 0 0 0
31 1.04 0.88 64 96 10 0 1 0
32 0.40 0.40 72 56 0 0 0 0
33 1.04 0.68 120 112 10 0 1 0
34 1.32 1.44 62 58 10 10 1 1
35 0 0.40 92 70 0 0 0 0
36 2.88 3.92 68 66 960 900 6 7
37 0.96 1.32 144 150 0 15 0 1
38 1.52 0.88 134 74 10 0 2 0
39 0.12 0 52 60 0 0 0 0
40 1.52 1.36 124 82 30 5 3 1
41 1.84 2.92 154 148 45 375 5 6
MN 1.21 1.05 101 92 62.1 62.1 1.2 1.05
SEM 0.2 0.18 7 7 23.9 44.9 0.4 0.4
MD 0.96 0.92 104 84 15 0 0 0
Table 68
ST SEGMENT ANALYSIS - CONTROL GROUP
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PAT MINS
T1
MINS
T2
HRST
1
HRST
2
DURS
T1
DURS
T2
EPIST
1
EPIST2
42 168 1.72 134 114 25 35 3 3
43 2.40 1.88 104 108 290 50 6 4
44 3.20 2.52 86 108 215 240 7 6
45 0.36 0.32 70 78 0 0 0 0
46 0.20 1.04 118 132 0 5 0 1
47 1.92 1.24 96 100 85 5 5 1
48 1.84 1.40 128 122 80 20 4 1
49 0 1.76 106 148 0 10 0 1
50 0 0 102 70 0 0 0 0
51 1.16 1.32 102 96 5 5 1 1
52 1.84 1.88 90 64 85 285 3 5
53 0 0.04 82 68 0 0 0 0
54 1.32 1.28 124 136 5 5 1 1
MN 1.35 1.15 104 102 50.3 38.9 2.3 1.4
SEM 0.21 0.19 6 5 22.5 15.4 1.1 0.4
MD 1.20 1.04 110 106 10 5.0 1.0 1.0
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DISCUSSION 
ST SEGMENT CHANGES
There are many reports on ambulatory ECG and ST segment analysis in 
ischaemic heart disease in general, and on the importance of the total ischaemic 
burden (Chierchia et al 1983; Deanfield et al 1984; Gottlieb et al 1986; 
Deanfield 1987; Selwyn 1987; Nabel et al 1987; Pepine et al 1987; Epstein et 
al 1988; Stern et al 1988; Mulcahy et al 1989a; Mulcahy et al 1989b; 
Deedwania & Nelson 1990; Northcote & Higgins 1990). There is only one 
published report on Hotter monitoring in the setting of exercise training in 
ischaemic heart disease. In a study of 40 patients with angina, already referred 
to in this work, Todd & Ballantyne (1992) found that ST segment depression 
was reduced in extent, frequency and duration in the exercise trained group at 
the end of one year. There was also a reduction in the reporting of angina 
pectoris by the patients. The mean number of episodes of ST depression in the 
exercise group was 8.3 (SD 8.0) at baseline and 5.2 (SD 7,0) at one year, p =  
0.02. In the control group it was 5.7 (SD 6.2) and 6.4 (SD 8.4) respectively.
The assessment of ST depression in these post-CAS patients was, like 
thallium scintigraphy, a means of measuring residual ischaemia. It is gratifying 
to find that at baseline there was minimal residual ischaemia in all the groups 
making it hard to show evidence of any change that may have been caused by 
exercise training. Indeed none was shown. It is generally thought that the 
higher the total ischaemic burden, the worse the prognosis. It would appear 
that these patients are fairly well protected in that regard.
211
Myocardial ischaemia after CAS may be due to different factors. These include 
early or late graft occlusion, low graft blood flow, anastomotic site stenosis or 
occlusion, distal stenosis in grafted vessels, progression in native CAD or pre­
existing or acquired abnormalities of microcirculation affecting vasodilatory 
coronary flow reserve (Kennedy et al 1990).
Coronary artery surgery either abolishes ambulatory and exercise- 
induced ST depression, or converts it to a painless phenomenon. Transient 
ischaemic episodes, primarily symptomatic episodes, are reduced in 40 - 60% 
of patients by bypass operations. Total ischaemia duration is also reduced. In 
a study of 28 patients, Droste found that 17 had at least one episode of transient 
ST change pre-operatively, compared to 7 post-operatively (Droste & Roskamm 
1992). Some workers have found that although the number of patients with ST 
changes falls post-operatively, the average number of episodes in those with 
continuing ST changes increases. For example, Crea et al (1987) found an 
increase from 7.1 to 9.7 episodes per patient. Egstrup (1988) found an increase 
from 1.8 to 3.25 episodes per patient.
Previous studies have shown that silent myocardial ischaemia on 24 - 48 
hour ambulatory ECG monitoring occurs in 13 - 50% of patients from three 
weeks to one year after CAS. Of these, 80-99% of episodes of ST depression 
are silent (Droste & Roskamm 1992).
In this study, 57% of patients had at least one episode of ST depression. 
These were silent in all but four patients - one in the control group, two in 
aerobic group and one in the power group. Exercise training could be a method 
of reducing transient ischaemia, as assessed by ambulatory monitoring. This
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did not occur in this study, and it may be that the patients did not attain the 
level of training required to show that effect. In most studies, on ambulatory 
ST segment changes, only episodes lasting at least twenty to thirty seconds are 
considered to be relevant. In the current study, episodes as short as five 
seconds were included in the analysis and may have caused an overestimation 
of such events, and perhaps the inclusion of what some may consider as 
artefact.
Kennedy et al (1990) reported on 94 patients between one and three 
months after CAS, and 184 patients a year after CAS. Silent myocardial 
ischaemia was detected in 20% of the early group and 27% of the late group. 
The mean frequency of episodes was 6 - 1 0  per 24 hours, and mean duration 
was 1 5 - 2 3  minutes. There was a circadian variation with peaks between 
06.00h and 12.00h, and between IS.OOh and 24.00h. Silent myocardial 
ischaemia was not associated with graft occlusion, low graft flow rates, distal 
residual stenoses, or ungrafted native vessels.
It has been suggested that ST segment shifts during exercise testing and 
ambulatory ECG recording may not have the same meaning early after 
myocardial revascularisation as they have before the intervention. (Ribeiro et 
al 1984; Quyyumi et al 1985; Kennedy et al 1990; Gohlke-Barwolf et al 1990; 
Patel et al 1993). There is poor correlation between ambulatory and exercise- 
induced ST segment changes and graft patency, yet rubidium tomographic 
perfusion studies suggest that they are still an expression of abnormal 
myocardial perfusion (Ribeiro et al 1984). In the above study by Kennedy and 
colleagues, silent myocardial ischaemia was not predictive of adverse clinical
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events after follow up of 62 months. This is supported by Dubach and 
colleagues (1989). In contrast, Egstrup (1988) reported on 36 patients studied 
by 36 hour ambulatory monitoring before and three months after CAS. Twelve 
patients had silent ischaemia after CAS and more cardiac events (6 vs 2) than 
the 24 who had no ST segment changes. Perhaps in the later stages after CAS, 
signs of myocardial ischaemia will assume the prognostic significance that they 
hold before revascularisation, since graft attrition and progression of native 
CAD may then overwhelm the protective factors at play in the early stages.
CHANGES IN HEART RATE
The mean heart rate and hourly minimum heart rates were reduced by 
training, but it had no effect on hourly maximum heart rates. This is a 
reflection of the resting bradycardia which is commonly induced by exercise 
training. It suggests that the training programmes may have increased resting 
vagal tone but did not blunt the chronotropic response in these patients. In the 
aforementioned study by Todd & Ballantyne (1992) there were lower nocturnal 
heart rates and a tendency towards lower hourly minimum and maximum heart 
rates after training, an effect which was compared to beta blockade (Todd & 
Ballantyne 1990).
Ventricular and supraventricular ectopic activity were not allowed for in 
the hourly heart rate measurements. This ectopy would have affected maximum 
as well as minimum heart rates, so I do not think it altered the results.
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VENTRICULAR ECTOPIC ACTIVITY
The wide variability in the ventricular ectopic activity in these patients 
is supported by previous studies on Holter monitoring for arrhythmias (Hinkle 
et al 1969; Morganroth et al 1978; Winkle 1980; Smith et al 1992). There was 
a low level of ventricular ectopy in the group, and perhaps a bigger population 
would be needed to show up any change induced by exercise training. Low 
grade ventricular arrhythmias are of uncertain prognostic significance.
It may be postulated that exercise training might alter the balance of 
sympathetic and parasympathetic tone in favour of diminished propensity to 
arrhythmogenesis. This was not found to be so in this study. Baseline was at 
least six weeks after CAS, by which time, any peri operative influences would 
have ceased to apply.
It is known that perioperative ventricular arrhythmias are common and 
often silent. On days 0 to 7 after surgery, ventricular arrhythmias were found 
in 66% of 50 patients who had continuous two-lead ECG monitoring for ten 
perioperative days (Smith et al 1992).
As with other aspects of this study, there are no previous published 
reports on the effects of exercise training after CAS with which to make direct 
comparisons. There are several studies on the effects of CAS itself on resting 
and exercise induced arrhythmias. The results have been varied.
Coronary artery surgery may not decrease the frequency or severity of 
resting or exercise-induced arrhythmias. In a study of 68 patients, 37 of whom 
had CAS, there was an increase in ventricular arrhythmias after three weeks - 
mean ventricular ectopic beats, 133 (SD 35) before, 292 (SD 57) at three weeks
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and a decrease after 18 months, 283 (SD 45), all not statistically significant. 
Twenty one patients had percutaneous transluminal coronary angioplasty, which 
had no influence on ventricular arrhythmias either. The early increase in 
ectopics could have been due to peri operative factors such as increased 
sympathetic drive. The authors conclude that factors other than ischaemia are 
responsible for ventricular arrhythmias (Rotman et al 1990).
Exercise-induced ventricular arrhythmias were found to occur less often 
before, than three months after CAS in two hundred patients, 16.0% vs 24.5%, 
p < 0.05 (Yli-Mayry et al 1990). This finding was irrespective of graft 
patency or left ventricular function. There were ten cardiac deaths in the group 
after a mean follow-up period of 61 +  19 months. None of these had exercise- 
induced ventricular arrhythmias, but had lower ejection fractions than the 
remainder.
In another study of 126 patients by the same authors, complex 
ventricular arrhythmias ( > 30 ventricular ectopics/hr, multiform, and repetitive 
complexes) were found more often three months after (n =  49) than before 
(n = 30) CAS on 24-hour Holter monitoring. After mean follow up of 50 
months, there were four witnessed sudden cardiac deaths. The ejection fraction 
was a stronger predictor of sudden cardiac death than was the presence of 
complex ventricular arrhythmias on Holter monitoring. Patients with normal 
ventricular function are protected against sudden cardiac death even in the 
presence of complex arrhythmias after surgery (Huikuri et al 1990).
In an observational study of 400 patients undergoing coronary artery 
surgery, nine had severe ischaemia and exercise induced ventricular
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arrhythmias preoperatively. None were observed during follow-up of one to 
four and a half years after CAS (Rasmussen et al 1987). The authors concluded 
that reduction of ischaemic exercise-induced arrhythmias may contribute to the 
reduction in mortality resulting from CAS, in larger patient series.
Thirty two patients had exercise ECG, 24 hour Holter monitoring and 
cardiac catheterisation before and again twelve months after CAS (Moller et al 
1983). Exercise induced ventricular arrhythmias occurred in only three 
patients. The prevalence of ventricular arrhythmias during Holter monitoring 
was 56% and 66% pre- and post-operatively. Complex ventricular arrhythmias 
occurred in 18% pre and 28% post-operatively. Graft patency was 77%, and 
left ventricular performance was not altered significantly by CAS. The 
conclusion was that the occurrence of ventricular arrhythmias is not affected to 
any great extent by coronary artery surgery.
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SECTION XIV
ECHOCARDIOGRAPHY
Echocardiography was done using a Hewlett-Packard Sonos 1000 
ultrasound scanner and 3.5MHz probe. Scans were done at baseline, after 
three and six months. M-mode and two-dimensional (2D) echocardiography 
were used to assess the effects of exercise training on cardiac dimensions. The 
scans were done with the patient in the left lateral position.
It was initially hoped that estimates of ejection fraction could be obtained 
reliably from the 2D scans to be compared with that obtained by radionuclide 
ventriculography. It soon became clear that this would not be so. It was 
difficult to obtain 2D scans that were technically adequate for this purpose in 
a number of patients. Taking this together with the known limitations of left 
ventricular ejection fraction derived from echocardiography, it was not 
pursued, and the 2D scans were not analysed further.
Paradoxical septal motion is common after cardiac surgery, though its 
mechanism is still debated. A note was made of the pattern of septal motion. 
Doppler, exercise and dobutamine echocardiography were not part of the study.
The M-mode scans were analysed. The following measurements were taken in 
the standard way; right ventricular internal dimension in diastole (RVIDD), 
aortic root (AO), left atrium (LA), left ventricular internal dimension in 
diastole and systole (LVIDD, LVIDS), interventricular septum (IVS), left 
ventricular posterior wall (LVPW), fractional shortening (FS). Interventricular 
septal motion (IVSM) was graded as normal, hypokinetic or paradoxical.
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Left ventricular mass was derived from M-mode measurements using the 
formula:
Ivm ={lvidd+ivs +lvpwŸ -{Ividâf xl.04g
RESULTS
The scans were stored on videotape for later analysis. This part of the 
study is perhaps more subject to observer bias than the others. In order to try 
to reduce this effect, the scans were analysed in random order at the end of the 
study, and the results tabulated only after all the scans had been reviewed.
Baseline and six month scans were compared in sixty four patients (table 
69). In the remainder, technically adequate pairs of scans were not obtained.
There were no significant differences within or between the groups in the 
measured variables or in the interval changes. There was a trend towards 
thinner left ventricular posterior wall in the aerobic exercise group at six 
months compared with the other groups; control 0.08cm, aerobic -0.08cm, 
power -0.002cm, p = 0.07. These differences are highly unlikely to be of any 
clinical relevance.
Left ventricular mass (LVM) is shown in table 70. There was an 
increase in left ventricular mass in the control group and a decrease in the 
exercise trained groups. This is a most unexpected finding. Power exercise 
training usually causes left ventricular hypertrophy.
Paradoxical septal motion was seen in 25 patients (39.1%) at baseline.
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hypokinetic motion in 33 (51.6%) and normal motion in six (9.4%) (tables 71 
and 72). In three patients, paradoxical septal motion became hypokinetic after 
six months.
DISCUSSION
Exercise training has been shown to have variable effects on cardiac 
dimensions and contraction measured by M-mode and 2D echocardiography. 
In normal persons, prolonged and intensive endurance exercise causes a modest 
degree of right and left ventricular chamber enlargement (Gilbert et al 1977; 
Ehsani et al 1982; Golan et al 1985), increased left ventricular wall thickness, 
and left ventricular mass, but no change in ejection fraction (Tabakin et al 
1965; Hanson et al 1968; Hartley et al 1969). In wrestlers and weight trainers, 
left ventricular wall thickness increases (Morganroth et al 1975; McKillop et 
al 1989). Other studies have failed to demonstrate any change in these 
variables with training (Froelicher 1987a).
In 10 patients with coronary artery disease, Ehsani et al (1981) found 
that a year’s aerobic training resulted in an increase in left ventricular end 
diastolic dimension, posterior wall thickness, and mass. Conversely, Ditchey 
et al (1981) did not find any changes in a group of 14 patients. These studies 
are limited by the lack of control groups. In another study reported by Ehsani 
et al in 1982, there was an increase in left ventricular end-diastolic diameter 
from 47mm to 51mm after a year of aerobic training in 8 men. Left ventricular 
fractional shortening decreased progressively during graded isometric handgrip 
before training but not after it. In that study, there was a control group of 5
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patients who did not show such changes. There have been no previous reports 
in patients who have been exercise trained after coronary artery surgery.
This study concurs with the view that exercise training does not directly 
affect cardiac dimensions. Again, the arguments regarding intensity and 
duration of training could be invoked. Most exercise rehabilitation programmes 
in UK practice take place once or twice a week for six to eight weeks. It would 
be fair to assume that no effect on cardiac dimensions could result from those 
programmes.
Abnormalities of septal motion are recognised phenomena after cardiac 
surgery. The exact mechanism is debated. Loss of pericardial restraint by 
pericardiotomy may allow the heart to move anteriorly in systole. 
Perioperative ischaemia, pericardial effusions and clot in the right ventricle 
have also been suggested as possible causes. The incidence of abnormal septal 
motion is reported as 56-100% by cineangiography, radionuclide 
ventriculography or echocardiography (Rubenson et al 1982; Ribeiro et al 
1985).
In the study by Ribeiro et al (1985) 45 patients were studied by cross- 
sectional echocardiography before and 8-10 days after bypass surgery. 
Fourteen developed new septal wall motion abnormalities. Of these, 11 
developed hypokinesia (8 with normal CK-MB), 2 developed akinesia (due to 
infarction), and 1 dyskinesia in a previously akinetic region. They concluded 
that most new septal motion abnormalities were not caused by transient 
ischaemia, or perioperative infarction.
Lehmann et al (1990) studied 24 patients by continuous intraoperative
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transoesophageal echocardiography during cardiac surgery. They found that 
mean left ventricular fractional shortening did not vary among regions in the 
initial stages of surgery, but changed dramatically after the discontinuation of 
cardiopulmonary bypass. There was an apparent medial hypokinesis and lateral 
hyperkinesis due to cardiac translation. Pericardiotomy did not affect septal 
motion. They concluded that new abnormalities in septal motion appear to be 
directly related to events occurring during cardiopulmonary bypass.
In the present study, 10 patients (7 aerobic, 2 power 1 control) had 
previous anterior myocardial infarctions, which could have caused septal 
hypokinesia. Right ventricular enlargement and overload may have contributed 
in causing paradoxical septal motion. Subgroup analysis failed to find any 
difference in right ventricular dimensions between those with and those without 
paradoxical septal motion, (table 73) None of the three in whom septal motion 
changed during the study had myocardial infarctions, or decreases in right 
ventricular dimensions. Paradoxical septal motion could concievably influence 
the left ventricular function and estimates of ejection fraction.
There are obvious limitations to the results on left ventricular mass. 
Three-dimensional information is derived from a two-dimensional image. 
There are inherent limitations due to the asymmetry of left ventricular 
geometry. Since the measurements are cubed, any errors are compounded. The 
results are bontraiy to what has been found previously. There is no explanation 
such as hypertension, for the increase in LV mass in the control group. One 
would have expected an increase rather than a significant decrease in LV mass 
in the power-trained group.
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Changes in mean body weight in the three groups do not account for the 
differences in left ventricular mass. The body weight in the power group 
remained static, while that in the control and aerobic groups increased slightly. 
Changes in left ventricular mass index follow the same pattern as LVM.
There are limitations to their interpretation, but these results would again 
suggest that the exercise training programmes used in this study did not cause 
a direct central or myocardial effect. Its convincing benefits were probably of 
peripheral origin.
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TABLE 69
M-MODE ECHOCARDIOGRAPHIC MEASUREMENTS cm mean(SEM)
CONTROL AEROBIC POWER
RVIDD 1 3.8 (0.1) 3.9 (0.1) 3.9 (0.1)
RVIDD2 3.9 (0.1) 3.8 (0.1) 4.0 (0.1)
AGI 3.8 (0.1) 3.7 (0.1) 4.8 (1.0)
A02 3.9 (0.1) 3.7 (0.1) 3.7 (0.1)
LAI 3.1 (0.1) 3.4 (0.1) 3.3 (0.2)
LA2 3.3 (0.1) 3.3 (0.1) 3.2 (0.2)
LVIDDl 5.8 (0.2) 6.2 (0.2) 5.9 (0.3)
LVIDD2 6.1 (0.2) 6.1 (0.2) 5.9 (0.2)
LVIDS 1 4.7 (0.2) 4.9 (0.2) 4.8 (0.2)
LVIDS2 4.6 (0.2) 4.7 (0.2) 4.5 (0.2)
IVSl 1.3 (0.05) 1.3 (0.04) 1.3 (0-07)
IVS2 1.4 (0.05) 1.3 (0.05) 1.2 (0-06)
LVPWl 1.2 (0.04) 1.2 (0.05) 1.1 (0.08)
LVPW2 1.3 (0.04) 1.2 (0.03) 1.1 (0.04)
ESI % 0.19 (0.01) 0.22 (0.02) 0.52 (0.3)
FS2 % 0.25 (0.02) 0.22 (0.01) 0.24 (0.02)
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TABLE 70
LEFT VENTRICULAR MASS, BASELINE, SIX MONTHS AND INTERVAL 
CHANGE (g) mean (SEM)
CONTROL AEROBIC POWER ANOVA
LVMl 374.2 (29.2) 437.5 (25.4) 408.2 (38.9) 0.3
LWM2 440.5 (32.0) 399.2 (25.2) 344.8 (20.4) 0.06
INTLVM 60.9 (25.6) -35.6 (25.6) -56.3 (39.4) 0.02
LVMl baseline LVM; LVM2 six month LVM; INTLVM interval change
TABLE 71
SEPTAL MOTION AT BASELINE
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CONTROL AEROBIC POWER
NORMAL 1 3 2
HYPOKINETIC 11 13 9
PARADOXICAL 11 8 6
TABLE 72
SEPTAL MOTION AT SIX MONTHS
CONTROL AEROBIC POWER
NORMAL 1 3 2
HYPOKINETIC 11 15 10
PARADOXICAL 11 6 5
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TABLE 73
MEAN RIGHT VENTRICULAR END DIASTOLIC DIMENSION AT 
BASELINE cm
CONTROL AEROBIC POWER
NORMAL 3.23 3.8 3.74
HYPOKINETIC 3.83 3,87 3.89
PARADOXICAL 3.73 3.89 3.86
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SECTION XV
GENERAL DISCUSSION
The work of this thesis shows that power (strength) exercise training can 
be carried out safely in post-CAS patients with an improvement in exercise 
performance. It confirms that aerobic exercise training confers early benefit 
in exercise performance. A favourable haemostatic profile results from 
exercise training with a reduction in fibrinogen levels in the aerobic-trained 
group and a slight fall in factor VII levels in the power-trained group. In these 
patients, neither mode of exercise training caused clinically important changes 
in lipid levels, or myocardial function in terms of ischaemia, ventricular 
arrhythmias, perfusion, contraction or mass. The improvement in exercise 
performance would translate into a better ability to cope with daily physical 
activities. The reduction in fibrinogen levels would reduce subsequent cardiac 
events and improve the patients’ prognosis. Power exercise training should be 
a useful addition to the traditional aerobic programmes used in cardiac 
rehabilitation. In post-sternotomy patients it may be wise to defer exercise 
training until wound healing is complete.
There is a small risk of cardiac events during physical activity (Winslow 
1987; Thompson 1988). There were no deaths or cardiac arrests during the 
training sessions. No heart rate or other cardiovascular monitoring was done. 
The patients symptoms were used as a guide for their rate of training. A 
training effect was achieved with a lower minimum and mean heart rate with 
increased exercise ability after training. The routine performance of 
cardiovascular monitoring in exercise classes is doubtful.
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The patients assigned to exercise training attended most of the sessions, 
though as in any study, compliance was not absolute (Radtke 1989). The use 
of specialised gymnasium equipment for power training would increase the 
financial cost of the programme should it be recommended for every cardiac 
rehabilitation centre. Conversely, no such cost would be incurred for the 
aerobic exercises which could be home-based. Similar benefit has been found 
in supervised and unsupervised exercise programmes (Stevens & Hanson 1984; 
Bethell & Mullee 1991), and in low and high intensity exercise (Goble et al 
1991; Worcester et al 1993).
The inclusion of patients with history of previous MI made the study 
sample representative of post CAS patients seen in clinical practice. Many 
candidates for CAS come from the post-MI population, and this is likely to 
increase in the era of thrombolysis. It may be suggested that these post MI 
patients make the group less homogeneous in terms of viable cardiac muscle 
susceptible to influence by exercise training. It is known though that even 
infarcted myocardium has some residual viability (Liu et al 1985; Schelbert 
1988). In that regard, the investigations to use in future studies may be more 
sophisticated tests of myocardial perfusion and function such as thallium re­
injection studies (Dilsizian et al 1990; Rocco et al 1991; Dilsizian et al 1991), 
quantitative thallium single photon emission computed tomography (SPECT) 
(Strauss & Boucher 1986; Kiat et al 1988; Maddahi et al 1989; Mahmarian et 
al 1990), positron emission tomography (Bonow et al 1991), exercise and 
dobutamine echocardiography (Crouse et al 1992).
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Improved myocardial perfusion is less likely to be observed after 
exercise training post CAS than it is after MI (Foster 1986). Coronary 
angiography and graft studies would have provided the anatomical detail on 
coronary perfusion. It is pertinent to the question of graft occlusion and the 
effects that exercise training might have on its occurrence. Of particular 
relevance to this study is the possible effect on graft patency of the lowering 
of fibrinogen levels after aerobic exercise training. Future studies could be 
directed at that aspect. There was no clear effect on myocardial perfusion 
using thallium scanning, except in a small subgroup with previous anterior 
infarction. Anatomical information might have been of interest in this 
subgroup.
Cardiopulmonary exercise testing would have increased the objectivity 
of the treadmill exercise tests. It is useful to measure the anaerobic threshold 
directly (Coplan et al 1986; Ades & Grunvald 1990; Blumenthal et al 1991). 
However the inclusion of a control group does compensate to a large extent 
because it enables us to exclude habituation as a factor in the marked increase 
in treadmill time achieved by the trained groups. Motivation is a confounding 
factor which is difficult to control for and indeed to measure. It is however 
common to all studies which involve active cooperation from the subjects.
This study was about effects, not mechanisms. Future studies could try 
to discover the mechanisms underlying the effects of strength as well as aerobic 
exercise training. So far, such studies have been in aerobic exercise training. 
They have yielded varying results as to whether these effects are of peripheral 
origin, confined to changes in skeletal muscle and arteriovenous oxygen
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difference, or of central origin with improvements in cardiac performance 
(Froelicher 1987a).
The widespread use of the internal mammary artery graft has added 
survival benefits for the post-CAS patient. To show an increase in this good 
prognosis due to exercise training would take very large numbers of patients 
and prolonged follow-up. A study of that nature is unlikely to be done. In 
post-MI patients the prognosis has improved steadily and especially with 
thrombolysis. Those who survive to undergo exercise rehabilitation are likely 
to do well. I believe that the question about the prognostic benefit of exercise 
rehabilitation is not likely to be taken any further. We are left with pooled 
results from various studies of post-MI exercise training from which to draw 
conclusions - in that situation, prognosis is improved with 20% reduction in all­
cause mortality operating over three years and 25% reduction in reinfarction 
rate (O’Connor et al 1989).
It may have been useful to include psychosocial measurements in the 
assessment of these patients. Factors such as mental state, general well-being, 
quality of life, and work status were not included because I think that these 
factors are susceptible to influences such as socioeconomic climate, that can not 
be controlled.
From other observations that I made during the study, it was clear to me 
that exercise rehabilitation need not be universally applied. In simple terms, 
the majority enjoyed the workout, camaraderie and contact with staff, but two 
patients were vaguely uncomfortable with it and may not have derived as much 
general benefit from the programme as was possible.
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Prediction of outcome in exercise rehabilitation is another vexed question 
(Myers & Froelicher 1990). Studies by van Dixhoorn et al (1989, 1990) 
suggest that psychosocial factors can influence the outcome of cardiac 
rehabilitation. The present study did not examine any such factors. It may be 
particularly interesting to assess psychological changes after CAS and the 
effects that exercise training could have on them.
Linear regression analysis showed a negative correlation between 
baseline exercise performance and interval change in treadmill time in the 
exercise trained groups (figures 20 to 22). For the aerobic group, r  = - 0.42, 
p — 0.03; for the power group, r  = - 0.39, p =  0.05; there was no correlation 
between the two variables in the control group. This suggests that those with 
low baseline exercise performance tend to derive more benefit from exercise 
training than those with high baseline exercise performance. There was a 
positive correlation between baseline treadmill time (MTTl) and six month 
treadmill time (MTT3) in all the groups (figures 23 to 25). This correlation 
was strongest in the control group in whom there was no correlation between 
baseline treadmill time and interval change in treadmill time (r — 0.87, p < 
0.00001). In the aerobic group, r =  0.65, p =  0.0003; in the power group, 
r  =  0.77, p < 0.00001. After exercise training, those with a low baseline 
exercise performance improved more than those with high baseline 
performance. In this group, the degree of benefit could be predicted from the 
intercept and slope of the appropriate graph. The results could perhaps be 
extrapolated to similar patients using the same training programmes.
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Treadmill exercise may not be a fair means of testing the effects of 
power training. The delay in the appearance of significant improvement in 
treadmill time could be a reflection of this. Future studies could examine the 
patients by standardised power exercise tests such as the one repetition 
maximum test using arm and leg muscles. This would assess any changes in 
muscle strength and may be done in addition to the treadmill test to determine 
if there is any difference in the two methods of testing in assessing the effects 
of aerobic and power exercise training. A further refinement could be the 
determination of the effects of such training on peripheral muscle structure and 
function involving blood flow patterns, muscle metabolism and biopsy. To date 
such studies have been done in small groups of patients with heart failure and 
after aerobic training (Sullivan et al 1988).
So far, investigators have concentrated on the effects of different 
strategies on systolic dysfunction in CAD. There is increasing evidence for the 
importance of diastolic dysfunction in CAD. Diastolic function can be assessed 
noninvasively by Doppler echocardiography (Channer et al 1986). It would be 
interesting to assess whether exercise training affects diastolic function, by 
Doppler studies of mitral inflow. The ratio of peak early diastolic velocity (E) 
to peak late diastolic velocity (A) or E/A ratio provides information about left 
ventricular relaxation. This could readily be followed up in a controlled study 
on exercise rehabilitation. At the time of this study, the necessary tools for 
investigating diastolic function were not available to the author.
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Cardiac rehabilitation is being expanded now to include patients with the 
whole spectrum of cardiac disease i.e. angina, post-MI, post-CAS and other 
cardiac surgery, post-PTCA and heart failure (Conn et al 1982; Coats et al 
1990; P.RE.COR group 1991; Todd et al 1992; Pashkow 1993), and the elderly 
(Elkowitz & Elkowitz 1986; Ades & Grunvald 1990; Blumenthal et al 1991). 
There should be no doubt about its usefulness which has been questioned by 
some authors (Gleichmann 1987; Tunstall Pedoe 1990; Lipkin 1991; Chua & 
Lipkin 1993), and its role should be expanding.
Cardiac rehabilitation can be recommended strongly after coronary artery 
surgery. It would confer added clinical benefits, allow the patients to improve 
their functional capacity and favourably influence aspects of their 
cardiovascular risk factor profile.
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LIST OF ABBREVIATIONS
ACE: angiotensin converting enzyme
ANOVA: analysis of variance
CABG: coronafy artery bypass grafting
CAD: coronary artery disease
CAS: coronary artery surgery
CASS: Coronary Artery Surgery Study
CV: cardiovascular
ECG: electrocardiograph
HDL: high density lipoprotein
IMA: internal mammary artery
LAD: left anterior descending
LAO: left anterior oblique
LDL: low density lipoprotein
LV: left ventricle
MI: myocardial infarction
VLDL: very low density lipoprotein
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CERTIFICATE 
FOR THE
ADMINISTRATION OF RADIOACTIVE MEDICINAL PRODUCTS 
Certificate Reference Number RPC 232- 2 ( 8 }
The Health Ministers within the meaning of the Medicines Act 1968 hereby certify that for the purposes of section 60 of that Act and of regulation 2 of the Medicines (Administration of Radioactive Substances) Regulations 1978 ,
Norman Mackay Victoria Infirmary Glasgow G42 9TY
may administer for 2 years from the date of this certificate or for the duration of the project,whichever is the shorter, the radioactive medicinal products specified in the Schedule to this certificate for the purpose(s) there specified.
Signed by authority of the Health Ministers
Date 20/01/89
Health Services Division Department of Health
JTO N Mackay Victoria Infirmary Glasgow G42 9TY bate of Certificate 20/01/89
SCHEDULE TO CERTIFICATE NUMBER RPC 2 32- 2 ( 8) Sheet 1
* Nuc-Serial lide Chemical form Treatment or Investigation Purpose
43.a. l.vi 99mTc Tc04-
81.a. 1 201T1 T1+
Objective as Researchstated in applicati­on dated 14/11/88
Research
* as listed in Appendix I of the Notes for Guidance Unlisted Serial numbers are included for ease of identification by the ARSAC Secretariat
DHSS
Department of Health and Social Security 
Alexander Fleming House Elephant and Castle London SE1 6BY
SS366S 01-W7 8822 wt .
\U of lM^Ç.cUCu^ wX Yow rtftfinc*
CHaoj^ ^  (K  « a - i
Dear Q( lU,acVaM
THE MEDICINES (ADMINISTRATION OF'RADIOACTIVE SUBSTANCES) REGULATIONS 1978 
CERTIFICATE TO ADMINISTER RADIOACTIVE MEDICINAL PRODUCTS
With re ference  co your app l i ca t i o n  dated llj- N cv-e^wio-e^ R'?^! aa a l so  wri ting  on 
b e h a l f  o f  Health Minis ters  co enc l ose  c e r t i f i c a t e  number RPCQ.^Q— 2 - ^ 9  Y  
Which aut horises  you to administer the radioactive  medicinal products l i s t e d  in  
the Schedule to the c e r t i f i c a t e  for the purposes there s p e c i f i e d .  The normal 
p l a c e ( s )  o f  administrat ion of  the radioact ive  medicinal products and the usual  
l e v e l  o f  administered a c t i v i t y  for the purpose of  the c e r t i f i c a t e  are understood 
to  be those  s e t  out in your c e r t i f i c a t e  applicat ion  which forms the basis  of  th i s  
a u t h o r i s a t i o n .
A ut hor isa t io ns  for administrat ion of  d iagnost ic  and therapeut ic purposes are 
v a l i d  for  5 yea rs .  Those for research purposes are v a l id  for 2 years or for 
the duration  of  the research project  i f  th i s  i s  l e s s  than 2 years .
Every c l i n i c a l  research i n v e s t i g a t i o n  involving  the use o f  radi oact ive  medicinal  
products should be checked and approved by an e t h i c a l  committee as recommended 
in the report  is sued by the Royal Col lege  of  Physicians .  In a l l  in s t a n c e s , 
u l t im a te  approval for the project  as a whole w i l l  l i e  with the e t h i c a l  committee 
which should ensure that the applicant  holds  the necessary autho risat ion  and 
ta ke s  note o f  any comments made by the ARSAC.
I f  you wish to seek va r ia t io n  cr renewal of  your c e r t i f i c a t e  you should do so 
by making ap pl ic a t io n  in good time to the above address.
Tours s i n c e r e l y
R J MOORE
Enc
apo_ ::a- : : m - cp - : E "  -=c:uc’ 3
;vace jHcer '^eci:i*3s : f  =aci:a::iv#  Suc stares s ' =s5u la ;:c rs  :5"3” .SI.' 13"3 \o
refers  z e rc ls ::" ; Z 'is zlsase rsac zazs'ully :re  nocss 3wi:arcs 
;:s ''s :s rc s  "’-.'csr .rSu' :a :c : :_ la r_ / arcs II aro III
11. =Isase corclscs I" : , :e s c : l : c  : r  olack IrK arc sucmic as scon as :c s s : : l s  :c ere
lecarcrsrc  c*' - s a l e  arc Social Security, Ilv lslon  -61A, Poem h <xu**#
Elscrarc arc lascis , _:nccr SEI ta x
PART A ap»_:cant ( te lrç  ere 'u lly  rsglscered o rac tltlo re r  c lin ica lly  rs sc o rs ltls  ^cr acmlnistracicn 
of racicactlve nec lc lra l croduccs)
1.1 Surname . . .    1.2 Forenames ..  .Î^.QriR^R..............................................
1.3 Pest =osltlcn . . . .Q o .n s u l t a n t ,  P h j . ? i ç i ? n .....................
1.4 Date of apcointmenc .........................................
! s General medic ine /Nuc lear  medicine
1.6 Accress for corresccrcercs
Divis ion  of Medicine,
The V ic to r ia  In f i r m ary ,
Glasgow G42 9TY.
1.7 Name ana accrsss of emolcying aucnority/organisaticn
Grea te r  Glasgow Health Board,
Bath S t r e e t ,
GLASGOW Gl.
1.9 wedical/Cental qualifications and cates
MB.ChB 1959
MRCP Glas 1962
MRCP Edin 1963
MD 1973
FRCP Glas 1974
FRCP Edin 1975
1.9 Other q u a ilf ica tlc rs  relevant to acmlnistracicn of racloactive suescaress, -»itn cates.
l . i :  =:svi3us sxceri2''C“ arc ::3 ir;.-g  reiavar: to acm iristraticn of radioactive -ec io ira i orocucts.
,=•13356 o i.e  re ta i ls  i-c l-c i-g  rates, •'anes o ' i r s t i t^ t io r s  ard -at^re of „c:'< arc oroouctSo-^sP 
f t o i z r  - . - e  acclicant is 'a n il ia r  ' .
S t o b h i l l  General H o sp i t a l  1967 -  1972 -  Ted c e l l  and p l a t e l e t  
k i n e t i c s  using chromium. P l a t e l e t  s t u d i e s  suing Se lenomethionine .
The V i c t o r i a  In f i rmary  1979 -  
Procedures  covered in  c u r r e n t  c e r t i f i c a t e .
1.11 C e rtif ica tes  to aaninister radioactive medicinal products currently or o revicusl/ "eld ( i f  any) 
Date C ertifica te  reference nomoer
12. 3 .8 7  RPC 232-2 (7)
1 -ereoy acoly for a te r t i 'io a te  to administer the radioactive ^medicinal procucts lis ted  in =art 3 
of tn is  form for the ourocses there specified. I •'ave availaole to me for sucn adm inistra tion  
the supporting services indicated in Part C of the form.
Signature .........................................................................   = a « ................
-AST 3 ocrti.-n.ee
3- =£5E.ARCh 'see oaras 25 arc 2" of Notes 'o r %ioance)
3.1 Ir. resoect o ' each orooosec st^ov olease soeci'y :-
3.1.1 *"e -are arc accress o ' 0“e oremiaes <»rere :"e stwCy is :o oe ^ncertaKen
Th e _Vic t p r i a  _In f i rm a ry ....................................................................................
Lan g s id e , ........................................................
Glasgow.G42 9TY..................................................................................................
3.1.2 The rames arc o u a li 'io a tic rs  of other oarticioating  p rac titio re rs  ( i f  any)
Dr. N. MacKay MD FRCP 
Dr. D. Bal lan tyne  MD FRCP 
Dr. D. Wosornu MB MRCP
3.1.3 The oojects of the study (as in the suDmission to the Ethical Commit: 
A oocy of th is  suomission may oe attached.
See a t ta c h e d  shee t
E t h i c a l  Corr . i t t ee  approva l  g r an ted  9 .11 .8 8
e e ) ,
3.1.4 D etails of :aoionuclice(s) to oe administered*
Padio-
nuclice
Chemical
fortm
Pcute of 
adm inistration
=roocsed
activity
‘Ajmcer and 'reouency 
of administrations
Brief re ta ils  of other 
nuclioes to oe aomih- 
isterec  simultareously 
or seouertiallv
T1201
Tc99r.
Thal lous
Ch lor ide
Per techne
t a t e
( p r e  i n j ­
e c t i o n  of 
Amerscan)
IV
IV
80 MBq 2 s epa ra te d  by 6 nonths None
800 NBq :  se pa ra te d  by6 months
None -  On each oc 
of  99mTc w i l l  be 
a f t e r  a d m i n i s t r â t
oasion a d m i n i s t r a t i o n  
at l e a s t  2 weeks 
ion of 201 T1
•In the case of research involving neutron activation analysis appropriate re ta i ls  should oe entered 
- - - -  ) .. Oar*. 0 anr* » "“ 'ererce  made under 3 .1.a
3ûp- a zontiruec
3.1.5 le ta i l s  o a tia r ts  : :  :e st-ciec
Numcer Age range Sex Clinical Condition Estimate of effective dose ecuivalent per administration*
S ix ty 35-70 years male •After coronary 7mSv per a d m i n i s t r a t i o n  for
a r t e r y  bypass 99m-Tc l a b e l l e d  red c e l l sg r a f t i n g 25mSv per a d m i n i s t r a t i o n  for
201-Tc ■
►in mSv.calculated as in caraçracn ^3 of the Notes for Guidance
3.1.6 C etails of any normal control suDjects to Pe studied none
Namoer Age range Sex Any other relevant information
Estimate of effective dose 
ecuivalent per administration*
*in -nSv.calculated  as in caraçracn 43 of the Notes for Guidance
3 . 1 . 7  I f  pregnant «lomen cr -xirsing mothers are to ce studied give reasons and c e ta i.s  of specraz 
rad ia tion  protection measures to oe tawen.
Not a p p l i c a b l e
=4RT 3 ccrcihuec
3 . 1 . 3  y  i :  is  crccosea to a c r i- is te :  rare or -ru sta i sucstances :."e 'ollowing i.-for-ation 
is  recuestaa.
a. "he fcr-u la of the raciocharhaceuticai ana the s ite  of i t s  lace i.
0 . A summary of the ani.-al. exceryents.
0 . A description of the methoc _sed to estimate the human raciation  acscroeo rose 'rom
the animal oata.
d. A table showing the animal oata for each organ.
Not a p p l i c a b l e
3.1.9 I f  i t  is  proposed to expose patients or normal subjects to any macnine-oroduced rad ia tion , 
the following information is reouested:
a. The nature of the machine-produced ionising radiation;
0 . The Purpose of the exposure;
0 . "he numcer of exposures, or the length of exposure, as relevant;
d. An estimation of the to ta l effective dose equivalent.
Not a p p l i c a b l e
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PART AAC - - A c i . y i i i  s v a :L ;a L i  *c “- e  aî» . : ü .s :
1. In rescec: of e orsmises* sc e c i'lsd  in 3 of th is  fora as tme oiacs t e s t s . *_"eracy
or rssearon are xirmaily to oe oarries out please ; iv e : -
1 . 1  "he -ame of *-"e orsmises
The V i c t o r i a  In f i rm ary ,
Glasgow 042 9TY
1.2 D eta ils  of iv a ila c le  sc ie n t ia l:  suooort serv ices in d u c in g  as a c c r x r ia te : -
The ’'■iPe, r e s t  anc x a l i f io a t io n s  o f the senior s c ie n t is t  r e sco n s iile  'or 
sc o e n t if lc  services
Mr. M. B. D. Cooke BA, CPhys, M I n s t  P.
P r i n c i p a l  P h y s i c i s t
The cost anc x a l i ' l c a t io n s  of other s c ie n t if ic  s ta f f
The V i c t o r i a  Inf i rmary  -  P r in c ip a l  p h y s i c i s t ,  two medical,^ te c h n ic i a n s ,
MPT2 and MPT3.
Regional  Radionucl ide  Dispensary,  Western In f i r ma ry ,  Glasgow - Top grade
p h y s i c i s t  and o th e r  p h y s i c i s t s ,  p r i n c i p a l  pharma­
c i s t ,  f i v e  medical  physics  and pharmacy t e c h n i c i a n s .
"he f a c i l i t i e s  a v a ila c ie  for oosLmetry, storage anc stocx control, cisoe^s.ng, „a t.en t  
monitoring and eouicment ca libration .
Victoria -  Radiopharnaceuticals are received daily in single doee vials fron the regional radio­
nuclide dispensary (see below), therapeutic doses are not stored on the premises overnight. 
Radioisotope laboratory with clean bench area reserved for preparation of injections and blood 
Labelling, shielded fire  cupboard, lockable refrigeration. Ccntanination monitor, dose calibrator. 
Western -  Clean laboratory with t^^o  contained work stations. Radioisotope Laboratory with 
approved store. Radioisotope calibrators (4) and calibration sources, contamination monitors (4). 
Ivell counter and radiochrcnatogram scanner. Packaging equipment. Remote store for radiocative 
\as te . Procedures and record keeping approved by Radiological Protection Adviser and Medicines 
Inspector.
•w^ere more than one premises is  involved g leese  give the ih forration  in resoect cf each, 
using a c c lt io n a i sneets as necessary.
: : p r e c
1 . 3  *>e najcr items of ecLiomer: availaole (arc their rates of naixfactute) 'o r  oirr/L-g out
the srccequres lis te o  in the aooUcatian
One Technicare  Sigma 410 Gamma Camera, Apri l  1978 
ADAC/CGR 7310 Computer March 1981
One LKB 1280 "Ultragamma" au toma t ic  counter  with p r i n t e r ,  October 1976
1.4 "he ana o f 'lo ia i  accress of the Aaciatian Protection acviser
Mr. J .  Kennedy
West of  Scotland Health Boards
Department of C l i n i c a l  Phys ics  and BioEngineering 
11 West Graham S t r e e t ,
Glasgow G4 9LF
1.3 The Paciation Protection icv iser shouic sign tele* to incicata tpat "e is sa tis f le c  
•it"! your irrangemencs or realimg with oontamihation acrioencs.
Sic -a tu re  .1 ..................................................................... Gate
1 . 9  Th.e -ame, oositlon arc o f 'lo ia i  accress of the oersan oomoietihg =art C (This ahtxûo oe 
the oerscn with overall re sc o rs ib iiity  for the sc ien tific  ascects of e -cry («rich hay 
or hay ,hot Oe the aoclioan tl).
Mr. M. B. D. Cooke 
P r i n c i p a l  P h y s i c i s t
Department of C l i n i c a l  Phys ics and Bio-Engineering 
V i c t o r i a  Inf i rmary  
Glasgow G42 9TY
..........................................  O at. A .................
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